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Thesis Abstract 
It is highly advantageous to be able to develop bioprocesses early on in the 
product design lifecycle, where strategic options and alternatives can be 
considered cheaply and effectively.  Resources are however often in very 
short supply at this point in the process, typically with very limited quantities 
of feedstock available and with minimal access to capital equipment.  As such 
there is significant advantage in being able to develop chromatographic 
processes at very small scales that will only require small quantities of 
feedstock and can utilise common laboratory equipment.    
If the height of the packed bed is not maintained during scale up then it 
becomes difficult to predict chromatographic behaviour and efficiency. This 
seriously limits how small a chromatography system can be and still be 
representative of how a process scale chromatographic separation will 
behave.  Ultra scale-down (USD) methodologies for chromatography take a 
different approach.  A small scale device, which may or may not have 
geometric similarity to the process scale equipment, generates data which 
when combined with a specific methodology and mathematical model allows 
the prediction of the large scale equivalent.   
The work in this thesis sought to develop a USD methodology and model to 
accurately predict large scale chromatographic behaviour using very small 
scale devices.   
The development of a model separation was required to act as a source of 
realistic experimental data for the development of a USD methodology.  This 
model separation required a suitable feedstock, a suitable USD device and a 
suitable sorbent on which to perform the separation.   
It was found that the most suitable feedstock of those tested was a FAb 
fragment containing periplasmic lysate produced in E. coli,  due to the ease of 
pre-chromatographic processing and industrial relevance.  Several designs of 
very small column were investigated and it was found that PRC pre-packed 
columns (Pall Life Sciences) had superior separation characteristics and were 
therefore selected as the USD device of choice.  This was combined to 
produce a viable separation process using MEP HyperCel presented in the PRC 
pre-packed column format with FAb fragment containing periplasmic lysate as 
a feedstock.  A linear pH gradient produced a clearly resolved two peak 
system with excellent FAb fragment purity that was deemed very suitable as a 
reference separation for the USD methodology development. 
The premise of the USD methodology was the deconvolution of each relevant 
peak within an elution profile into its four curve coefficients, namely height, 
width at half height, skew and peak location.  These four curve coefficients 
for each peak in the small scale chromatogram could then be individually 
modelled using a transformation function into the large scale equivalents and 
then recreate a large scale chromatogram prediction from these values.  This 
was also used to predict how the chromatograms will change with respect to 
altering the packed bed height and linear velocity of the loading and elution 
steps.  The methodology that was developed was shown to be effective and 
was typically accurate to under 5% difference normalised root mean square 
when the predicted large scale chromatograms and real large scale data was 
compared.  
The methodology was further validated by testing with a range of different 
chromatographic systems and processes.  These included changing the 
feedstock by reducing the FAb fragment titre by 50%, changing the 
chromatographic ligand to PPA and also a multi-variate change that altered 
the ligand, the sorbent backbone and the feedstock all at once.  The 
transformation functions were found not to be generic and required system 
specific alterations.  However, the methodology itself was shown to be very 
effective across a wide range of chromatographic conditions and systems and 
as such would be a good basis for ultra-scale down development in elution 
chromatography. 
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Abbreviations 
BSA  Bovine Serum Albumin 
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1 Introduction 
1.1 Historical Perspective  
Chromatography (lit. “colour writing”) is a powerful chemical method for the 
separation of complex mixtures.  Although work had been done with paper 
chromatography in the 1800s the first real column chromatography was 
carried out by Mikhail Semanovich Tsewett in 1903 (Tsewett et al, 1906) to 
separate plant pigments and it was he that named the technique due to the 
separation of colours.  Over the next century various advances and new 
techniques were discovered and put to use in a range of industries and 
applications. 
Chromatography, in a variety of forms, has proved to be an exceptionally 
powerful technique for the separation of a range of chemical species.  In 
particular it has been developed extensively for bio-separation, particularly in 
the bio-pharmaceutical industry where purity is paramount.   
1.2  Chromatography Concepts 
Chromatography is an umbrella term for any technique that relies on the 
affinity of a sample, or its differential partition, for a stationary phase and a 
mobile phase.  The mobile phase is by definition moving and can either be a 
liquid or a gas while the stationary phase, sometimes called the sorbent, is 
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usually a porous solid or a liquid supported by a solid.  Columns or plates are 
used to support the stationary phase itself and to provide a conduit for the 
mobile phase.  The system varies depending on the type of chromatography 
employed, but generally the sample is applied or injected along with the 
mobile phase onto the stationary phase and moves along it.  The constituents 
of a sample will have a range of affinities for both the stationary phase and 
the mobile phase and this influences the relative mobility of the components, 
causing them to separate as they progress down the column or the plate.  
Components in the sample which either have a high affinity for the mobile 
phase or a very low affinity for the stationary phase will move very quickly 
along the column and will exit the column first, while those with low affinity 
for the mobile phase or high affinity for the solid phase will exit later, leading 
to separation. 
1.3 Industrial Relevance 
Initially chromatography systems were used almost exclusively for analytical 
purposes but the preparatory applications have developed greatly over the 
decades since its inception.  Engineering advances have allowed liquid and 
expanded-bed chromatography capital equipment to be scaled to hundreds of 
litres and still provide acceptable throughput, making chromatography an 
effective and cost-efficient method of purification. 
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This is particularly important within the biological pharmaceutical industries 
where often chromatography is the only way to purify the target molecule to 
regulatory standards; typical chemical separation techniques can involve 
harsh solvents, high temperatures and high pressures which will render labile 
biological products, particularly proteins with complex tertiary structures, 
inactive.  As such chromatographic unit operations are present in almost all 
biotechnological purification processes and are actually a requirement of some 
regulatory authorities. (Sofer et al, 1989). 
Analytical applications for chromatography should not be overlooked however.  
Biological pharmaceutical development and batch release for commercial 
supply requires a battery of analytical tests be conducted and 
chromatographic techniques have proven to be very powerful tools.  High 
Performance Liquid Chromatography (HPLC) in particular has proven to be a 
reproducible and sensitive quantitative analytical method for analysis of 
product and impurity profiles, commonly utilising ion-exchange, reverse-phase 
and gel filtration methods for this purpose.   
1.4 Types of Chromatography 
The principles of chromatography can be applied in many forms and utilising 
many chemical interactions to achieve the desired separations.   
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1.4.1 Surface chromatography 
1.4.1.1 Paper and Thin Layer chromatography 
Paper chromatography was the forerunner of modern packed bed 
chromatography and is very simple in principle.  The paper fibres act as the 
stationary phase and the flow of the mobile phase is accomplished by the 
diffusion of the sample and carrier solvent through the paper.  This technique 
is actually still used in some industries for the test purity of compounds due to 
the process being inexpensive and fast  (Sherma & Fried, 2003). 
In most analytical applications however thin-layer chromatography (TLC) is 
preferred.  A glass, metal or plastic plate is covered in a thin layer of a solid 
absorbent and the samples are spotted onto the plate.  Diffusion of the 
mobile phase up the plate carries and separates the samples which then can 
be visualised with UV light or a chemical visualising agent, such as molybdic 
acid for lipids.   This technique is still fast and inexpensive but offers 
improved resolution, though the sample is still essentially non-recoverable 
after this process, limiting its use to analytical applications (Sherma & Fried, 
2003). 
1.4.2 Column chromatography 
The final type of chromatography is column chromatography, an extensive 
field with many industrial and analytical applications and as such has many 
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different functions.  Column chromatography splits broadly into three types, 
gas chromatography, liquid chromatography and liquid-liquid (or counter-
current) chromatography. 
1.4.2.1 Gas chromatography 
Gas chromatography is used where the sample is in gaseous form and there 
are three types in existence.  Gas adsorption utilises a packed bed of solid 
absorbent within the column which the sample is pumped through, commonly 
used to separate gaseous mixtures (Grob & Barry, 2004).  In gas-liquid 
chromatography the solid part of the packed matrix is inert but it coated with 
an absorbent liquid, separating the gaseous analytes by order of volatility as 
affected by affinity for the stationary phase.  Both of the above applications 
uses columns of 2-4mm in diameter which means the column needs to be 
1.6-10m long under normal circumstances.  Capillary chromatography uses 
very fine columns (approx 0.2mm) and coats the stationary phase on the 
inside surface of the capillary. 
Detection is often done with thermal conductivity detectors or electron 
capture detectors, but other detection systems exist for particular analytes 
and applications.  
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1.4.2.2 Counter-current chromatography 
Counter-current chromatography, sometimes referred to as partition 
chromatography, exploits the partition coefficient between two immiscible 
liquids (Foucault et al, 2001).  There is no solid component in this form of 
chromatography so there is no irreversible adsorption (except for the column 
itself which is designed to be non-absorbing) so high product yields can 
theoretically be obtained.  Modern commercial instruments work on a coil 
planet centrifuge method to mix the phases and then partition them.  This 
technology is very much developing into the industry at the moment (Marston 
& Hostettmann, 2006). 
1.4.2.3 Liquid chromatography  
Liquid chromatography is where the sample, analyte or feedstock is in the 
liquid phase and the stationary phase is a solid sorbent or a gel supported by 
a solid sorbent.  The solid phases are often made of silica gel, cellulose or 
agarose materials. The bead can act as the separating material by its physical 
nature (as in gel filtration) or be coated with ligands for binding the materials 
of interest. There are many different types and applications of this sort of 
chromatography and is used extensively in industry as a preparative and 
analytical tool, particularly within the biotechnology industry. 
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1.4.2.3.1 High performance liquid chromatography  
High performance liquid chromatography (HPLC) uses a very narrow column 
and high pressures to reduce running time and diffusion within the column, 
increasing resolution and performance (Lillehoj & Malik, 1989). This system is 
very commonly utilised within the analytical chemistry/biochemistry fields as it 
gives excellent resolution with small samples volumes.  Use as a preparative 
technique has been limited so far due to the relatively small capacity and the 
use of volatile and often highly flammable solvents (in the case of the very 
common reverse-phase HPLC) making it dangerous, difficult and generally 
uneconomical to use on an industrial scale. 
1.4.2.3.2 Expanded bed chromatography  
Expanded bed chromatography uses a sorbent with a variety of bead sizes 
that are far denser than normal and that can be derivatised with a range of 
potential ligands.  Expanded bed columns are not packed but fluidised, and 
have an mobile adaptor that can be raised or lowered during operation 
(Anspach et al, 1999).  The up flow, used for primary capture, allows the 
beads to become buoyant and rise up the column thus expanding the bed and 
increasing the bed voidage.  This means very viscous feed materials, even an 
unclarified culture directly from a fermentation, can be run through the 
column and provide selective capture of proteins with negligible pressure 
drops.  When the loaded column is run in down flow the beads settle and it 
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acts more like a packed bed, suitable for concentration and elution (Chase et 
al, 1994; Fenneteau et al, 2003).         
1.4.2.3.3 Packed bed chromatography 
Packed bed techniques are the most common form of chromatography used 
within the biopharmaceutical industry.  In this form of liquid chromatography 
the stationary phase, usually in the form of beads between 20-100µm, is 
packed under pressure (either with liquid flow or mechanically) into the 
column to form a consistent and close matrix.  This method has the capability 
to scale up to industrially relevant volumes whilst still retaining, packing, 
ligand selection and operating conditions notwithstanding, good separation 
characteristics.   
1.5 Packed bed chromatography – Bioprocess 
applications and ligands 
The large variety of potential ligands that can be bound to a large variety of 
solid phases makes packed bed chromatography very versatile and this is why 
it is found so frequently within industry for both analytical and preparative 
sections of processes (Jungbauer et al, 2005).  A diagrammatical 
representation of a typical rig for packed bed chromatography is shown in 
Figure 1.1. 
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Figure 1.1:  A diagrammatical representation of a packed bed 
chromatography rig.  A: Buffer or feedstock, B: Pump, C: Column adaptor, D: 
Packed bed chromatography matrix, E: Frit, F: Column, G: UV detector. 
 
1.5.1 Stationary phase 
The stationary phase, or solid phase or matrix, within a chromatography 
system impacts heavily on the capabilities of a system.  This is obviously the 
case with gel filtration where the solid matrix, rather than a ligand, is key to 
the separation potential.  However, even within ligand based packed bed 
chromatography the stationary phase is important as the structure of the 
matrix, together with the geometries of the column and frit design, impact 
heavily upon the internal hydrodynamics and therefore separation efficiency 
of the chromatography system.   
UV
m
AU
A
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C
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G
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Ideally a stationary phase should be hydrophilic to allow wetting, chemically 
inert, be able to form macroporous structures and have good compressible 
strength so as to resist the pressures of packing and operation.  
Polysaccharides, such as cellulose and agarose, have proven to be good 
materials for chromatographic bead manufacture, but the compromise is a 
lack of compressible strength in their native form.  Advances in silica gel and 
ceramic designs have begun to address the compressibility problems 
(Kawahara et al, 1989; Cortes et al, 1987), as have evolutionary advances to 
the traditional polysaccharide media (O'Neil & Sellick, 2004). 
1.5.2 Stationary phase packing 
The packing of the matrix into the chromatography column, and from this the 
bed porosity and matrix structure, is critical to the separation effectiveness of 
packed bed chromatography.  Three forms of packing exist, gravity, flow and 
mechanical, and they are often used in combination on a single column.  
Gravity packing is where the matrix slurry is simply left to settle over a period 
of time within the column.  This method is not particularly effective as the 
bed height will reduce once a fluid flow is applied, but it can be appropriate 
for very small scale applications or with ceramic sorbents, which are heavy 
enough to settle reliably.  However, gravity packing is usually taken as a 
starting point for other packing methods (Guiochon et al, 1997). 
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Flow packing is where the bed is subjected to a steadily increasing fluid flow, 
typically using the equilibration and loading buffer of the chromatography 
process itself to prevent unforeseen pressure or compression issues during 
later operation and to ensure comparability.  Laboratory scale column packing 
almost solely utilises this method and is it commonly applied to pilot scale 
columns as well, although the high flow rates required can cause 
hydrodynamic flow issues with the large scale distributors (Yuan et al, 1999).  
Flow packing can be problematic with certain stationary phase materials 
however – cellulose sorbents are naturally elastic and as such require 1000 
cm/h linear velocities to pack effectively, a linear velocity many manufacturing 
chromatography skids are incapable of producing.  Ceramic hydrogel 
sorbents, such as the Ceramic HyperD range from Pall Life Sciences, have 
also been observed to swell under low ionic strength conditions, so the low 
ionic strength equilibration buffer for an ion-exchange ligand will create 
substantial pressure drops during packing.  Typically packing flow rates are 
over 25% more than the fastest expected operation flow rate and within 80-
90% of the critical velocity for bed compression.  Feeds are often far more 
viscous than loading buffers, leading to higher pressure drops, therefore a 
safety factor has to be implemented to prevent bed compression during 
normal operation.   
Mechanical packing is a technique where the bed is physically compressed 
using a mobile adaptor.  This is very common for pilot scale chromatography 
rigs and larger and may be the only method of producing acceptable packing 
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in very large chromatography columns.  The mechanical pack compresses the 
bed slowly under a slow flow rate to ensure even packing throughout the 
entire bed. 
Gases are a significant problem during the packing process, as bubbles will 
deform the matrix structure and cause channels within the packed bed that 
will increase apparent dispersion and peak band broadening.  For this reason 
all buffers are degassed before entry into a packed bed system; this is 
however rarely appropriate for feed streams as the air liquid interfaces would 
cause an unacceptable level of protein shear.   
The compressibility of the bead is a critical aspect of the packing regime, as is 
the stationary phase bead size.  Bed compression is defined by Equation 1.1, 
 
 
 
where L0 is the gravity settled bed height, L is the height of the bed and λ is 
the level of bed compression. 
Bed porosity with a packed bed is then defined from the level of bed 
compression, as shown in Equation 1.2,  
 
0
0
L L
L
−λ = (1.1) 
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0
1
ε − λ
ε =
− λ  
where ε0 is gravity settled bed porosity, λ is the level of bed compression and 
ε is the compressed bed porosity. 
Packing quality is typically ascertained by an acetone pulse analysis and HETP 
calculation, as detailed in section 1.6.1.   
1.5.3 Elution 
The elution of proteins from a chromatography column is commonly achieved 
by modification of the mobile phase.  This can work by modifying an aspect of 
the bound protein, an aspect of the stationary phase or by the introduction of 
a competing species which displaces the proteins of interest.  There are two 
methods of elution commonly used. 
Step elution is performed by rapidly changing the conditions to two or three 
set levels, eluting the proteins off in blocks.  This method allows efficient, low 
volume capture at the expense of resolution. 
Gradient elution is performed  by altering the elution buffer concentration as 
a steadily increasing proportion of the mobile phase.  This provides much 
higher resolution and separation of the proteins in the feed, but results in a 
higher process volume and less capacity.   
(1.2) 
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A combination of the above elution methods is often used within a single 
bioprocess – step elution is applicable for primary capture where yield is the 
over-riding priority, with gradient elution being utilised for the purity driven 
polishing steps. 
1.5.4 Negative Chromatography 
Sometimes referred to as “contaminant capture” chromatography, this 
technique is utilised when it is more effective to bind the impurities in a feed 
stream rather than bind the target molecule itself, with the target molecule 
appearing in the flow through (Levison et al, 2003).  This is commonly 
employed to remove particularly hazardous contaminants late in the 
purification process, for example endotoxins, or to remove undesirable nucleic 
material. 
1.5.5 Ion exchange chromatography  
Ion exchange chromatography is the most commonly used within industry 
due to its high capacity and good selectivity, as well as domestically in water 
filters and wastewater treatment.  It is also relatively inexpensive, at least 
compared to affinity sorbents such as Protein A (Lillehoj & Malik, 1989). 
Nearly every protein has charged groups on its surface, due to the acidic and 
basic amino acids within its structure.  Highly polar groups also contribute a 
small amount of charge, and cumulatively this produces a protein’s net 
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charge.  Each protein has a certain pH, its isoelectric point (pI), where it has 
no net charge, but these conditions are often avoided in protein preparation 
due to the increased likelihood of aggregation when electrostatic repulsion is 
removed.  The polarity and magnitude of a charge found on a particular 
protein can be manipulated by modifying the pH and ionic strength 
conditions, although other factors such as the state of the protein’s tertiary or 
quaternary structure and the relative location of the highly charged amino 
acids throughout the protein structure can also contribute.  The differences in 
these net charges can be exploited for separation purposes by using charged 
ligands.  
There are two types of ion-exchange ligand, cationic (binds positive charges) 
and anionic (binds negative charges) and these are categorised further into 
strong and weak charges, which is not a reference to the strength of binding.  
Strong ion-exchange resins work across a large range of pH and ionic 
strength values and often have a capacity independent of the buffer pH.  On 
the other hand weak ion-exchange resins are dependent on pH conditions for 
the capacity they demonstrate and this range tends to be narrow.  Examples 
of commonly used ligands are summarised in Table 1.1. 
Proteins can be eluted from an ion-exchange matrix either by changing the 
pH, thus modifying the net charge, or by increasing the ionic strength of the 
buffer which introduces a competing ion to displace the protein from the 
matrix.  
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Ligand Classification 
Carboxymethyl (CM) Weak cation 
Sulphonic acid (S) Strong cation 
Diethylaminoethyl (DEAE) Weak anion 
Quarternary ammonium (Q) Strong anion 
Table 1.1 – Examples of strong and weak ion-exchange ligands commonly 
used in chromatographic applications 
Ion-exchange systems have been proved sometimes to be unstable and can 
lead to different elution volumes found with small changes in ionic strength 
and pH.  It has also been found that the pI of a protein does not necessarily 
dictate how it will interact with an ion-exchanger of a particular type and the 
resulting chromatographic behaviour can be unpredictable (Yamamoto et al, 
1999).  
Ion exchange is very common in industrial processes due to the low cost of 
the media and high binding capacities.  However, low ionic strength is 
required in the feed (typically under 3mS) for adequate binding, which is 
usually far lower than the liquor from a bioreactor – as such the feed will 
need to diafiltered or more commonly diluted to achieve this.  At larger scales 
this involves extremely large holding tanks and can make ion exchange 
processes infeasible.  
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1.5.6 Affinity Chromatography 
Affinity chromatography has the highest specificity of all the modes of 
operation currently used and the ligand is highly selective.  Adequate 
purification from a single affinity chromatography step is not unheard of, even 
in a primary capture capacity (Jungbauer et al, 2005). 
Affinity chromatography has several forms. Immobilised metal-ion affinity 
chromatography (IMAC) is a very common form of affinity chromatography, 
where the ligand on the solid phase consists of a 2+ ion, such as copper or 
nickel.  Proteins to be captured are modified using recombinant techniques to 
include a his-tag, a loop of at least six histidine residues on the N or C 
terminus of the protein, which binds selectively to the 2+ ion on the solid 
phase.  However, this has caused some problems within the 
biopharmaceutical industry as the regulatory authorities are concerned about 
the potential immunogenicity of his-tags for human therapeutics and would 
like to see it removed at least by the start of human trials, adding to the cost 
of the process.  This is however offset by the ligand itself being very cheap by 
chromatography standards (Hefti et al, 2003; Low et al, 2007).   
Affinity ligands can also be more sophisticated, for example protein A ligands 
which selectively bind immunoglobulins, or even using recombinant antibodies 
as a ligand; this has been further evolved by the use of cheaper synthetic 
equivalents of such protein ligands (Roque et al, 2005).  Affinity 
chromatography processes are designed to be highly selective, but are 
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extremely expensive and tend to have lower capacities than other ligands.  
The use of a protein affinity ligand also restricts the cleaning regimen, as 
most proteins become unstable under the alkaline conditions a CIP process 
will require.  The cost of purchasing enough media for a large production 
scale process can be extremely prohibitive but despite this affinity ligands, 
particularly Protein A and G, remain very popular for high cost separations 
involving antibodies. 
1.5.7 Hydrophobic interaction chromatography 
Hydrophobic interaction chromatography (HIC) works in an opposite fashion 
to ion-exchange chromatography, using hydrophobic ligands such as butyl or 
octyl (Roettger & Ladisch, 1989).  Most proteins have hydrophobic patches on 
their surface due to long chains of hydrophobic amino acids, such as 
tryptophan and phenylalanine, though these are far less common than the 
charged groups used in ion-exchange chromatography.  In this sense a 
protein could have a similar size and charge to another, making it difficult to 
separate with ion-exchange or gel filtration, but have enough hydrophobic 
differences to make resolution possible with HIC.   
A high lyophilic salt concentration is used to get proteins to bind to the matrix 
and elution is performed by a reduction in the ionic strength of the mobile 
phase.  High salt concentrations can be difficult to use in practice as many 
proteins will either precipitate or denature under such conditions, and binding 
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to the ligands itself can also encourage denaturation (Ingraham et al, 1985).  
Logistical issues of disposal of large amounts of environmentally unfriendly 
salt can also be a factor, especially at larger scales. 
1.5.8 Hydrophobic charge induction chromatography  
Hydrophobic charge induction chromatography (HCIC) is a newer ligand 
system was designed to overcome some of the shortcomings of the HIC 
system whilst retaining selectivity based on hydrophobicity.  The most 
common ligand for this mode of chromatography is 4-Mercapto-Ethyl-Pyridine 
(MEP), which is selected  because the pyridine ring is hydrophobic at 
physiological pH, allowing hydrophobic patches to bind (Burton & Harding, 
1998).  Elution is performed by lowering the pH, at which point the pyridine 
ring becomes positive and repels the protein, leading to desorption.  The 
advantage is hydrophobic binding is accomplished under low salt 
concentrations and at physiological pH, which stops protein aggregation and 
denaturation.  This ligand is often used for IgG capture and purification, as 
the MEP ligand has a pseudo-affinity for this class of molecules (Schwartz et 
al, 2001). 
As low levels of salt are required and elution is obtained by pH manipulation, 
HCIC chromatography is economical to scale up to process scales. 
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1.5.9 Reverse phase chromatography 
Reverse phase chromatography (RPC) is similar to HIC in ligand selection, 
except organic solvents are used to elute the proteins.  The use of organic 
solvents has limited its use for preparative processes within industry, due to 
contamination issues with therapeutics and safety issues with solvents that 
are both volatile and highly flammable (Lindsay & Barnes, 1992).  However, 
many HPLC systems use this method and it gives excellent separation, 
making RPC a good choice for analytical applications. 
1.5.10 Gel filtration 
Gel filtration, or size exclusion chromatography (SEC), is a very commonly 
used mode of chromatography within industry for both smaller scale 
preparative and analytical applications.  Unlike the other matrices found in 
packed bed chromatography gel filtration matrices have no ligands, as it is 
the structure and composition of the bead itself that produces the separation 
characteristics.   
The solid phase is similar to the sorbent backbone used in most other packed 
bed chromatography materials, but the pore size has strict tolerances.  
Proteins larger than the pore size, taking stearic hindrances into account, will 
flow almost unimpeded through the column, and come out in the void volume 
(although in practice some stationary phase/protein interaction will have an 
effect on elution).  Smaller proteins have restricted mobility as they penetrate 
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the pores and therefore elute later, producing a separation based on the 
relative size of the protein. Conformation is however important, as globular 
proteins will have a different mobility to relatively unfolded proteins  (Mori & 
Barth, 1999).  The quality of the column packing is absolutely critical to size-
exclusion chromatography performance, as the separation effectiveness is 
defined by the bead structure within the column.   
This form of chromatography tends to produce excellent resolution compared 
to other elution chromatography methods, particularly in the case of 
aggregates or conformation changes where there may not be distinct charge 
or hydrophobicity differences.  However, as elution cannot be controlled by 
the elution buffer concentration all protein components will elute within a 
single column volume, limiting resolution of highly complex mixtures and 
significantly restricting available capacity.   This method is therefore 
practically restricted to small scale preparatory applications (such as final 
polishing steps) and, particularly when combined with HPLC, to analytical 
applications.   
Size-exclusion chromatography also has uses for buffer exchange and 
desalting applications, as the separation is buffer independent (Chen et al, 
1992).  
24 
 
1.5.11 Chromatographic Sequence Selection 
A downstream process for a biological product will typically require at least 
two chromatography steps as part of the purification regime.  The sequence 
of these steps, and indeed the chromatography methods that are selected, 
are of critical importance to the final yield, purity and ultimately the 
economics of the entire process. 
Assuming a two step chromatography process, the steps will fall into two 
categories.  The first step will be primary capture.  In primary capture yield is 
the most important requirement, as a complex feed liquor will lead to a great 
deal of non-specific binding to a chromatography matrix and as such high 
purities values are unlikely.  This chromatography step will also be key in 
increasing product concentration in the feed and reducing the liquor volume.   
The second chromatography step will have purity as the most vital feature, as 
this “polishing” step will be critical in ascertaining final product purity. 
The actual chromatographic mechanism used at each stage is highly 
dependent on the feed and target molecule properties.  However, high 
capacity methods, such as ion-exchange, are typically deployed in a primary 
capture step as the binding capacity is so high, which reduces the quantity of 
matrix and scale of chromatographic capital equipment required.  It is also 
important to take the eluent conditions into account – the eluent of an ion-
exchange step that is eluted with salt will have a very high ionic strength and 
25 
 
as such will be unsuitable for further ion exchange without diafiltration.  
However, this eluent would be highly suitable for HIC, as the high salt 
conditions promote binding to such a ligand.   
1.6 Chromatography Operation and Performance 
Ultimately chromatography processes are judged on yield and 
separation/purity efficiency for the target molecule.  However, 
chromatography is a complex process so a number of system parameters 
have to be investigated to fully evaluate performance, using a variety of 
models and techniques.  These system parameters should fully describe 
chromatography performance under specific sets of conditions and are 
important for comparison of sorbents and conditions in relation to a particular 
process.  This is typically measured by analysis of the elution profile. 
1.6.1 Theoretical plates 
Theoretical plates are used to define the separation efficiency for a single 
species within a chromatography column.  The concept of the theoretical 
plate was taken from distillation columns where the column was divided into a 
number of sections or plates.  This is analogous to a packed bed (which has 
no physical plates, so are theoretical) where the equilibrium is the partition of 
the solute between the sorbent surface and mobile solvent.  The more plates 
within the column the higher the efficiency and the greater level of separation 
26 
 
that will be achieved.  This is usually tested in practice by injecting a pulse of 
a non-retained tracer molecule (such as acetone or blue dextran) into the 
column and analysing the peak characteristics.  The number of theoretical 
plates is defined by Equation 1.3, 
 
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where N is the number of plates, tR is the peak distance from the injection 
point and Wh is the peak width at half peak height. 
The number of theoretical plates within a column is defined by the length of 
the column, which leads to the less system specific height equivalent to one 
theoretical plate (HETP).  HETP is calculated by dividing the length of the 
column by the number of plates and is expressed as a height of a single plate 
within the column, which is limited to being greater than the bead diameter.  
It is generally accepted that for acceptable packing and column efficiency the 
HETP should be less than four times the diameter of the sorbent bead. 
The use of theoretical plates to predict chromatographic performance is only 
really useful as a reference however and the equation is empirical in nature.  
A number of assumptions also have to be made whilst using the HETP 
method to judge the standards of packing and separation capability.  It is 
assumed that the diffusion coefficient for the marker pulse used will be 
identical to the components of interest during normal chromatography 
(1.3) 
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operation and this is, in practice, unlikely.  It is also assumed that there is no 
time factor for approaching equilibrium with a theoretical plate, which is also 
unlikely for large proteins and molecules.   
Unusual chromatographic conditions, such as electrically driven flows for 
HPLC (Grimes et al, 2002) or rectangular “columns” (Golay et al, 1981) 
significantly impairs the accuracy of Equation 1.3 as a method of determining 
plate height and as such new expressions have been derived for these cases.  
The equation for calculation of theoretical plates above is useful however as 
the values for equation 1.3 are easily acquired from a chromatogram, unlike 
the more accurate equations that are based on first principles and require 
parameters that are difficult to analyse and obtain.   
1.6.2 Van Deemter Equation 
Rate theory accounts for dispersion processes within a column that lead to 
peak broadening on the chromatogram.  Rate theory in this case is taken 
from gas chromatography and has been applied to liquid chromatography.  A 
number of equations have been derived for the calculation of dispersion and 
plate number, such as the Huber equation (Tallarek et al, 1996) and Knox 
equation (Berthod et al, 1989), but the 50 year old Van Deemter derived 
equation has been shown, in the absence of experimental artefacts, to be still 
the most accurate of the dispersion equations for the majority of processes 
(van Deemter et al, 1956; Usher et al, 2008).  Three factors were identified to 
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be critical to column efficiency; diffusion along the column, mass transfer 
resistance (such as gel layers on the beads and diffusion within the beads) 
and disturbances in the flow (wall effects and “path effects”).  If these three 
factors are known then plate height can be calculated.  The simplified Van 
Deemter equation is expressed in Equation 1.4,  
 
where H is plate height, A is eddy diffusion, B is longitudal diffusion, u is the 
linear velocity and C is the value for the mass transfer kinetics. 
The Van Deemter equation is particularly useful for calculating optimal linear 
flow velocities and is used to this end during process development. 
1.6.3 The General Rate Model 
The general rate model utilises a series of partial differential mass balance 
equations to describe chromatography processes and is considered one of the 
most complex models to be used (Felinger & Guiochon, 2004).  The model 
can be broken down into four sections; the behaviour of the analyte within 
the bulk mobile phase in the interstitial space, the mass transfer onto the 
external surface of the stationary phase, the diffusion into the pores of the 
bead and finally the absorption onto the surface/ligand within the bead itself.   
B
H A Cu
u
= + + (1.4) 
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The mass flux of the analyte within the bulk mobile phase is described in 
Equation 1.5,  
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where C is the concentration of the analyte in the mobile phase, uh is the 
interstitial velocity of the mobile phase, rp is the average radius of the 
stationary phase particles and DL is the axial dispersion coefficient. F in 
Equation 1.5 is defined in Equation 1.6, 
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where ε is the external porosity.  N0 in Equation 1.5 defines the mass transfer 
of the analyte to the surface of the sorbent bead and is defined in Equation 
1.7, 
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where Cp is the concentration of the analyte within the pores, kf is the 
external mass transfer coefficient, rp is the particle radius, r is the radial 
distance within the particle and Dp is the pore diffusivity coefficient.  In this 
case the particles are assumed to be spherical and modifications must be 
(1.5) 
(1.6) 
(1.7) 
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made for other stationary phase structures, for example utilising a cylindrical 
geometry instead of spherical to model the pores within monolith columns.    
The diffusion of the analyte within the pores of the bead itself is defined by 
the mass balance in Equation 1.8,  
2
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where εp is the internal porosity of the stationary phase and Np is the mass 
flux of the analyte from the interior of the mesopore to the surface of the 
bead.  Np is further defined in Equation 1.9, 
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where q is concentration of the analyte that has been adsorbed on the 
stationary phase, ka the adsorption rate constant and Ka the equilibrium 
constant for adsorption.   
The general rate model accurately describes the mass transfer and adsorption 
properties which underpin the effectiveness and performance of packed bed 
chromatography.  The disadvantages of this model lie mainly within its 
complexity and reliance on coefficient values that can be very difficult to 
obtain experimentally, especially in multi-component binding systems where 
(1.8) 
(1.9) 
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the potential for multiple species to bind to the stationary phase need to be 
considered. 
1.6.4 Yield determination 
The relative protein yield of a process can be analysed in a multitude of ways, 
at least off-line from the chromatography equipment itself.  The assays that 
are available are highly dependent on the material to be analysed and each 
assay will have a sensitivity and lower limit of quantification (LLOQ), which 
can be highly restrictive for small scale applications.    
Typical off-line assays for determination of protein content include the Lowry, 
Bradford and BCA assays, but all have the limitation of requiring a standard 
curve derived from the assay of a highly purified protein, in contrast to the 
potentially complex mixture that is a chromatography eluent. UV spectrometry 
at 280nm can also provide an approximate gauge of how much protein is 
within a fraction, but without detailed knowledge of the extinction coefficients 
of the polypeptides within the sample this method will be inexact.   
Specific protein concentrations can also be obtained  by a great many 
methods, but the methods employed are highly dependent on the target 
protein of interest.  Enzyme-linked immunosorbent assays (ELISA) can give 
rapid and extremely sensitive results but require an antibody that binds to the 
protein of interest and a suitable antibody-enzyme conjugate as a detection 
system; this also applies to Western blots, where proteins separated by 
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electrophoresis are transferred to a membrane and treated with antibodies to 
identify bands (Baines et al, 2001).  If the target protein has a biological 
activity then this can also be utilised in an assay and is particularly common 
for the analysis of enzymes; this is also true if the target protein has an 
associated metal ion, in which case spectroscopic techniques could be 
appropriate.  Affinity HPLC has also proven to be a very effective and 
reproducible method for protein quantification, particularly for 
immunoglobulins where commercial affinity ligands in small scale 
presentations (Protein A, G and L) are readily available.   
Although time-consuming and with necessary capital outlays, mass 
spectrometry methods are also highly effective at determining protein 
concentrations.  This is particularly true for surface-enhanced laser 
desorption/ionisation (SELDI) methods which were designed for analysis of 
protein mixtures (Issaq et al, 2002).   
On-line analytical methods are required to monitor the chromatographic 
process and generally consist of a UV spectrometry flow cell located at the 
terminus of the column.  Typically these UV cells operate at a wavelength of 
280nm, since aromatic amino acids absorb at this wavelength, although the 
200nm wavelength will also detect the peptide backbone of the protein.  In 
the case of primary capture and for complex mixtures 260nm is also analysed, 
as this will detect nucleic acid contamination.   
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1.6.5 Purity determination 
The ease of determining purity is again highly dependent on the protein of 
interest and its intrinsic attributes.  There are however several conventional 
methods that are applicable to all classes of proteins. 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is an 
very popular technique for analysis of complex protein mixtures, separating 
the proteins with respect to molecular weight (under reducing conditions) or 
with respect to molecular weight and conformation (under non-reducing 
conditions).  Visualisation of the proteins is usually accomplished by staining, 
either with Coomassie blue or by silver staining.  Closely related species in 
molecular weight can be difficult to visualise but with the right densitometry 
equipment it is possible to acquire a semi-quantitative concentration and 
purity for a selected protein (Goetz et al, 2004). 
A range of other analytical techniques are also commonly employed to 
ascertain purity, such as SEC HPLC, affinity HPLC, isoelectric focussing and 
mass spectrometry. 
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1.7 Scale up and Down of Chromatography 
Processes 
1.7.1 Scaling up from laboratory to manufacturing scale 
There are a number of occasions during manufacturing development where a 
chromatography process will need to be scaled up.  This is generally due to 
transfer from the research and development processes to a pilot scale 
equivalent or to a new facility, or in cases where the entire production 
process is scaled up to provide more material for later phases of clinical trials 
or for additional commercial supply.   
However, scale up of chromatography unit operations present significant 
challenges.  Much of chromatographic performance is dictated by particular 
hydrodynamic phenomena and the influence of each phenomena can change, 
sometimes quite drastically, at different scales.  Unfortunately current 
understanding of these phenomena is still partial and the complexity and 
large number of variables makes predicting chromatographic behaviour at 
different scales difficult to model by conventional methods.  This provided the 
motivation for this EngD study. 
Conventionally scaling is done empirically and rarely in a single step, with ten-
fold increases in interior column volume at each stage being typical from 
laboratory to manufacturing facility.  This is expensive and requires large 
quantities of feedstock, which delays downstream process development until 
much later in the product development cycle. 
35 
 
1.7.2 Non-chromatographic scale up factors 
In considering scale-up it is not just the column and quantity of matrix that 
needs to be scaled up but also the associated pipe work, pumps and skids.  
This can create a very large discrepancy in the extra-column volume of pipe 
work and internal instrumentation that the process liquor will have to travel in 
order to reach and leave the column at different scales.  Moreover, the 
proportion of internal column volume compared to the extra-column volume 
in a small scale chromatography rig can be orders of magnitude different to 
those seen at manufacturing scales; the extra-column volumes can even be 
equal or larger than the internal column volume due to engineering limitations 
with the chromatography apparatus. As diffusion and dispersion effects are 
observed within this extra-column volume this can lead to non-comparable 
chromatographic behaviour.   
The materials of construction are also likely to be dissimilar between 
laboratory and manufacturing scale chromatography apparatus.  Laboratory 
scale chromatography columns and associated equipment are conventionally 
made of glass and various plastics.  Manufacturing scale equipment beyond a 
certain scale is produced in electro-polished stainless steel, including the pipe 
work.  Although these materials are selected for being inert, any interaction 
with solvents, feed liquor or the stationary phase will potentially have an 
effect on chromatographic effectiveness.   
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1.7.2.1 Extra-column band broadening 
In large columns extra-column peak broadening (or band broadening) is 
negligible, as the internal column volume far exceeds the extra-column 
volumes.  This is not the case for small columns however (Kaltenbrunner et 
al, 1997), as the small volumes are liable to contain dead spaces and require 
proportionally larger instrumentation volumes to be effective, particularly with 
micro-chromatographic systems (Beisler et al, 2003).   
The total band broadening is a combination of dispersion in the pipe work, 
dead volumes, instrumentation volumes and an electronic response (for 
detectors), as shown in Equation 1.10, 
 
where pw is dispersion from the pipe work, inst is the dispersion from the 
instrumentation, dead is the dispersion from the dead volume and er is the 
dispersion from the electric response 
Although this equation is used to determine extra-column derived dispersion, 
dead volumes also need to be taken into account within the column itself, in 
the event of poor packing or poor column/frit design.  In practice it is found 
that modern apparatus only has a very small instrumentation dead volume, 
electric response rates are too fast to be an issue and properly designed 
equipment for fluid flow will have minimal dead space, therefore only leaving 
2 2 2 2 2
ex pw inst dead erσ = σ + σ + τ + τ (1.10) 
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pipe work and hold up volume as a significant contributor to extra column 
dispersion.   
1.7.3 Chromatographic factors 
Scale up of the chromatographic system itself has a number of variables that 
need to be considered.  As with all scale up procedures, or indeed any 
experimental process, as many of the potential system parameters as possible 
need to be maintained as constant but it is recognised that some of the 
parameters will need to be modified to suit the larger scale design 
requirements.   
Parameters such as buffers and the chemical conditions of the separation and 
feed, together with the quantity of sample loaded per mass of matrix, should 
be maintained and there should be few reasons why these should change at 
larger scales.  This also applies to such parameters as relative gradient 
volumes and linear velocity/residence time, as these are critical for 
chromatographic performance and will make comparability of the two scales 
very challenging if not maintained.  The volumetric flow rate through the 
column will obviously increase substantially as the process is scaled up, but 
the residence time within the column should remain equivalent. 
The main parameter that will need to be changed to scale up a 
chromatographic process is the size of the column itself.  It has long been 
recognised that scaling up of chromatographic processes is facilitated if the 
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bed height is kept constant and extra intra-column volume is generated by an 
increase in column diameter (Sofer and Hagel, 1997).  These changes also 
have important economic considerations which are only applicable for 
commercial manufacture (Joseph et al, 2006). 
There are a number of major complicating factors associated with increasing 
the bed diameter.  In a conventional laboratory scale column the column 
walls provide structural support to the matrix inside, allowing higher linear 
velocities and the use of potentially more viscous feeds before critical 
pressure drop is observed, so a high linear velocity parameter may not be 
able to be preserved during scale up.  It also has been shown that the 
packing structure of the matrix is different within a certain range of the wall, 
the so-called wall effect (Shalliker et al, 2000) and this can influence 
dispersion within the column.   
The distributor design is also far more complex in a large scale column with a 
large diameter.  In laboratory scale columns the frit and distributor are not 
particularly complex, as its relatively easy to ensure an even flow across the 
whole axial cross-section of the column.  However, in large columns the fluid 
flow has to be distributed across a much large surface area and at high flow 
rates this can cause dead volumes and jetting effects.  The different designs 
for large scale distributors can potentially interact with process materials and 
affect sample injection (Broyles et al, 1999) so would therefore need to be 
monitored during scale up procedures.   
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1.8 Thesis Aims 
The aim of the work contained within this thesis was to produce an ultra 
scale-down methodology that allows accurate prediction of large scale 
chromatographic behaviour using data derived from ultra scale-down devices.    
There were several factors and constraints that directed this work: 
• All feedstocks utilised had to be industrially relevant and realistic, 
rather than the mixture of various purified proteins typically used in 
such studies. 
• As a number of highly effective high-throughput chromatography 
systems already exist, any methodology produced should favour the 
accuracy of the large scale chromatogram prediction over the speed of 
obtaining such data. 
• Any model separations used to develop the ultra-scale down 
methodology should industrially applicable and should be directed to a 
valuable and realistic target molecule.   
• The methodology to be developed should have an experimental 
premise and be based on apparent data, with minimal reliance on 
existing complex theoretical models.  In this way the methodology 
should “bridge” between purely experimental and experience derived 
process development and the mostly theoretical approaches.  
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• The methodology and model to be developed needs to be validated 
and tested for robustness by exposure to different separations utilising 
different ligands and sorbent backbones.   
1.9 Thesis Synopsis 
This thesis details the investigations that took place between October 2005 to 
September 2009 within the Biochemical Engineering Department of UCL and 
in collaboration with Pall Life Sciences.  
The results of this investigation are contained within 5 chapters as 
summarised in Figure1.2. 
1.9.1 Chapter 2 – Feedstock Selection 
This chapter details the investigation into various biological feedstocks 
considered as suitable candidates for use with a model chromatographic 
system 
1.9.2 Chapter 3 – Ultra Scale-Down Device Selection 
This chapter is concerned with the investigation into three different small 
scale (1mL internal volume) pre-packed chromatographic column designs, to 
identify the best candidate for use in the formulation of a ultra scale-down 
methodology. 
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1.9.3 Chapter 4 – Separation of FAb fragments by Mixed Mode 
 Chromatography 
The feedstock (FAb fragment containing periplasmic lysate from E. coli) and 
the ultra scale-down device (Pall Pre-Packed PRC columns) were selected in 
Chapter 2 and 3.  This chapter investigated the separation of a FAb fragments 
from the periplasmic lysate and the most suitable chromatographic conditions 
to take forward. 
1.9.4 Chapter 5 – Formulation of an Ultra Scale-Down 
 Methodology for Chromatography Scale Up 
This is the critical keystone chapter of the thesis.  The data obtained from the 
studies in Chapters 2-4 were incorporated into an experimental system that 
was utilised to develop a methodology and mathematical model, to allow the 
accurate prediction of large scale chromatographic behaviour using small 
scale data. 
1.9.5 Chapter 6 - Validation of Methodology and Model for the   
Ultra Scale-Down of Elution Chromatography 
This chapter consists of three separate validation studies.  These studies were 
applied the methodology and model developed in Chapter 5 to other 
experimental chromatographic systems. 
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1.9.6 Business Case 
This chapter addresses commercialisation potential and proposes routes for 
bringing the concepts investigated in this EngD to market. 
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2 Feedstock Selection 
2.1 Abstract 
A suitable feedstock was required as a feed for packed bed elution 
chromatography.  This feed had to be realistic, industrially relevant, 
inexpensive and contain a relevant target molecule to give direction to the 
chromatographic separation.  Four forms of bovine whey (differing in how the 
whey was extracted from the milk) and a recombinant FAb fragment 
containing E. coli periplasmic lysate were investigated as to their suitability for 
use as an industrially representative model feed stream.  The relevant target 
molecule was bovine IgG for whey and FAb fragments for the periplasmic 
lysate.   
Whey produced by acidification, treatment with rennet, spray-drying and 
tangential microfiltration (“ideal whey”), together with the periplasmic lysate 
feed, were separated by reducing SDS-PAGE.  Target molecule concentration 
was analysed by ELISA (for IgG) and by Protein G HPLC (for FAb fragments). 
It was found that the spray drying process caused extensive denaturation of 
the protein components of the whey and IgG concentrations were 60% less 
than the 0.5mg/mL IgG concentration found in whey obtained by the use of 
rennet and acidification.   A concentration of 0.55mg/mL FAb fragments was 
found within the periplasmic lysate feed stream. 
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Ease of processing the potential feed streams to produce a liquor suitable for 
packed bed chromatography was also investigated.  Ideal whey proved to be 
very difficult to process in significant quantities dues to microfiltration 
membrane fouling, while whey produced by acidification and rennet required 
a time-consuming and variable manual skimming process.  The periplasmic 
lysate feed however proved to be straight-forward and quick to process via 
centrifugation and 0.22µm depth microfiltration.  It was concluded that FAb 
fragment containing periplasmic E. coli lysate, despite its cost, was the 
preferred feedstock for use in further experiments.   
2.2 Introduction  
2.2.1 Feedstock Selection 
A feedstock suitable for scale-down experiments was required.  This feedstock 
required a number of attributes: 
• Realistic – it is common to use largely synthetic or highly processed 
feeds for chromatography modelling work (Pedersen et al, 2003).  This 
can lead to unforeseen issues in application of the research to complex 
industrially relevant feeds with a diverse range of contaminants.  A 
feedstock that derives from a potential industrial process was therefore 
sought containing a wide range of protein contaminants; however, the 
components of this feedstock will have to be easily quantifiable to 
facilitate analysis, so feeds highly contaminated with host cell proteins 
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and nucleic material, such as bacterial homogenates, would not be 
suitable.   
• Inexpensive and available – even experiments at the sub 10mL scale 
can require substantial quantities of feedstock and expensive 
feedstocks will limit experimental scope.  An experimental feed derived 
from food sources, such as cow’s milk or hen’s eggs, would be suitable 
on grounds of cost, as would an already developed fermentation 
process that has been optimised for high titres of expressed protein. 
• Contain realistic target products – the feedstock must contain a high 
value and specific product to give a sense of purpose to the separation.   
If any further investigation is to involve the highly IgG selective MEP 
HyperCel then an IgG or IgG fragment would be an excellent and 
relevant target protein. 
Two feedstocks were examined for suitability, namely whey in various forms 
and a periplasmic lysate from E. coli containing recombinant FAb fragments, 
produced in-house using a developed and optimised method. 
2.2.2 Whey as a Model Protein System 
Dairy whey is of use within industry as it contains several proteins of note, 
the major ones being defined in Table 2.1. 
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There are two kinds of whey commonly produced within the dairy industry; 
sweet whey and acid whey.  These are defined by the extraction process used 
to separate the whey from the casein proteins, commonly identified as curds.   
Protein Concentration (g/L) 
β-lactoglobulins 3-4 
α-lactalbumin 1.2-1.5 
Serum albumin 0.3-0.6 
Immunoglobulins (including IgG) 0.6-0.9 
Table 2.1: The protein composition of bovine whey. 
 
The majority of the whey in use in the dairy industry is sweet whey which is 
produced by the use of rennet, an enzyme located in the fourth bovine 
stomach.  Acid extracted whey is produced by precipitating the curds at pH 
4.6 and due to the selectivity of the precipitation reaction it has a different 
protein composition to sweet whey.  Whey also contains a great deal of 
lactose, some minerals, vitamins and lipids.  Whey is treated as a waste 
product in the cheese making industry, therefore substantial quantities, in 
spray dried form,  can be obtained for under £50 per kilogram.   
Although whey is usually a waste product of the more profitable cheese 
manufacturing it can still be used for animal feedstocks or for the production 
of lactose (Pedersen et al, 2003).  The proteins contained in whey also have a 
number of commercial uses and have typically been recovered by 
precipitation.  The research that has gone into using transgenic milk to 
produce therapeutic proteins has also increased interest in the bio-processing 
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of whey (Pollock et al, 1999) from bovine, caprine or ovine sources.  More 
recently a combination of membrane filtration and ion exchange 
chromatography is used as a purification route to the same end in an effort to 
increase efficiency.  Yields have been shown to be poor using conventional 
ion-exchange chromatography but the membrane ion-exchange 
chromatography systems have been shown to improve this (Bhattacharjee et 
al, 2006) and in particular cationic ion-exchange resins have proved useful in 
separating out the valuable immunoglobulin G (Gerberding et al, 1998). 
Even with the difficulties with processing whey on an industrial scale it has 
merit for use as a model system (Pederson et al, 2003), particularly for newer 
technologies such as simulated moving beds (Andersson et al, 2006).  It is a 
complex mixture made up of different proteins, lipids and polysaccharides and 
therefore provides a more realistic feedstock than artificially produced protein 
mixtures.  The proteins include very valuable commercial proteins such as IgG 
which make it relevant to potential industrial processes.  Whey is also very 
economical to use as its a waste product; even whey produced in-house 
comes from inexpensive bovine milk. 
2.2.3 FAb Fragment Containing E. coli  Periplasmic Lysate 
E. coli based expression systems have traditionally been favoured for its 
extensively characterised genetic make-up and its ability to grow extremely 
rapidly with minimal specialist fermentation nutrient needs (Makrides et al 
1996; Baneyx et al 1999).  Small scale expression of plasmid encoded 
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recombinant proteins within E. coli are typically regulated by use of lac 
promoters.  Significant limitations have been shown with this promoter at 
larger scales however, including the relatively high cost of non-hydrolysable 
induction agents such as IPTG.  The T7 bacteriophage promoter system (via 
pET vectors) addresses this problem by being a strong promoter hence 
massively over-expressing the target protein within the cell.   However, strong 
promoter systems can produce a high relative proportion of inclusion bodies 
and have ramifications for correct target protein folding  (Schein et al, 1989; 
Hannig et al, 1998).  A reduction in fermentation temperature has been 
utilised to counteract inclusion body formation (Sorensen et al, 2005) but this 
has other metabolic impacts upon the cell and the fermentation progression. 
Conventional recombinant protein expression in E. coli, as well as Gram-
negative prokaryotes generally, produces an intracellular product that is then 
liberated via a homogenisation or lysis step.  This produces a complex, 
viscous liquor with a multitude of host cell protein contaminants, nuclear 
material and other cell debris that can inhibit the effectiveness of proceeding 
downstream purification (Middelberg et al, 1991; Geciova et al, 2002).  This 
has been addressed by the use of periplasmic targeting and lysis systems, the 
concept being that the product is transported to the periplasm and only the 
periplasm is lysed to liberate the product into the extra-cellular space.  This 
leaves most of the host cell protein and nuclear contaminants still within the 
cell which are removed effectively with the primary capture clarification step.  
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The engineering of the molecular biology so as to ensure that a functional 
and correctly folded protein is produced via the periplasm is not a trivial task.  
An 18-30 amino acid leader sequence directs proteins to the periplasm and to 
fold correctly they need to arrive in a loosely folded form, as assisted by 
chaperone proteins (Langer et al, 1992).  Although the periplasm is an 
excellent environment for the finalising of the folding of proteins of eukaryotic 
origin (Missiakas et al, 1997), this can lead to high rates of mis-folding and 
inclusion body formation in non-native protein products.  Localised proteases 
are also in abundance in the periplasm leading to protein degradation 
(Gottesman et al, 1996) and the process of transporting an over-expressed 
protein in the periplasm can lead to slower growth rates and cell damage if 
the cells walls are not reinforced with additional magnesium and phosphate 
during fermentation.  Research into increasing the permeability of the outer 
membrane so that the product can be transported into the bulk liquor, much 
like mammalian and eukaryotic yeast systems, has had some success using a 
variety of approaches (van der Wal et al, 1998; Wan et al, 1998). 
2.2.4 Aims of This Chapter 
This chapter investigates whey and a periplasmic E. coli lysate for suitability 
as a economical, realistic and reproducible feedstock for packed bed 
chromatography experiments at small scale. 
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2.3 Materials and Methods 
Unless otherwise stated all chemicals were sourced from Sigma-Aldrich 
(Dorset, UK). 
2.3.1 Whey  
Sweet whey was obtained from Colston Bassett Dairy (Colston Bassett, 
Nottinghamshire, UK) and was stored at -20°C.  Spray-dried whey solution 
was produced using spray-dried whey (Sigma) at 10% W/W in distilled water.  
This solution/suspension was centrifuged at 3000 RPM within a Beckman JE-
26 centrifuge to remove solid particulates and stored at 4°C.  Acid-extracted 
whey was produced using standard supermarket skimmed milk acidified using 
7M sulphuric acid  to pH 4.6.  This was then heated in a 65°C water bath for 
5 minutes to accelerate precipitation and then centrifuged for 5 minutes at 
3000 RPM in a Beckman GS 6R centrifuge.  The liquid fraction was then 
removed using a Pasteur pipette into a clean Falcon tube and stored at 4°C. 
2.3.2 FAb lysate feedstock production - Fermentation 
The host cell was E. coli  W3110 containing the A33 FAb fragment plasmid 
(UCB Celltech, Slough, UK).  Primary seed cultures stored at -80°C were 
thawed and grown up in 2L shake flasks containing LB broth at  37°C until 
OD600nm >1.  Flask contents are aseptically transferred to secondary culture 
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flasks containing defined media utilising glycerol as the carbon source.  The 
cultures were then incubated at 30°C until the OD600nm was between 2-4. 
The contents of the secondary culture flasks were then transferred aseptically 
into a 20L LH fermenter containing 12L sterile SM6Gc defined media with 
112g glycerol per litre.  Initial fermenter conditions are pH 6.95 with 400RPM 
agitation linked to a DOT value of 30%.  Air was sparged until 26 hours from 
inoculation at which point the air is replaced with 40% oxygen (BOC, UK). 
When the OD600nm reached 40 the temperature was reduced to 25°C and 
160mL of 1M MgSO4 was added via an injection port.  At 30 hours from 
inoculation and again at 34 hours from inoculation 120mL of 1M sodium 
phosphate was added via an injection port.  The 80% glycerol feed was 
switched on at 24mL/h during the DOT spike and the recombinant protein 
production was induced by the addition of 30mL 15g/L IPTG.  Harvesting took 
place at 80 hours after inoculation. 
Primary clarification of the liquor was performed in a Carr P6 Powerfuge (Carr 
Centritech Franklin, MA, USA) at 5000g.  The cell paste was stored at -20°C. 
Final concentration of FAb fragments within the lysate was 0.55mg/mL. 
2.3.3 FAb lysate feedstock production – Periplasmic lysis 
Liberation of the FAb fragments by periplasmic lysis of the centrifuged 
biomass was performed by stirred incubation for 16 hours at 60°C in 1L of 
lysis buffer (50mM Tris-HCl, 20mM EDTA, pH 7.4) per Kg of biomass.  The 
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resulting lysate was centrifuged in a Beckman JE-26 fixed rotor centrifuge at 
10,000 RPM for one hour to remove cells/cell debris and the supernatant was 
stored in a conventional freezer at -20°C.  Before application to packed bed 
chromatography the lysate was filtered using a Nalgene 0.22µm depth filter 
with the filtrate being retained.  Without pH adjustment the feed is pH7.4; 
this was adjusted to pH 6 for CM Ceramic HyperD experiments using 
concentrated HCl and to pH 8.8 with 4M NaOH for PPA and MEP HyperCel. 
The single fermentation batch from which the feedstock for the study in this 
chapter was derived will be referred to as “Batch 2”. 
2.3.4 ELISA Assay for Detection of Bovine IgG   
The ELISA assay was performed in NUNC 96 well microtitre plates by coating 
with anti-bovine IgG antibody (B9884, Sigma), blocking with bovine antibody 
free BSA and then binding the samples and controls for 1 hour.  A secondary 
anti-bovine IgG antibody conjugated with peroxidase (A5295, Sigma), which 
reacts with the OPD and produces a quantifiable colour change, was 
incubated for 1 hour.  Washes were performed with PBS and 0.2% PBS-
Tween.  The detection reagent was OPD and was read at 490nm in a Tecan 
Safire II plate reader. 
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2.3.5 Protein G HPLC 
Protein G HPLC for analysis of FAb fragment concentration was performed on 
an Agilent 1200 HPLC using Protein G packed Sepharose Fast-Flow Hi-Trap 
columns (GE Healthcare) at a flow rate of 2mL/min.  Elution was via pH 7.4 to 
2.2 gradient over 10 minutes. The controls consisted of pure FAb fragment 
purified using mixed-mode chromatography. 
2.3.6 Tangential Flow Filtration 
Tangential flow filtration was performed on skimmed milk to produce ideal 
whey.  A Millipore Labscale system was utilised according to manufacturer’s 
instructions, with a 0.1µm Pelicon microfilter run at a constant TMP of 1.2 
bar.  The permeate was collected and stored. 
2.3.7 General Analysis 
Absorbance at 280nm was measured in a conventional laboratory 
spectrophotometer in UV compatible cuvettes.  SDS-PAGE was performed 
using 4-20% tris-glycine gels (Invitrogen EC6025BOX) under reducing 
conditions at 140 volts for 1 hour then stained with Coomassie blue utilising 
Invitrogen’s SeeBlue system.   
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2.4 Results and Discussion 
Different forms of whey and a FAb fragment containing E. coli periplasmic 
lysate were analysed for their protein composition and to the level of pre-
processing required to produce a feed liquor suitable for packed bed 
chromatography.   
2.4.1 Protein Composition – Whey 
The proteins in processed whey sourced by acidification, spray dried and 
rennet (sweet) methods were separated using reducing SDS-PAGE.  This is 
shown in Figures 2.1 and 2.2. 
This gel was prepared and run under reducing conditions so the IgG appears 
as two bands; the light chains at 25KDa and the heavy chains at 50KDa.  The 
lanes with the spray-dried whey samples show poor resolution and smearing  
indicating extensive denaturation and breakdown of the proteins found within 
the sample.  The spray-drying process involves the vaporisation of the slurry 
under a stream of hot air and this would involve a great deal of shear at the 
air/liquid interfaces and high temperatures.  Under these conditions protein 
denaturation and breakdown would be expected. 
A comparison of acid-extracted whey and sweet whey is shown in Figure 2.2. 
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Figure 2.1:   A reducing SDS-PAGE gel showing samples from both acid-
extracted whey and spray-dried whey feedstocks.  The marker is pre-stained 
Benchmark (Invitrogen) and the general staining is with Coomassie blue. Key: 
1:  Marker  2: Bovine IgG control  3: Spray-dried whey  4: Acid extracted 
whey. 
Lactalbumin
Lactoglobulin
1                      2                          3
IgG light 
chain
IgG heavy chain
BSA69KDa
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Figure 2.2:  A reducing SDS-PAGE gel showing samples from both acid-
extracted whey and sweet whey feedstocks.  The marker is pre-stained 
Benchmark (Invitrogen) and the general staining is with Coomassie blue. Key: 
1: Marker  2: Acid-extracted whey  3: Sweet whey. 
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Figure 2.2 shows clearly there is almost no qualitative difference between the 
protein composition of sweet whey and acid-extracted whey; protein bands 
are clear and degradation seems limited for both samples.  Although extra 
proteins are theoretically added to sweet whey due to the addition of rennet 
they cannot be visualised at such a low concentration and should have 
minimal impact on any chromatographic separation.  Acid-extracted whey and 
sweet whey both show a good number of discrete protein contaminants and 
good concentrations of the target molecule and therefore, on this basis, 
would make a good model system for chromatographic separation. 
Table 2.2 shows the bovine immunoglobulin concentration as determined by 
ELISA.  Literature values are approximately 0.6mg/mL IgG in conventional 
bovine whey (Pedersen et al, 2003) and the acid-extracted and sweet whey 
values broadly agree with this.  Spray-dried whey shows only 30% of the 
literature value, presumably due to high levels of protein denaturation created 
by the spray drying process. 
Whey IgG Concentration (g/L) 
Spray-dried 0.2 
Acid-extracted 0.5 
Sweet 0.5 
Table 2.2: IgG concentration in the whey samples tested, as determined by 
ELISA. 
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2.4.2 Protein Composition - FAb Fragment Containing Lysate 
The protein composition of the periplasmic lysate is shown in Figure 2.3.   
The actual identity of the majority of the proteins within the lysate is difficult 
to elucidate without extensive analysis but the major contaminant at 
approximately 50kDa is believed to be periplasmic alkaline phosphatase 
In this batch of periplasmic lysate the FAb concentration was resolved to be 
0.55mg/mL by Protein G HPLC (section 2.3.7).  This titre can vary to a limited 
degree between batches but this is controllable by manipulation of the 
volumes of buffer used in the periplasmic lysis (section 2.3.3). 
 
 
 
 
 
 
 
 
Figure 2.3:    A reducing SDS-PAGE gel showing samples from an E. coli 
periplasmic lysate containing recombinant FAb fragments.  The marker is pre-
stained Benchmark (Invitrogen) and the general staining is with Coomassie 
blue.  Key:  1: Periplasmic lysate  2: Marker  3: FAb control.  FAb band is boxed. 
 
1             2            3        
69KDa 
25KDa 
59 
 
2.4.3 Pre-Processing of Feedstocks 
There were considerable pre-processing issues with both the acid-extracted 
and sweet whey.  Spray dried whey was quick and easy to clarify, but the 
high lipid content of the full fat sweet whey created considerable difficulties 
for the removal of supernatant from centrifuged samples, as the fats 
coagulate and float to the surface.  The same problem was encountered by 
the curdling acidification process with skimmed milk leading to a necessary 
and none too effective skimming process to remove.  This skimming process 
was manual, time-consuming and, because of the manual intervention 
required, creates unacceptable levels of batch to batch variability.   
FAb containing periplasmic lysate on the other hand did not require pre-
processing once the fermentation and upstream clarification was complete.   
2.4.4 Ideal Whey 
“Ideal whey” is essentially demineralised whey produced by tangential flow 
micro-filtration.  In this work a 50cm2 Pelicon TFF cassette (Millipore, 
Watford, UK) was used to treat skimmed milk in order to limit lipid content.  
Observed fluxes were extremely low, in the region of a 0.8mL/min/m2 at the 
start of operation.  This was further reduced as the membrane fouled, 
rendering the filtration process unacceptably slow.  As a result this option was 
not pursued any further. 
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2.5 Conclusions 
Four potential feedstocks were investigated for use as a feed for the model 
chromatographic system; spray-dried whey, acid-extracted whey, sweet whey 
and a E. coli derived periplasmic lysate containing FAb fragments. 
All three whey products were relatively inexpensive to obtain.  However, the 
time and effort required to process the whey feeds into something suitable for 
packed bed chromatography was substantial.  In the case of ideal whey it 
proved impossible to process substantial quantities of feed at all, let alone 
enough for laboratory scale chromatographic separations, so this feed would 
not be suitable for any thorough study that would require large quantities of 
feedstock.   
Periplasmic FAb containing lysate was much more expensive to produce, as it 
required a 96 hour fermentation process, however the extent of pre-
processing needed to produce a suitable feed for packed bed 
chromatography, after the pilot scale centrifugation, was very short.   
All the feedstocks investigated could be considered realistic.  Although 
research into transgenic milk continues the biopharmaceutical industry is far 
more focussed on recombinant feeds from prokaryotic or eukaryotic hosts, so 
the periplasmic lysate would have to be considered the more relevant of the 
feeds.  All the feedstocks contained a realistic target molecule, either a FAb 
fragment or a complete immunoglobulin molecule.   
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The additional cost of producing the periplasmic lysate is more than 
compensated by the ease of processing the feed ready for packed bed 
chromatography.  To this end the FAb fragment periplasmic lysate was 
adopted as the basis for future investigations involving the selection of an 
ultra scale-down experimental device and the formulation of an ultra scale-
down methodology.    
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3 Small Scale Chromatography Device Selection 
3.1 Abstract 
It is not feasible during early process development to run investigative 
chromatographic separations at large scale.  A large number of individual 
experiments may be required to fully analyse and optimise all the operational 
chromatographic parameters; even at laboratory scales this would require a 
great deal of highly expensive feedstock that may not be available in 
sufficient quantities.  A number of different small-scale chromatographic 
techniques and platforms have been developed in order to study 
chromatographic behaviour very rapidly and only requiring minimal quantities 
of feedstock, known collectively as high-throughput screening methods (HTS).  
These include microwell based systems, microfluidic systems and very small 
columns amongst others.  The very small volumetric needs of these systems 
can however introduce significant engineering constraints and produce 
unpredictable chromatographic behaviour that does not correlate with the 
expected chromatographic outputs at laboratory or process scale.   
Three separate very small column designs containing pre-packed ion-
exchange and HCIC media, namely Pall Life Sciences PRC, a Pall Inc. AcroSep 
prototype and GE Healthcare HiTrap, were investigated in this chapter with 
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regard to a range of chromatographic parameters.  The PRC format showed 
superior separation characteristics and higher total plate numbers than the 
HiTrap or AcroSep designs.  It was concluded that the PRC small column 
format would be the most appropriate for further investigations.   
3.2 Introduction 
3.2.1 Small Scale Chromatography 
Scale in chromatography, and bio-process unit operations generally, is 
subjective.  Although the terms laboratory, pilot and process scales are freely 
used they can apply to a range of unit operation sizes and depend more on 
application than scale; typically however column volumes of less than 250mL 
are considered laboratory scale operations, with systems larger than this 
being referred to as pilot or process scales depending on whether that sized 
unit operation will be used for production or as a stepping stone for scale up 
procedures. 
For industrial purposes only large laboratory scale to preparatory scale is used 
for reasons of economics.  In chromatography the volumes given above do 
not just apply to the volume of the chromatography device or the volume of 
the feed liquor, but is a mean value of volumes required for the effective 
elution of the product stream and the completion of a full chromatographic 
cycle, including loading, washing, elution and regeneration.  For example, 
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although a 1mL column would only potentially require 5mL of feed the 
process would require 10-15 CV for washing and perhaps 5 CV for elution, 
requiring the handling of much larger volumes of liquid than would be initially 
apparent.     
It is however neither feasible nor economic to run every chromatography 
investigation or process at large scale.   In early phase process development 
the process feed is usually produced in shake flasks or in very small 
bioreactors and often using a non-optimised process, so the feed will only be 
available in low volumes and/or titres. There are also a range of 
chromatographic process options available for the purification of any target 
molecule and a thorough investigation requires that many individual 
experiments that would take considerable time and resources at laboratory 
scale of operation.  A key function of scale-down devices is to produce high-
throughput screening (HTS) methods that allows for the very rapid or 
simultaneous analysis of dozens of chromatography sorbents and operating 
conditions; a degree of automation could be envisaged for these screening 
methods that would add significantly to the rate of investigation (Rege et al, 
2006).    
There have been a number of approaches to performing chromatography at 
small scales, including microfluidic approaches, microwells, batch methods, 
specialist pipette tips and very small columns (Chhatre & Titchener-Hooker, 
2009). 
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3.2.2 Microfluidic Devices 
Microfluidic devices are extremely small, typically working with volumes of  
under 500µL and as low as a few µL.  Microfluidic devices were inspired by 
microchips and microdot chips systems that have been used for affinity ligand 
scouting (Regnier et al, 1999; M. Schena et al, 1998) and for analysis of DNA 
hybridisation libraries (Heller et al, 1997) in the form of microarrays. 
This led to the micro-machining of channels on quartz or plastic chips which 
could act as a capillary for electrophoresis and liquid chromatography.  Using 
current engineering methods it is possible to pack micro-capillary channels 
with under 1µL matrix volume for HPLC processes, either driven by 
conventional pump/vacuum systems (Vanhoutte et al, 1997) or by electro-
osmotic flow (Bartle & Myers 2001).  Most of the issues with microfluidic 
liquid chromatography systems are not conceptual but in the engineering of 
such small devices; they are difficult to pack in a reproducible fashion and 
have a tendency to leak at operating pressures and during decoupling from 
the pumping system.   Due to the huge differences in the hydrodynamics of 
such systems compared to process scales it is currently very difficult to scale 
up process chromatographic parameters from microfluidic devices alone.  
However, significant data such as dynamic and maximum protein binding 
capacities have been obtained with 1.5µL microfluidic systems which 
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compared well with conventional sized chromatography columns (Shapiro et 
al, 2009). 
3.2.3 Non-Column Chromatography 
Non-column chromatographic methods have no flow parameters but instead 
rely on agitation to mix the solid and solvent phases.  There are very few 
industrial process uses for non-column chromatography as it offers few 
advantages over a typical packed bed system.  Elution volumes are typically 
very large and restricted to isocratic procedures.  Engineering constraints 
exist (such as shear damage to the matrix) due to the need to agitate large 
numbers of beads.  Historically non-column incubation methods were used 
extensively for screening chromatographic conditions (Scopes et al, 1987) and 
even now non-column methods are still useful for small scale experimental 
investigations.  Contaminant removal chromatography is viable as it requires 
no elution of valuable product and non-column methods have been used for 
feedstock pre-processing before packed bed chromatography (Levison et al, 
1989) due to it being inexpensive and fast.  Although batch methods can give 
rudimentary binding data, actual process data is difficult to obtain using these 
methods. 
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3.2.4 Microwell Chromatography  
The typical 200µL volume 96-well plate format is highly standardised among 
laboratory equipment/analytical systems as well as those responsible for 
robotic automation so is an attractive base for high-throughput 
chromatographic systems.  These systems can be used in two ways: as a 
batch/non-column system (albeit with a much smaller volume than 
conventional non-column chromatographic systems) where the wells are self-
contained, or as a rudimentary flow-through system utilising filter plates. 
The use of 96 well plates for solid phase applications have been in use for 
over 15 years (Venn et al, 2005).  Typically these systems are used for the 
analysis of multiple products on a single purification or affinity technique, for 
example the screening of protein and DNA libraries as well as affinity libraries 
(Lesley et al, 2001; Lowe et al, 2001).  A significant limitation of the 96 well 
plate format is that although many experiments can be run simultaneously 
the actual mechanism is still non-column chromatography and as such it is 
more difficult to obtain flow related process data, although this method has 
still been used to great effect with affinity and ion-exchanger resins to 
determine binding capacities (Bergander et al, 2008).  The lack of a flow 
characteristic can be addressed by the use of filter plates, 96 well plates that 
contain a filter instead of a base which acts as a frit.  The liquid phase is 
drawn through the base of the plate either by vacuum or by centrifugation.  
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This has been adapted to a number of purification applications such as ion-
exchange and HIC (Shih et al, 2002; Rege et al, 2006) and has been linked to 
SELDI for rapid analysis of multiple samples  (Wierling et al, 2007).  The 96 
well plates have been stacked to give acceptable mimics of chromatographic 
behaviour (Coffman et al, 2008) and there has been success with automating 
the process using Tecan robotic systems (Bensch et al, 2005). 
Although far more process data can be obtained using stacked microwell 
high-throughput techniques, including elution profiles and potentially purity 
and yield estimations, the capacity to predict a chromatogram with any 
degree of accuracy is still poor.  In practice an approximation of the 
chromatogram is formed by taking data from a series of single well 
experiments at discrete data points and as such resolution of the whole peak 
is limited.  The key advantage of the 96 microwell format is for effective high-
throughput screening, which is highly applicable to very early phase 
experiments such as rapidly screening of sorbents and conditions. 
3.2.5 Pipette Tips  
A novel response to the challenge of high-throughput small scale but 
predicative chromatography is the use of pipette tips packed with 
chromatographic resin, which can be as small as 10µL in internal volume, but 
can be as large as 500µL.  Early work used a similar device to a pipette tip 
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but loaded into bespoke equipment for gas chromatography purposes (van 
Hout et al, 1999).  More recently resin packed tips combined with a robotic 
system, utilising microwell plates for buffers,  have been demonstrated to be 
capable of processing a multi-stage chromatographic purification (Creasey et 
al, 2001) and allowed reasonably accurate predictions of final purity and yield 
of a given chromatographic separation (Wenger et al, 2007).  These 
chromatography tips are commercially available from a range of suppliers, 
including the key supplier PhyNexus (Chhatre & Titchener-Hooker, 2009). 
3.2.6 Very Small Columns 
A detailed review of the scaling down of preparative column chromatography 
processes are presented in Chapter 1 Section 1.7.  In summary small columns 
that do not maintain bed height of the process scale rig give poor prediction 
of chromatographic performance due to a number of factors, including extra-
column volumes influencing peak broadening, wall effects and other 
hydrodynamic influences (Kaltenbrunner et al, 1997). 
3.2.7 Aims of This Chapter 
Although the microwell, microfluidic and pipette tip based small scale 
chromatography methods have much to recommend them, for these 
particular experiments a precise process chromatography mimic is required, 
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rather than the pseudo-chromatographic outputs typically produced by the 
scale-down systems detailed above.   
Very small columns are capable of producing comparable data to a large scale 
chromatographic equivalent with minimal amounts of feedstock, without the 
serious engineering issues that are apparent at the microfluidic scale.  As 
such small scale columns were selected as the ultra scale-down method of 
choice.  A number of pre-packed small scale (1mL) chromatography columns 
are commercially available and three different column designs were 
investigated in this chapter, with regard to critical chromatographic 
parameters such as pressure drop, HETP and dynamic binding capacity. 
3.3 Materials and Methods 
Unless otherwise stated all reagents and chemicals were sourced from Sigma-
Aldrich (Dorset, UK). 
3.2.1 Small Scale Columns 
Three different small scale columns were tested: Pall Pre-Packed PRC , 
prototype Pall AcroSep and the GE Healthcare Hi-Trap.  All columns had an 
internal volume of 1mL and were pre-packed with the sorbent to 
manufacturer tolerances.  Each was supplied sealed in 20% v/v ethanol.  The 
aspect ratio of the columns tested are shown in Table 3.1. 
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Column Aspect Ratio 
PRC 1:10 
AcroSep 1:1.57 
Hi-Trap 1:3.5 
Table 3.1: The aspect ratio values for each of the column designs tested 
 
3.2.2 Equipment 
All experiments were performed using an ÄKTA Basic chromatography 
systems utilising an A280nm UV cell for detection and Unicorn control 
software for the operation of the separations (GE Healthcare, Chalfont St 
Giles, U.K.). 
3.2.3 Height Equivalent to a Theoretical Plate (HETP) Analysis 
Height equivalent to a theoretical plate was measured by introducing a 50µL 
5% v/v acetone/50mM NaCl pulse via a loop directly onto the column.  A flow 
rate of 0.1mL/min was used for all columns and the resulting 280nm 
absorbance peak was recorded.  Integration of said peak and quantification of 
the HETP was performed using Unicorn Evaluation software. 
3.2.4 Dynamic Binding Capacity 
The dynamic binding capacity was measured by analysing breakthrough 
protein concentrations, utilising a 280nm UV flow cell, for each column type at 
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the terminus of the column.  The flow rate was kept constant for all column 
types at 1mL/min.   
The different sorbents/ligands were tested with commercially available 
analytical grade proteins, solubilised in the appropriate loading buffer at 
5mg/mL as described in Table 3.2. 
Ligand 
type 
Binding Protein Loading Buffer Conditions 
CM Lysozyme 50mM sodium acetate pH 4.8 
Q BSA 50mM Tris-HCl pH 9 
Table 3.2: The loading buffer conditions for the cationic and anionic ion-
exchange experiments 
 
Columns were equilibrated and prepared with 20CV of loading buffer before 
the protein feed was loaded. Cleaning was performed with 5CV 1M NaOH.  
Columns were stored in 20% v/v ethanol.  
3.2.5 Test Separation 
A test separation was performed using a complex feedstock, a clarified 
periplasmic lysate from E. coli containing recombinant FAb fragments (Section 
2.3.2).  The periplasmic lysate contained 0.55mg/mL FAb fragments.  Before 
application to packed bed chromatography the lysate was filtered using a 
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Nalgene 0.22µm depth filter to remove particulates, with the filtrate being 
retained.   
Due to the relatively high pI of the FAb fragments (pI 9) binding to a Q ligand 
would only be achievable at a loading buffer pH value significantly above this.  
Such a high pH buffer causes precipitation effects within the periplasmic 
lysate and causes unacceptable fouling of the chromatography columns, 
therefore the test separation was only performed upon the columns packed 
with CM sorbents.     
3.3.1.1 Chromatographic Separation Procedure 
The loading, washing and elution steps were performed at 150cm/h.  Each 
pre-packed column was equilibrated with an equilibration buffer consisting of 
3CV 20mM pH 4.8 sodium phosphate.  The pH of the FAb fragment feed was 
altered with 0.1M HCl to pH 4.8 and then 1 CV was loaded onto the column. 
The column was then washed with 5CV of 20mM sodium acetate equilibration 
buffer.  Elution was performed via a linear pH gradient over 10CV, utilising an 
elution buffer consisting of 50mM diethylamine/1M NaCl at pH 12.  Peak 
fractions were taken for further analysis.  Cleaning was performed with 5CV 
NaOH and the columns were stored in 20% ethanol. 
Elution chromatograms for each column design were recorded and fractions 
were analysed using SDS-PAGE.  SDS-PAGE was performed using 4-20% Tris-
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glycine gels (Invitrogen EC6025BOX) under reducing conditions at 140 volts 
for 1 hour then stained with Coomassie blue utilising Invitrogen’s SeeBlue 
system.   
3.4 Results and Discussion 
3.4.1  HETP 
Figure 3.1 shows the results for each column design and ligand. 
It can be seen that there are no statistical differences in HETP between the 
different column designs.   
However, resolution is not determined by HETP; with all other factors such as 
column geometry and extra-column volume being equal, it is defined by the 
total number of theoretical plates present within the column.  Despite having 
the same internal volume all three column designs were of different lengths 
and this influences how many total theoretical plates are available for a 
separation. 
Figure 3.2 demonstrates the substantial difference this makes.  PRC columns 
are over 4 times as long as the Hi-Trap and this corresponds to far more 
theoretical plates in total, much like a capillary chromatography system 
(Bartle & Myers, 2001).  With all other chromatographic parameters 
remaining equal, the PRC columns should theoretically display greater 
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resolution in a chromatographic separation relative to the AcroSep or Hi-Trap 
column designs. 
 
 
 
 
 
 
 
Figure 3.1: The HETP value for each column design and sorbent, as 
determined by the acetone pulse method as detailed in section 3.2.3.  Error 
bars are calculated to 1 standard deviation from triplicate experiments with 
each column design. 
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Figure 3.2: A bar graph showing total number of plates for each column 
design and ligand, ascertained by the multiplication of the HETP value 
presented in Figure 3.1 by the column length.  Error bars are calculated to 1 
standard deviation.   
 
3.4.2 Dynamic Binding Capacity 
The literature value for the dynamic binding capacity (DBC) of MEP HyperCel 
for human IgG, the molecule the ligand shows pseudo-affinity for, is 
32mg/mL (Pall Life Sciences Product Note, USD 2629).  The cost of procuring 
enough IgG to observe breakthrough, and hence gauge DBC, would be 
prohibitive and as such the dynamic binding capacity of MEP HyperCel was 
not tested.   
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Ion exchangers are characterised by high binding capacities.  As seen in 
Figure 3.3, for the range of sorbents tested the DBC was between 20 and 
60mg/mL for 5% breakthrough.  The DBC was comparatively higher for the 
AcroSep and PRC columns compared to the Hi-Trap.  The probable reason for 
this is that the hydrogel found within the ceramic sorbents packed into the 
PRC and AcroSep columns is characterised by superior mass transfer 
properties, as compared to Sepharose FF.   
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Figure 3.3:  A bar graph showing the dynamic binding capacity values for 
each column design and ligand, for a suitable protein as defined in section 
3.2.4.  ■ - 5% breakthrough, ■ -  50% breakthrough.  Error is calculated to 1 
standard deviation.   
 
78 
 
The relatively quick 1mL/min loading flow rate gives a short residence time of 
1 minute, which will favour those sorbents rapid mass transfer characteristics; 
if the residence time was extended then the apparent DBC of the Sepharose 
FF sorbents would likely to have increased substantially. 
3.4.3 Test Separation 
Figures 3.4 and 3.5 show a test separation of a valuable target molecule from 
a realistic feed, namely FAb fragments from a crude E. coli periplasmic lysate 
(section 2.3.2).  As strong binding of the FAb fragments to the Q ligand would 
require significant pH adjustment of the feed liquor (see section 3.2.5) and 
hence only the CM ligand sorbents were tested.  The MEP ligand was also not 
tested as it is only available in the PRC column design format; the separation 
of FAb fragments utilising this particular sorbent is investigated in Chapter 4.   
As seen in Figure 3.5, with the relatively slow gradient over 10CV only a 
single peak was observed at approximately 20mS conductivity for all three 
column designs.  What was notable however was that the peak height of the 
elution peak was much higher with the PRC format profile than with the other 
column designs, and eluted in a very similar volume.  This indicates a higher 
chromatographic resolution for the PRC design.  As the residence time for all 
the experiments was kept constant and the PRC and AcroSep designs shared 
the same ceramic sorbent, this can only be attributed to the additional 
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number of theoretical plates found within the PRC designs, as demonstrated 
in section 3.3.1. 
Qualitative analysis by reducing SDS-PAGE of the elution peak is shown in 
Figure 3.4.  A significant concentrating effect of the FAb fragments was 
observed but selectivity was poor with several major contaminants being 
collected in the peak fraction for all three columns designs. 
1                     2              3                         4                                   1       2                 3
69KDa
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Figure 3.4:  A reducing SDS-PAGE gels showing 1mL sample fractions taken 
from the first elution peak from a range of separations utilising a CM ligand 
and different column designs and sorbent backbones.  Staining was with 
Coomassie blue and the marker was Benchmark pre-stained marker 
(Invitrogen).  The peak fractions and FAb bands are boxed. 
Gel A: 1. FAb feedstock  2. Marker  3. AcroSep elution peak  4.  PRC elution 
peak; Gel B: 1. FAb feedstock  2. Marker  3. Hi-Trap elution peak. 
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Figure 3.5: Three 
chromatograms showing the 
elution profile for the 
separation of FAb fragments 
from a crude periplasmic 
lysate using a gradient 
elution with a variety of 
column designs and sorbent 
backbones.  The red dashed 
series is the conductivity.    
A: CM Ceramic HyperD in 
PRC format, B: CM Ceramic 
HyperD in AcroSep format, 
C: CM Sepharose in Hi-Trap 
format.  
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3.5 Conclusions 
The objective of this chapter was to investigate three different small (1mL 
internal volume) pre-packed column designs regarding common 
chromatographic parameters affecting operation and separation 
characteristics, namely HETP and dynamic binding capacity. A test separation 
of an E. coli periplasmic lysate was also performed to evaluate 
chromatographic separation of a complex and realistic feedstock. 
It was found that as regards dynamic binding capacity there was little 
difference between the column designs.   
There was little significant difference between the HETP measurements, but 
the PRC column design demonstrated approximately four times the total 
number of theoretical plates compared to the AcroSep and Hi-Trap designs, 
due to its long and narrow aspect ratio.  The PRC design also displayed, albeit 
qualitatively, a sharper elution profile that the Hi-Trap and AcroSep column 
designs. 
There were major differences in dynamic binding capacity, particularly with 
the Hi-Trap Q binding BSA.  The highest dynamic binding capacities were 
observed with the PRC Ceramic HyperD, for both CM and Q ligands. 
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This data clearly recommends that the PRC design is the most suitable for 
future small scale experiments and this was therefore taken forward for 
further studies.  
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4 Separation of FAb Fragments by Mixed-Mode 
 Chromatography 
4.1 Abstract 
FAb fragments have become important targets for biological therapeutic 
development.  They are formed from immunoglobulin G proteins by the 
removal of the FC region, leaving a stable 2 chain polypeptide of 
approximately 50KDa in size that contains the antigen binding epitope.  Mixed 
mode chromatography ligands, including the very closely related HCIC 
ligands, are novel ligands that bind by a mild hydrophobic interaction and 
elute via a charge repulsion brought about by a pH change, providing 
separation on basis of hydrophobicity in low salt conditions.  The MEP ligand 
shows pseudo-affinity binding behaviour with immunoglobulin G molecules.  
Two mixed-mode sorbents, MEP HyperCel and PPA HyperCel (Pall Life 
Sciences, Portsmouth, UK) were investigated as to their chromatographic 
performance when separating FAb fragments contained within a complex E. 
coli periplasmic lysate feed liquor.  The dynamic binding capacity, at 150cm/h 
loading linear velocity and pH 8.8 for purified FAb fragments at 50% 
breakthrough, was found to be 9.8mg/mL for PPA HyperCel and 5.0mg/mL 
for MEP HyperCel; this dropped to 2.1mg/mL for PPA HyperCel and 2.4mg/mL 
for MEP HyperCel at pH 7.4 with the complex lysate feedstock. This value was 
increased by the addition of 0.5M ammonium sulphate to the loading buffer 
and by raising the buffer pH to 8.8. 
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Chromatographic resolution was excellent with both sorbents, and FAb 
purities of >95% were observed.  Two individual FAb containing peaks were 
identified by Protein G HPLC in both PPA and MEP chromatograms, with the 
second peak postulated as to being a different FAb species, potentially di-FAb 
or FAb fragments with an uncleaved leader sequence.   
A CM Ceramic HyperD (Pall Life Sciences, Portsmouth, UK) ion exchanger 
sorbent was also investigated as a comparator and the resolution and purity 
obtained was significantly lower than those seen with PPA HyperCel and MEP 
HyperCel under the same linear velocity conditions. 
4.2 Introduction 
4.2.1 FAb Fragments 
FAb and F(ab)2 fragments have proven to be useful tools in targeted clinical 
therapies (Huhalov & Chester, 2004; Mountain & Adair, 1992), affinity based 
biosensors (Rogers et al, 2000) as well as in-vitro diagnostic tests 
(Borrebaeck et al, 2000) and have several advantages over using complete 
immunoglobulin G molecules.  The Fc region (absent in FAb fragment 
preparations) has associated immunological effector functions which can 
cause unexpected pharmacokinetic behaviour in vivo;  its use for intravenous 
human therapies when glycosylated by appropriate mammalian or yeast hosts 
can have significant effects on blood clearance and immunogenicity.  F(ab)2 in 
particular can have increased affinity for the target epitope due to the lack of 
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stearic hindrance from the Fc region which makes them appropriate for use in 
high sensitivity applications.  Novel uses for engineered fragments include use 
as bespoke and specific affinity ligands (Kleymann et al, 1995). 
4.2.2 Chromatographic Separation of FAb Fragments 
The lack of the Fc region however can present bioprocess purification 
challenges.  Previously immobilised metal ion affinity chromatography (IMAC) 
based methods have been shown to be successful in isolating FAb fragments 
(Skerra et al, 1994), but potential immunogenic effects of the His tags makes 
this unattractive in a regulated process environment.  Protein A and G 
chromatography sorbents typically bind the Fc region with the greatest 
affinity, although the low affinity binding of protein A/G to the FAb and Fv 
regions can be exploited in analytical assays.  This is in contrast to the newer 
Protein L, which binds strongly to the Fv region and is suitable, at least as 
regards specificity, for the purification of FAb fragments and scFv fragments 
(Sasso et al, 1991).  Other issues also exist with using the Protein A/G/L class 
of affinity sorbents as a primary capture step, such as protease leaching, the 
need for very low pH elution and high cost media.  Protein A sorbents also 
typically have a reduced lifetime due to the lack of resistance to alkali, though 
there has been progress in resolving this particular issue (Hahn et al, 1998).  
Ion exchangers are likewise not strong contenders as they require low ionic 
strength feeds to bind efficiently and most feeds for primary capture 
purification steps have a salt concentration that is far too high for effective 
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binding, though some success in secondary purification has been reported 
using pH gradients rather than typical salt gradients (Mhatre et al, 1995).  
Issues of high salt content can be solved by expensive early diafiltration or by 
dilution of the feed, but the massive increase in process volume leads to 
greatly increased capital costs and difficult waste disposal issues (Queiroz et 
al, 2001).  Hydrophobic interaction chromatography is also inefficient as this 
involves expensive disposal of large quantities of lyophilic salts, as well as 
difficulties such as protein precipitation and the essential inclusion of 
downstream diafiltration steps such high salt concentrations require (Roettger 
& Ladisch, 1989; Jungbauer et al, 2005).  
Mixed-mode chromatography and the related hydrophobic charge induction 
chromatography (HCIC) ligands were designed to address many of the issues 
inherent in the binding of antibodies and their associated fragments.  
Originally mixed-mode functionality was proposed with two different ligands 
on the same bead (Belew et al, 2001), but this has since been replaced with a 
single ligand with multiple functional groups with different binding 
mechanisms (Burton et al, 1997; Lindner et al, 2005) . Mixed-mode ligands 
have been used previously for purification of target molecules as diverse as 
chemicals (Xu et al, 2007), antibodies (Burton et al, 2001), enzymes (Burton 
et al, 1997) and nucleic acids (McLaughlin et al, 1989).  The ligands consist of 
both hydrophobic and hydrophilic groups, utilising aliphatic and aromatic 
amines on the same ligand which provides two modes of operation dependent 
on the working pH.  HCIC sorbents bind principally by pseudo-affinity to IgG 
and its variants while modern mixed-mode sorbents principally bind by 
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hydrophobic interaction, even in low salt conditions and at physiological pH.  
This simultaneous orthogonal mechanism of operation allows excellent 
separation and purification in a single step, even with complex feeds.  
However, the protein binding mechanisms are complex and can be difficult to 
predict, although recent investigations using quantitative structure-property 
relationships are starting to provide a more rational basis of separation and 
operation (Ghose et al, 2005; Yang et al, 2007).  In both mixed-mode 
systems and HCIC, desorption is obtained by a reduction in the pH at which 
point the ligand becomes charged and bound molecules elute selectively by 
electrostatic repulsion.  Key advantages of mixed mode chromatography are 
the flexible binding conditions with respect to feed pH and ionic strength, 
resistance to cleaning cycles and good selectivity for common bioprocess 
target molecules. 
A range of mixed-mode and HCIC sorbents are commercially available for a 
range of applications.  Pall Life Sciences (Portsmouth, UK) produce MEP 
HyperCel, PPA HyperCel and HEA HyperCel which have proven purification 
capabilities for immunoglobulins, ß-lactoglobulins and metallo-enzymes. (Lees 
et al, 2009; Brenac Brochier et al, 2008).  GE Healthcare (GE Healthcare, 
Chalfont St Giles, U.K.) produce Capto MMC for similar separations, including 
purification of small proteins like human growth factor (Kaleas et al, 2010) 
and antibodies (Voitl et al, 2010), and there are over 18 different ligands 
under investigation or available for chromatography applications (Zhao et al, 
2007). 
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4.2.3 Aims of This Chapter 
In this chapter two sorbents, the HCIC MEP HyperCel and the mixed mode 
PPA HyperCel, were investigated with respect to the separation of FAb 
fragments from a complex E. coli lysate.  This was compared and contrasted 
to a standard separation using a CM ion exchanger. 
This chapter has two main objectives.  The first objective was to investigate 
the effectiveness of a selected mixed mode and hydrophobic charge induction 
sorbent at separating an antibody fragment from a complex feed liquor, using 
a conventional carboxy-methyl ion exchange separation of the same feed as a 
reference. 
The second is to produce a reference chromatographic separation of the 
assorted proteins found within the E. coli lysate, especially with reference to 
the FAb fragments which were considered the separation target.  This 
reference separation will then be carried forward as an experimental system 
for the ultra scale-down methodology investigation as described in Chapter 5.  
The separation needs to be reproducible with more than one peak and with 
excellent purity (>90%) for the main FAb peak. 
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4.3 Materials and Methods 
Unless otherwise stated all reagents and chemicals were sourced from Sigma-
Aldrich (Dorset, UK). 
4.3.1 FAb lysate feedstock production - Fermentation 
The full method for the FAb lysate feedstock production may be found in 
Section 2.3.2.  The single fermentation batch from which the feedstock for 
the study in this chapter is derived was referred to as “Batch 2”. 
4.3.2 FAb lysate feedstock production – Periplasmic lysis 
The full method for the liberation of FAb fragments from the periplasm is 
detailed in section 2.3.3.  
4.3.3 Chromatographic separations – PRC pre-packed columns 
The chromatography columns used were Pall Life Sciences Pre-Packed 1mL 
PRC columns packed with either MEP HyperCel, PPA HyperCel or CM Ceramic 
HyperD sorbents (Pall Life Sciences, Portsmouth, UK).  All experiments were 
performed on an ÄKTA Basic chromatography system (GE Healthcare, 
Amersham, UK) utilising a absorbance 280nm UV flow cell.   
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4.3.3.1 MEP and PPA HyperCel Separation Procedure 
The loading, washing and elution steps were performed at 150cm/h.  Each 
pre-packed column was equilibrated with an equilibration buffer consisting of 
3CV 50mM Tris-HCl, pH 8.8 or 50mM Tris-HCl/0.5M ammonium sulphate 
depending on the experimental conditions.  The pH of the FAb fragment feed 
was adjusted with 0.5M NaOH to either pH 7.2 or pH 8.8 as experimental 
conditions dictated and then 1 CV was loaded onto the column.  The column 
was then washed with 5CV of 50mM Tris-HCl equilibration buffer.  Elution was 
performed via a linear pH gradient over 10CV, utilising an elution buffer 
consisting of 50mM sodium citrate, pH 2.2.  1mL fractions were taken 
throughout the elution gradient for the purposes of analysis, as described in 
section 4.3.5.  Cleaning was performed with 5CV NaOH and the columns were 
stored in 20% ethanol.  
4.3.3.2 CM Ceramic HyperD Separation Procedure 
The loading, washing and elution steps were performed at 150cm/h.  Each 
pre-packed column was equilibrated with an equilibration buffer consisting of 
3CV 20mM pH 6 sodium phosphate.  The pH of the FAb fragment feed was 
adjusted with 0.1M HCl to pH 6 and then 1 CV was loaded onto the column. 
The column was then washed with 5CV of 20mM sodium phosphate 
equilibration buffer.  Elution was performed via a linear pH gradient over 
10CV, utilising an elution buffer consisting of 20mM sodium phosphate 
pH6/1M NaCl.  1mL fractions were taken throughout the elution gradient for 
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the purposes of analysis, as described in section 4.3.5.  Cleaning was 
performed with 5CV NaOH and the columns were stored in 20% ethanol. 
4.3.4 Generation of a pure FAb sample 
Pure FAb was obtained by taking a 1mL fraction from the main peak as found 
in the separation of the lysate by MEP HyperCel. 
4.3.5 Analysis 
Protein concentrations were measured using the BCA Total Protein assay 
according to the method detailed in the instructions included within the kit.  
SDS-PAGE was performed using 4-20% tris-glycine gels (Invitrogen 
EC6025BOX) under reducing conditions at 140 volts for 1 hour then stained 
with Coomassie blue utilising Invitrogen’s SeeBlue system.  Protein G HPLC 
for analysis of FAb fragment concentration was performed on an Agilent 1200 
HPLC using Protein G packed Sepharose Fast-Flow Hi-Trap columns (GE 
Healthcare) at a flow rate of 2mL/min.  Elution was via pH gradient and 
controls consisted of pure FAb fragment purified using mixed-mode 
chromatography. 
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4.4 Results and Discussion 
The objective of this chapter was to investigate and compare the 
chromatographic separation of a realistic feedstock (FAb fragment containing 
E. coli periplasmic lysate)  on a range of sorbents, with the intention of 
purifying the FAb fragments from the other host cell proteins within the 
lysate.  To this end a number of critical chromatographic performance 
indicators were investigated, namely the elution profile, purity, yield and 
dynamic binding capacity.   
4.4.1 Dynamic Binding Capacity  for FAb Fragments– MEP 
 HyperCel 
The apparent dynamic binding capacity (DBC) was investigated for both PPA 
HyperCel and MEP HyperCel sorbents in PRC pre-packed columns formats 
under a range of pH and conductivity conditions.  FAb titre within the feed 
was 0.55mg/mL. 
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Figure 4.1:  Dynamic binding capacities for increasing percentage 
breakthrough values, regarding FAb fragments bound to MEP HyperCel, 
loaded at 150cm/h.  +(NH4)2SO4 indicates feed and equilibration/loading 
buffers included 0.5M ammonium sulphate.  Pure FAb was a >95% purified 
FAb fraction used as a feed.  For clarity only the X error bars for the pH 8.8 
(▲) series are shown, to 1 standard deviation.  ▲ = pH 7.2, ▲= pH 8.8, ▲ 
= pH 7.2 + (NH4)2SO4, ▲ = pH 8.8 + (NH4)2SO4, ▲= pure FAb at pH 8.8.  
 
It is clear that there are significant increases to dynamic binding capacities 
when FAb fragments are loaded at pH 8.8 (which approaches the pI of the 
FAb fragment, which is 9) rather than physiological pH.  
It is understood that the primary binding mechanism of HCIC and mixed-
mode sorbents are hydrophobic therefore bringing the loading pH closer to 
the pI will result in a less charged fragment and potentially stronger binding, 
as seen by a clear 15% increase in binding capacity between loading at 
physiological pH 7 and pH 8.8.  This was further supported by the binding 
capacities observed when 0.5M ammonium sulphate was included in the 
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loading buffers – a 34% increase in binding capacity was seen at pH 7.2 with 
a pronounced 160% increase seen at pH 8.8.  A protein in a hydrophobic 
state is likely to be influenced more by salt concentration than one with a 
moderate net charge.  Whether the binding capacity was increased only for 
the target FAb or for contaminants as well is discussed in section 4.4.4. 
4.4.2 Dynamic Binding Capacity for FAb Fragments – PPA 
 HyperCel 
The addition of ammonium sulphate to the loading buffer for PPA HyperCel 
appeared to have an unpredictable and irreproducible effects on the binding 
of FAb fragments, most likely due to an increase in non-specific binding, and 
was therefore not investigated further. 
The dynamic binding capacity results for PPA HyperCel broadly followed the 
results for MEP HyperCel.  It was clear for both sorbents that a degree of 
non-specific binding was occurring as shown by the large increase in binding 
capacity when purified FAb fragments are loaded.  Although PPA HyperCel 
binds more FAb fragments per mL of sorbent than MEP HyperCel more 
contaminant proteins were also bound, leading to roughly equivalent DBC 
using complex feeds.  This supports the pseudo-affinity binding mechanism of 
MEP ligand that reduces non-specific binding, while the PPA ligand binds by a 
less selective mild hydrophobic interaction. 
The DBC values for both sorbents are low compared to the quoted literature 
Figures;  >20mg/mL for human IgG MEP HyperCel and >40mg/mL BSA for 
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PPA HyperCel (Pall Life Sciences, Technical Datasheet).  There are various 
contributing factors however; the literature values were obtained using pure 
proteins at high concentrations (~5mg/mL) in ideal salt conditions and with 
target proteins that have physiological or near physiological pI.  It also should 
be noted that FAb fragments are only 25KDa, much smaller than the 150KDa 
of an intact IgG molecule, and this renders a direct comparison by mass/mL 
difficult.  The binding capacity data does however suggest that MEP 
HyperCel’s pseudo-affinity is far more pronounced for the absent Fc region of 
IgG rather than the FV/FAb fragments investigated here.   
The DBC values for the sorbents and running conditions are summarised in 
Figure 4.3. 
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Figure 4.2:  Dynamic binding capacities for various percentage breakthrough 
values, regarding FAb fragments bound to PPA HyperCel at 150cm/h.  Pure 
FAb was a >95% purified FAb fraction used as a feed at 5 mg/mL.  x = pH 
7.4, ■ = pH 8.8, ▲= Pure FAb from a 95% purified fraction at  5mg/mL. 
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Figure 4.3:  A comparison of dynamic binding capacities for FAb fragments on 
both PPA HyperCel and MEP HyperCel sorbents, loaded at 150cm/h under 
various pH and buffer conditions, from a crude periplasmic lysate. (NH)2SO4 
indicates 0.5M ammonium sulphate was added to the loading and 
equilibration buffer.  Pure FAb indicates a purified preparation utilised as a 
feed rather than the complex lysate.  Blue(■) bars are at 10% breakthrough 
and red (■) are at 50% breakthrough.  
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Figure 4.4:  A set of elution 
profiles obtained by the 
separation of the proteins in 
FAb fragment containing E. 
coli lysate.  A: 300cm/h 
loading and elution linear 
velocities, B: 150cm/h 
loading and elution linear 
velocities, C: 50cm/h loading 
and elution linear velocities.  
The red series on the 
secondary axis of elution 
profile B is the FAb fragment 
concentration taken from  
1mL fractions of the eluted 
material, as determined by 
Protein G HPLC.   
The separation was 
performed using MEP 
HyperCel in PRC format with 
a 10CV pH gradient (pH 8.8-
pH 2.2) at 150cm/h. 
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For all the separation analysis runs the PRC column was loaded with 0.55mg 
of FAb fragments per mL of sorbent as defined in section 4.3.3.  The elution 
chromatograms are presented in Figure 4.4 for a range of loading and elution 
linear velocities. 
It is clear from the elution profiles that separation over a gradient of 10 CV 
gives excellent resolution at acceptable flow rates.  The recommended linear 
velocity for running separations using MEP HyperCel is 100cm/h although 
good separation is still shown at 150cm/h.  The Protein G HPLC analysis 
(section 4.3.5)  of the fractions show that both the peaks present here are in 
fact FAb fragments, as it is highly unlikely E. coli would produce any other 
antibody analogue that would bind to the Protein G ligand.  Identification and 
purity is discussed in section 4.4.6.  
The FAb fragment peak elutes at pH 5.5.  This is atypical for MEP HyperCel, 
which tends to elute at pH 4.8.  As this FAb fragment is a basic protein elution 
could be initiated by net charge changes in the protein itself rather than the 
ligand, at pH 5.5.  The second peak elutes between pH 4.8 and pH 5. 
4.4.3 Chromatographic Separation of FAb fragments using 
 MEP HyperCel – Peak Purity and Yield 
Figure 4.5 shows convincing qualitative evidence for high purity of FAb 
fragments in the first peak of the elution profiles obtained from the individual 
chromatograms.  IgG FAb fragments are typically 50 KDa in size (Coleman & 
Mahler, 2003)  consisting of two very similar chains bound with disulphide 
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bonds.  Under reducing conditions this produces a strong band at 25 KDa 
seen here.  A very faint band is also visible at approximately 50 KDa and this 
is most likely this band is native FAb that has failed to reduce fully; FAb 
fragments are extremely stable even under reducing conditions (Röthlisberger 
et al, 2005). 
The second peak, eluting at approximately 50mL, is more complex to define.  
Protein G HPLC analysis (section 4.3.5) identified this peak as consisting of 
FAb fragments and the 25KDa size of the main band potentially confirmed 
this, although there is a consistent faint contaminant band at approximately 
22 KDa.   
There are a number of potential identities for this second peak.  The first is 
that it is formed primarily of FAb fragments with a leader sequence still 
attached; the production process directs the FAb fragments to the periplasm 
using a leader sequence which is then cleaved.  Potentially the leader 
sequence could still be attached if the periplasm is lysed before cleavage is 
complete.  The FAb fragment would still be 25KDa as the leader sequence 
would be reduced by the temperature and chemical reducing conditions prior 
to loading on the gel. 
The second potential identity is that the feedstock comprises  a mixture of 
FAb fragments and di-FAb – two FAb fragments still connected by a linker at 
the Fc terminus.  Again di-FAb would be reduced to single FAb chains by the  
reducing conditions on the gel and hence appear at 25 KDa on the SDS-PAGE 
gel.  The cleaning lane shows a small concentration of FAb fragments is 
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retained on the column after the elution conditions have been applied and 
only eluted when the column is cleaned.  
The chromatographic separation results are interesting as they demonstrate 
excellent separation of two very similar peptide entities using a chemical 
ligand.   Such resolution is rarely seen in ion exchange, HIC or affinity 
systems, particularly in primary capture applications. 
69KDa
25KDa
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Figure 4.5:  SDS-PAGE gels containing samples from fractions obtained from 
the elution profiles shown in Figure 4.4. Gel A presents the samples from the 
300cm/h loading/elution linear velocities.  Gel B presents the samples from 
the 150cm/h and 50cm/h loading/elution linear velocities respectively.  FAb 
bands are boxed.  Benchmark pre-stained marker (Invitrogen) was used in 
both gels and staining was performed with Coomassie blue.   
 
Gel A lanes: 1. Marker  2. Pure FAb control  3. 1st peak  4. 2nd peak  5. 
Cleaning peak (300cm/h run) 6. FAb lysate feedstock. 
 
Gel B lanes:  1. Marker  2.  FAb lysate feedstock  3. 1st peak 150cm/h  4. 2nd 
peak  150cm/h  5. Cleaning peak (150cm/h run)  6. 1st peak 50 cm/h  7. 2nd 
peak 50cm/h. 
101 
 
1               2          3                            4         5           6
69kDa
25kDa
 
Figure 4.6:  A reducing SDS-PAGE gel presenting samples taken from the 
elution stage of an MEP HyperCel separation of FAb fragments from an E. coli 
periplasmic lysate.  0.5M ammonium sulphate was included in the loading and 
elution buffers.  Gel lanes:  1.  Marker.  2&3: FAb lysate feedstock.  4&5.  1st 
peak  6. 2nd peak. 
 
As Figure 4.6 demonstrates the increased binding capacity achievable with 
high salt conditions for MEP HyperCel, as seen in section 4.4.2, does however 
come at a cost.  Operation at high salt concentrations reduces the selectivity 
seen previously and high concentrations of contaminants were observed co-
eluting with the product FAb fragments.  The Protein G HPLC assay could not 
give reproducible results due to the high ammonium sulphate concentration 
(Generon, Data Sheet Protein G Sepharose) but it is clear from the SDS-PAGE 
results that this separation is not viable at high salt levels. 
As expected from the qualitative SDS-PAGE results in Figure 4.7, quantitative 
purity of the 1st peak is very high (>92%) at both pH conditions with no salt, 
as determined by BCA total protein analysis and Protein G HPLC (section 
4.3.5).   This is particularly significant  for a primary capture step from a 
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complex feed where acceptable selectivity is difficult to achieve in practice.  It 
should be noted however that for industrial purposes it is likely both peaks 
would be taken and the di-FAb would be reduced in a further step.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7:  Samples from the highest concentration 1mL fraction from the 1st 
FAb peak of the elution profile, for all sorbents and relevant conditions tested, 
were subjected to Protein G HPLC and BCA Total Protein Assay analysis.  Blue 
(■) bars show the concentration of FAb fragments as determined by Protein G 
HPLC and the red (■) bars show the total protein concentration in the same 
fraction as determined by BCA Total Protein assay.  Error is shown to 1 
standard deviation.    
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4.4.4 Chromatographic Separation of FAb fragments using 
 PPA HyperCel – Elution Profile 
 
 
 
Figure 4.8:  A set of elution 
profiles obtained by the 
separation of the proteins in 
FAb fragment containing E. coli 
lysate.  A: 300cm/h loading and 
elution linear velocities, B: 
150cm/h loading and elution 
linear velocities, C – 50cm/h 
loading and elution linear 
velocities. 
The red series on the secondary 
axis of elution profile B is the 
FAb fragment concentration, as 
determined by Protein G HPLC, 
taken from 0.75mL fractions of 
the eluted material.   
The separation was performed 
using PPA HyperCel in PRC 
format with a 10CV pH gradient 
(pH8.8-pH2.2). 
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Separation analysis runs were conducted with the PRC column loaded with 
0.55mg of FAb fragments, as defined in section 4.3.3.  The elution 
chromatograms are presented in Figure 4.8 for a range of flow rates. 
The chromatograms in Figure 4.8 show a far more complex elution profile 
than seen with MEP HyperCel, with at least 6 distinguishable peaks visible in 
the chromatogram obtained with 50cm/h loading and elution linear velocities.  
This suggests a far less specific binding with the PPA ligand compared to the 
MEP ligand, which is consistent with the known binding mechanisms of the 
two ligands (Brenac Brochier et al, 2008).  A pseudo-affinity ligand like MEP 
HyperCel, by definition, exhibits fairly specific binding; the hydrophobic 
mechanism of the PPA ligand will bind any protein or peptide with a suitable 
hydrophobic patch, which will be a significant proportion of the proteins found 
within the lysate feed. 
The elution profile for FAb fragments was very similar to that seen for MEP 
HyperCel.  The FAb eluted in two separate peaks with the higher 
concentration of FAb in the first peak to elute.  The first FAb peak elutes at 
pH 5.6 and the second FAb peak eluted at approximately pH 5. 
4.4.5 Chromatographic Separation of FAb fragments using 
 PPA HyperCel – Peak Purity and Yield 
Figure 4.9 shows an strong band at 25KDa in lanes 1 and 2, which was 
confirmed as FAb fragments by the Protein G HPLC data shown in Figure 4.8.  
Purity was very good for a primary capture step, as shown qualitatively in 
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Figure 4.8 and quantitatively in Figure 4.9 at approximately 89%, as 
ascertained by BCA assay and Protein G HPLC.  This purity value was however 
below the value that was seen with MEP HyperCel.  This is compensated by a 
much higher product concentration for the peak fraction, over 1mg/mL.  The 
fact that PPA HyperCel and MEP HyperCel had similar DBC values for binding 
FAb fragments from a complex feed suggests elution is more complete for 
PPA HyperCel, while some FAb fragments are retained on the MEP HyperCel 
sorbent even after elution. 
 
         1                2              3                4   
69KDa 
25KDa 
 
Figure 4.9:  An reducing SDS-PAGE gel presenting the 1mL fractions obtained 
from the two most relevant peaks in the PPA HyperCel/FAb fragment lysate 
elution profile.  Staining is with Coomassie blue and the marker is Benchmark 
pre-stained marker (Invitrogen).  The FAb fragment bands are boxed. Gel 
lanes:  1: 1st FAb peak  2: 2nd FAb peak  3: FAb fragment feed  4: Marker. 
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4.4.6 Chromatographic Separation of FAb fragments using CM 
 Ceramic HyperD – Elution Profile 
A sample separation of the FAb containing feedstock was performed using a 
carboxy-methyl weak cationic ion exchanger, CM Ceramic HyperD.  This was 
for comparison with the mixed-mode and HCIC separations detailed in 
sections 4.4.4 to 4.4.7. 
As Figure 4.10 shows, little visible separation was achieved using the CM ion 
exchanger for the purification of FAb fragments.  Elution of the FAb fragments 
proved very difficult, eventually requiring a combined pH and salt gradient.  
Elution was eventually achieved at a pH 10.2 and a conductivity of 22mS, 
with the FAb concentration being present in the latter section of the peak.  
Whether this challenging elution is due to the FAb being very basic and 
therefore tightly bound or due to an interaction with the ceramic sorbent 
backbones is unclear.  The elution profile after 45mL of elution was essentially 
a cleaning peak due to the high pH. 
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Figure 4.10:  An elution chromatogram obtained by the separation of the 
proteins in FAb fragment containing E. coli lysate, at 150cm/h loading and 
elution conditions.  The separation was performed using a CM Ceramic 
HyperD column in PRC format, eluting with a 10CV NaCl gradient (0-1M).  
Equilibration, loading and elution were performed at pH 7.4.  ● – Elution 
profile at A280nm, ▲- FAb concentration as determined by Protein G HPLC. 
 
4.4.7 Chromatographic Separation of FAb fragments using CM 
 Ceramic HyperD – Peak Purity and Yield 
To keep the comparison to the mixed-mode sorbents consistent the feedstock 
was not pre-processed except for the necessary clarification steps for packed 
bed chromatography.  Typically ion-exchangers require to be operated at a 
conductivity of <3mS.  The clarified FAb feedstock had a conductivity of 
approximately 12-15mS.  Within an industrial process setting such a feed 
would be either diafiltered or more likely diluted to reduce the conductivity 
levels so that effective binding could be achieved.  This high ionic strength 
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probably explains why the FAb concentration of the elution peak is so low 
(Figure 4.10), as compared to the norm for an ion-exchanger of this type.  
The purity is approximately 75%, revealing there are other proteins within the 
feed with a similar pI and which therefore elute in the same fraction. 
 
 
 
 
 
 
 
 
 
Figure 4.11:  A reducing SDS-PAGE gel showing the protein composition of a 
1mL fraction taken from the most concentrated part of the FAb peak.  
Staining is with Coomassie blue and the marker was Benchmark pre-stained 
marker (Invitrogen).  Gel lanes are: 1. Feedstock  2: Marker  3: FAb peak 
fraction.  FAb bands are boxed and the sample of interest are boxed. 
 
Figure 4.11 shows several high concentration impurities, as well as a strong 
FAb band at 25KDa.  The highest concentration contaminant at approximately 
70KDa is potentially alkaline phosphatase; its periplasmic variant is liberated 
in the periplasmic lysis process in significant quantities. 
25KDa 
69KDa 
         1                         2                                                           3                 
109 
 
4.5 Conclusions 
The objective of this chapter was to investigate the effectiveness of the 
recently commercialised mixed mode and HCIC sorbents regarding the 
separation of FAb fragments from a periplasmic E. coli lysate, utilising a CM 
ion exchanger as a comparator. 
In the case of purifying FAb fragments MEP HyperCel has been shown not to 
be as effective as some chromatographic alternatives with regard to a primary 
capture step, as the dynamic binding capacity is comparatively low.  However, 
the selectivity and purity of the elution fraction is excellent, even when 
separating from a complex feedstock like the FAb fragment containing E. coli 
lysate examined here, which would make MEP HyperCel a good choice for 
secondary chromatographic purification.   
It has been shown here that CM Ceramic HyperD can purify and concentrate 
FAb fragments to a degree and if the feed is pre-treated it could be 
postulated that binding capacities would rise to the ion-exchanger norm 
(>25mg FAb/mL sorbent).  The high conductivity and high concentration of 
the eluted FAb fraction from such a separation would theoretically improve 
the binding to MEP HyperCel and would not need to be diafiltered before 
application.  The degree of selectivity even with closely related species would 
also make MEP HyperCel an excellent choice for purifications that involve 
closely related contaminant species. 
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PPA HyperCel produced a far higher yield in its peak fraction than MEP 
HyperCel but at the expense of a small drop in purity.  The mode of action of 
the PPA ligand is suited to a larger range of applications as it mainly binds by 
hydrophobicity rather than by pseudo-affinity like the MEP ligand.  It is 
therefore logical that the binding capacity will be relatively higher in the 
favourable ionic conditions within the FAb lysate with the compromise being 
binding of non-target proteins with suitable hydrophobic patches.   
HEA HyperCel, another mixed-mode cellulose based sorbent from Pall Life 
Sciences, was also investigated with respect to binding FAb fragments from 
the crude clarified lysate.  It was found to be ineffective in binding and 
separation of FAb fragments (data not shown), which shows that two mixed-
mode sorbents with very similar binding mechanisms (the HEA and PPA 
ligands)  can demonstrate very different chromatographic behaviour and have 
a range of diverse chromatographic applications. 
Both the PPA HyperCel and MEP HyperCel separations, although not 
optimised for an economic industrial process, give clear and reproducible 
results.  For this reason both the separations are suitable targets for future 
experiments and investigations. 
Of the three separations of FAb fragment containing lysate examined here 
(with the MEP, PPA and CM ligands), the MEP HyperCel experimental system 
is the most straight-forward to analyse.  There are only two peaks that can be 
well resolved at slow linear velocities and the peak consists of a single species 
of FAb fragment.  As such the MEP HyperCel experimental system, rather 
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than the PPA or CM systems, is the most suitable to use for the development 
of the ultra scale-down methodology and will be adopted for future studies. 
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5 Formulation of an Ultra Scale-Down 
 Methodology for Chromatography Scale-Up 
5.1 Abstract 
This chapter concerns the development of an ultra scale-down method and 
model to predict accurately laboratory scale (10-60mL internal column 
volume) chromatographic behaviour using very small (1mL internal column 
volume) pre-packed chromatographic columns.  The experimental system 
was based upon a gradient separation of a crude E. coli-derived lysate 
utilising the mixed-mode sorbent MEP HyperCel, as defined in Chapter 4.   
A methodology was formulated and based around an experimental regime 
created by application of  factorial design. The derived chromatographic data 
was processed with the exponentially modified Gaussian equation to derive 
curve coefficients for each peak within the chromatograms.  The curve 
coefficients were then transformed with a mathematically derived function to 
predict accurately the chromatogram produced at large scale when operated 
at a range of different packed bed heights and loading/elution linear 
velocities.  The formulated methodology and transformation functions were 
very effective at accurately predicting the large scale chromatogram using 
only the small scale chromatographic data, with the majority of predicted 
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large scale chromatograms being less than 5% different to the large scale 
chromatogram generated experimentally, as determined by normalised root 
mean square analysis.     
5.2 Introduction 
5.2.1 Applications – Accelerated Process Development 
The primary driver behind the development of an ultra scale-down system is 
to facilitate rapid process development.  The most useful point of application 
is in the early stages of process development where feed material is of 
limited availability and financial resources are most likely to be minimal.  This 
combination renders an extensive experimental programme at process scales 
infeasible.  A scale-down model for a particular process operation, with the 
study focussed by the application of a design of experiments (DoE) regime, 
can reduce massively the amount of feedstock and resources required to 
obtain accurate data on which to base full scale process decisions (Godavarti 
et al, 2002).  The limitation of conventional scale-down models is the extent 
of the scale down that is feasible before the physical size of a process is so 
small that geometric similarity to the large scale process is lost.  For example, 
traditional scale down of chromatography requires the bed height to be 
maintained whilst the bed diameter is reduced and there is a practical limit as 
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to how small a scale down column can be without introducing other 
variables, such as disproportionately large extra-volume to intra-column 
volume ratios which increase dispersion and reduce chromatographic 
resolution.      
Ultra scale-down methods differ from conventional scale down in that the 
ultra scale-down device does not necessarily bear any geometric or physical 
resemblance to the original item of equipment it seeks to represent.  There 
has been considerable success predicting large scale chromatographic 
behaviour using microwell based systems (Coffman et al, 2008) and in 
producing a performance mimic of tangential flow microfiltration using 
rotating disc shear devices (Ma et al, 2010).  As these ultra scale-down 
methods are decoupled from the restrictions of physically mimicking the 
process scale device they can be very small indeed, often requiring only a 
few millilitres of feedstock. 
The disadvantage of ultra scale-down devices is that a variety of physical 
effects, mostly hydrodynamic in nature, can produce non-linear performance 
differences that are non-trivial to translate between very small and large 
scale.  A “bridging” method is therefore required which links the ultra scale-
down data to the process scale data it is seeking to emulate.  This bridging 
method can be theoretical in nature, such as application of computational 
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fluid dynamics and mathematical modelling, but it can be notoriously difficult 
to apply simplistic models to real data obtained from experimentally 
separating complex feed streams.  The second method is to evaluate 
apparent results, to analyse the changes in process operational behaviour in 
terms of chromatograms, fluxes and other readily obtainable and process 
relevant data rather than theoretical terms and coefficients.  This has the 
advantage of providing industrially relevant results but lacks the capacity to 
provide any understanding of why the differences in purification behaviour 
between process scale and very small scale occur.  Either way ultra scale-
down methods are characterised by consisting of a methodology, as in how 
to use the device to obtain data and how to process this data, and potentially 
a mathematical model to bridge between the ultra scale-down data and 
process scale data. 
The use of such a methodology and model is to accelerate process 
development in the early stages of process design, when feedstock is scarce 
and resources very finite.  An understanding of how the purification will 
behave in certain unit operations, both upstream and downstream, will save 
considerable time and resources when it comes to process optimisation at 
pilot scale.    
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5.2.2 Applications - Quality by Design 
Quality by design is a regulatory approved concept for pharmaceutical 
product and process development quality systems, as laid out in ICH 
Guidelines Q8R2-Q10.  The concept is that a process, and to a lesser extent 
the pharmaceutical product itself, is designed with full understanding of its 
critical quality attributes (CQAs) and how these change with respect to 
changes in process parameters (Rathore & Winkle, 2009; Barker et al, 1994).  
Critical quality attributes are attributes which will directly impact upon 
product or process quality – in the case of a chromatography step this could 
be purification factor or impurity profile, or in an upstream process it could 
be product titre.  Each unit operation however can have potentially dozens of 
CQAs depending on how complex the process is and how liberally the 
classification of CQA is applied to process parameters (Clausing & Simpson, 
1990).  This is in contrast to the conventional “quality by inspection” where 
process and product knowledge can be fairly minimal, and the product is 
released on the basis of its end process analysis and limited data from in-
process controls. 
The key limitation in applying quality by design is the sheer depth of process 
and product knowledge that is required to be able to justify “full 
understanding” of a process.  Traditional experimental design is uni-variate in 
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nature, with one variable or parameter being changed at a time and the 
results recorded.  To understand fully a section of a biological production 
process (quality by design is nearly always applied in a modular fashion to 
each unit operation or even part of a unit operation) the analysis has to be 
multivariate in nature, with potentially very many separate yet inter-
dependent parameters being studied.  Computerised systems working with 
design of experiments principles can effectively reduce the time, effort and 
resources required to collect an adequate data set but at full scale this still 
requires a very large amount of feedstock and time.  The eventual goal is to 
provide a “design space” for each CQA, an experimentally mapped area in 
which full understanding of how process parameters modify the attribute is 
gained.  Design spaces have defined boundaries at which process 
understanding is judged to be limited and as long as the process parameters 
stay within those boundaries the CQA parameter can be predicted in a 
reproducible fashion. 
An ultra scale-down methodology is therefore critical to applying an effective 
quality by design strategy, as under normal circumstances the extensive data 
sets required will be infeasible to achieve at large scales.  Any ultra scale-
down method will have to be extensively validated and justified to the 
regulatory authorities before its data sets can be used to qualify a process, 
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but in principle the regulators are supportive of quality by design concepts.  
Currently any major changes to a manufacturing process or the product 
requires a variation submission to the regulatory authorities detailing the 
change and validation studies demonstrating that no change to product 
safety or efficacy has occurred.  A fully validated design space will allow 
process changes within the space to be performed without regulatory 
approval, although changes outside the design space boundary will still be 
required to submit to the variation process. 
5.2.3 Developed Ultra Scale-Down Methods 
Ultra scale-down (USD) methods have been successfully implemented before 
for a range of unit operations.  Typically, due to the potential complexity of 
utilising non-geometrically similar devices to scale down to such small 
volumes, these are limited to a single unit operation with a fixed feed.  USD 
has been demonstrated well in centrifugation steps, particularly 
centrifugation of precipitates (Boulding et al, 2002; Boychyn et al, 2004), 
expanded bed chromatography (Fenneteau et al, 2003; Willoughby et al, 
2004; Ghose & Chase 2000), ultra-filtration (Reynolds et al, 2005; Ma et al, 
2009), micro-filtration (Ma et al, 2009) and conventional ion-exchange 
chromatography (Kaltenbrunner et al, 1997).  The use of computer models 
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for decision analysis during bio-process design has also been demonstrated, 
particularly with industrially relevant chromatographic separations such as 
those for antibodies (Chhatre et al, 2007; Chhatre et al, 2008).  It has also 
been recognised that unit operation integration of ultra-scale down methods 
is critical for the ultimate aim of complete process prediction at very small 
scales and as such integrated ultra-scale down methods has been reported 
(Neal et al, 2003).  As described in section 3.2.4 microwell based 
chromatography scale-down methods have also had some measure of 
success (Coffman et al, 2008; Rege et al, 2006) as have the emerging 
microfluidic technologies (Shapiro et al, 2009).   
5.2.4 Modelling of Chromatographic Behaviour 
There are many theoretical models for chromatography in existence, but the 
practical application is typically limited to simple separations, which are of 
limited industrial relevance.  The theoretical basis of chromatographic 
separation, as demonstrated by the Van Deemter equation and general rate 
model, is discussed in sections 1.6.2 and 1.6.3. 
The output of a chromatographic process is not a series of coefficients 
however, and a method of chromatographic peak analysis is required to 
interpret experimental and process data derived from chromatograms.  Over 
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90 different empirical functions exist for the representation of 
chromatographic peaks (Di Marco et al, 2001), mostly with the objective of 
mathematically resolving individual peaks from a complex chromatogram.  
This process is referred to as deconvolution.   
5.2.4.1 Deconvolution functions 
Functions with the capability to resolve individual peaks from a complex, 
semi-resolved chromatogram are very important since they potentially enable 
the protein composition and yield at each point in the elution profile to be 
determined.  These deconvolution functions have often been taken from 
other analytical methods, including mass spectrometry or other spectroscopic 
techniques, and then applied to chromatograms derived from packed bed 
elution chromatography.  Another source of applicable functions is located 
within the field of statistics, as the similarities between chromatographic 
peaks and statistical peaks can be exploited.  Most of the mathematical 
functions are used for deconvolution of poorly resolved peaks, in essence 
breaking a complex chromatogram into its constituent peaks.  The three 
most common functions in use include the exponentially modified Gaussian 
function (EMG) (Naish et al, 1988; Foley et al, 1984; Foley et al, 1987), the 
Poisson function (Grimalt et al, 1982) and the log normal function (Olive et 
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al, 1991).  Each of these commonly used functions have their own merits.  
There is some debate with regard to the actual identity of the Poisson 
equation, as the name is attributed to different equations by different authors 
(Di Marco et al, 2001).  The Log-Normal and EMG functions both give good 
results, but the EMG is considered to give a more consistent fit (Naish et al, 
1988).  The key disadvantage to the EMG equation is that the skew value 
must be >0, but as fronted peaks are not typically seen in elution 
chromatography this is not considered relevant in a chromatographic context.  
The skew value in the case of these equations is not equivalent to asymmetry 
but a value calculated using the third moment of the mean deviation of the 
peak data, as is typical in statistical analysis.   
5.2.4.2 Chromatographic behaviour models 
Few models describing how chromatograms change with respect to process 
conditions exist for complex and realistic feedstocks.  Most are highly specific 
in nature, either relating to simple separations (such as affinity 
chromatography) or to particular feedstock/resin systems.  A more 
comprehensive chromatography model (as in not just restricted to 
chromatogram deconvolution) has been investigated by identifying statistical 
moments within the chromatographic data that represent process relevant 
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data, known collectively as chromatographic figures of merit (Papas et al, 
1989).  Some success has been demonstrated within the biochemical field 
using principal component analysis methods, on HPLC data (Pate et al, 
1999), for database mining (Chandwani et al, 1997) and for the analysis of 
small scale data sets (Edwards-Parton et al, 2008). However, mostly the 
models are restricted to analytical chemistry applications which are relatively 
simplistic when compared to biological applications. 
5.2.5 The Challenges of Application of Chromatographic 
Models 
There is currently a gap in knowledge between the theoretical models, 
utilised successfully on simple separations that are mostly synthetic, and the 
complex biological separations so common in the bio-process industries 
which are often optimised and scaled up or down using experience and 
experimental studies.  It has to be accepted that producing a theoretical 
model that engages first principles that can accurately describe 
chromatographic behaviour when applied to highly complex biological feeds 
is not currently possible.  Therefore the challenge is to be innovative in 
creating ways of bridging the gap between the theoretical descriptions and 
the purely practical experimental systems, utilising a methodology and model 
that works using chromatographic data to provide a predictive basis for scale 
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up.  Industrial process engineers are not interested in models that describe 
eddy diffusion or resistance to mass transfer, only in how this translates to 
differences in purity and yield of a valuable target molecule separated from a 
realistic feedstock – with this in mind any model needs only describe the 
chromatogram itself, not the underlying physics of mass transfer.  For this 
reason the challenge has to be approached with practicality firmly in mind.   
5.2.6 Aims of This Chapter 
• To formulate a methodology for data collection at small and large 
scales. 
• To mathematically deconvolute the chromatographic data into data 
sets that are amenable to mathematical modelling. 
• To develop a model that accurate predicts the changes in 
chromatogram between very small (1mL) scale to laboratory scale 
(20-60mL) systems.  This acts as a basis for greater scale up using 
conventional scale up rules. 
• To develop an experimental methodology that uses the model to 
generate design spaces for effective scale up in a way that would be 
useful in bio-process design and optimisation.  
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5.3 Materials and Methods 
Unless otherwise stated all reagents and chemicals were sourced from 
Sigma-Aldrich (Dorset, UK). 
5.3.1 FAb lysate feedstock production - Fermentation 
The full method for the FAb lysate feedstock production may be found in 
Section 2.3.2.  The single fermentation batch from which the feedstock for 
the study in this chapter is derived was referred to as “Batch 2”. 
5.3.2 FAb lysate feedstock production – Periplasmic lysis 
The full method for the liberation of the FAb fragments from the periplasm 
may be found in section 2.3.3.   
5.3.3 Chromatographic separations – PRC pre-packed columns 
The chromatography columns used were Pall Life Sciences Pre-Packed 1mL 
PRC columns packed with MEP HyperCel, PPA HyperCel or CM Ceramic 
HyperD sorbents (Pall Life Sciences, Portsmouth, UK).  All experiments were 
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performed on an ÄKTA Basic chromatography system (GE Healthcare, 
Amersham, UK) utilising a absorbance 280nm UV flow cell.   
Each pre-packed column was equilibrated an equilibration buffer consisting of 
3CV 50mM Tris-HCl, pH 8.8.  The pH of the FAb fragment feed was adjusted 
with 0.5M NaOH to pH 8.8 and then 1 CV was loaded onto the column.  The 
column was then washed with 5CV of 50mM Tris-HCl equilibration buffer.  
Elution was performed via a linear pH gradient over 10CV, utilising an elution 
buffer consisting of 50mM sodium citrate, pH 3.  1mL fractions were taken 
throughout the elution gradient for the purposes of analysis.  Cleaning was 
performed with 5CV NaOH and the columns were stored in 20% ethanol.  
The flow rate of loading and elution depended on the experimental variable 
being examined and ranged between 50cm/h and 300cm/h.  Apparent bed 
height was increased by linking up to 3 PRC columns together in series.  All 
columns were loaded with 0.55mg FAb fragments per mL of sorbent. 
5.3.4 Packing – XK16 Columns 
The XK16/20 and XK16/40 chromatography columns (GE Healthcare, 
Amersham, UK) were packed with the sorbent according to the 
manufacturer’s instructions supplied with the sorbent.  XK16 columns have a 
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1.6cm diameter.  Packing buffer was 50mM Tris-HCl pH 8.8.  Packing 
tolerances were 2000 plates per metre +/- 10% for the HyperCel sorbents  
with an asymmetry value < 2, as determined by acetone pulse.     
5.3.5 Chromatographic separations – XK16 
Separations were performed as described in section 5.3.3.  Bed height was 
between 5cm-30cm depending on the experimental variables being studied, 
and was defined as the height of the bed when fully packed ± 1cm.   
5.3.6 Matlab Analysis 
Analysis of the UV chromatograms was performed using Matlab version 7.1 
(The Mathworks, USA)  utilising the Curve Fitting and Optimisation toolboxes.  
Code for the algorithms for chromatogram/peak deconvolution was 
developed and provided by S. Edwards-Parton (University College London, 
London, UK) and is detailed in Appendix 1.  Full details of the Matlab analysis 
are given in section 5.4.   
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5.4 Experimental Premise   
This section details the hypothesis of how large scale chromatographic 
behaviour will be predicted by data obtained from an ultra scale-down 
device.  This is followed by how the analysis will be used to investigate this 
hypothesis utilising the experimental data.   
5.4.1 Objective 
The objective of the methodology developed in this chapter was to 
investigate how chromatographic peaks change with respect to linear velocity 
and packed bed height for non-geometrically similar columns.  This will be 
investigated at PRC Pre-Packed column scale, henceforth referred to as small 
scale (1-3mL internal column volume) and at XK16/40 scale, henceforth 
referred to as laboratory scale (10-60mL internal column volume).  This 
immediate experimental target was part of a larger objective, which was to 
design, test and validate an experimental and analytical methodology that 
allows the prediction of large scale chromatographic behaviour using small 
scale chromatographic data and very limited validation data obtained at 
larger chromatographic scales.  The two parameters selected as variables for 
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consideration were packed bed height (cm) and linear velocity of 
loading/elution (cm/h). 
5.4.2 Analytical Method Concept 
The uses of mathematical descriptions of peaks, whether chromatographic or 
statistical,  are detailed in section 5.2.4.   At the heart of the method is the 
assumption that a single peak can be broken down into four key parameters 
or curve coefficients.  These are detailed below and shown in Figure 5.1: 
Maximum peak height (h): Peak height at maximum, in units of milli-
absorption units (mAU). 
Width at half height (w) : Peak width at h/2, in units of elution volume 
(mL). 
Peak skew (s) : The peak skew value as derived from the peak height 
width and location. 
Peak location (z):  The location of the peak maximum height (h) on the x-
axis, expressed in units of elution volume (mL). 
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Figure 5.1:  A graphical representation of the curve coefficients. h: peak 
height, w:  peak width at half height, s: peak skew, z: peak location. 
Utilising only these four curve coefficients a chromatographic peak can be 
produced using an empirical function, of which several exist.  The function 
selected for use within this study was the Exponentially Modified Gaussian 
(EMG) due to its relative simplicity and proven good fit to experimentally 
derived peaks (Di Marco et al, 2001).  The EMG equation is shown below in 
equation 5.1,  
2
2
1
exp 1 erf
2 2 2
hw w x z w x zy
s s s s w
pi   − − 
= − − −    
  
  (5.1) 
where h is the peak height, s is the peak skew; w is the peak width at half 
height, z is the peak location and x is the elution volume in mL. 
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The only constraint of this function is that s>0.  This constraint is however 
not an issue in this study as with the exception of overpacking scenarios 
individual chromatographic peaks are always trailing and as such s will 
always be positive. 
It is very difficult to mimic accurately process scale chromatographic 
behaviour only utilising chromatographic data obtained at very small scales 
due to the large number of variables which affect the elution profile in 
different ways.  The hypothesis to be investigated in this chapter is that it will 
be possible to find usable mathematical relationships between the individual 
curve coefficients (h, s, w, z) at the two scales of scrutiny.  This concept is 
summarised in Figure 5.2. 
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Figure 5.2:  A flowchart summarising the proposed method for large scale 
chromatographic peak prediction using small scale data.  Subscripts S, M and 
L denote the curve coefficients for the small scale peak, during 
transformation and for the large scale peak respectively. 
 
The objective of the transformation function is to mathematically transform 
the small scale data until it accurately mimics the large scale data; this 
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function will be critical to the success of the methodology.  The 
transformation function will be a mathematical expression which describes 
the relationship between the small scale values (including the curve 
coefficient, the bed height and the linear velocity values) and the large scale 
equivalents.  Once the small scale peak curve coefficients have been 
transformed into their large scale equivalents (the formation of which is 
described in section 5.5.8) the predictive large scale peak can be effectively 
rebuilt using the curve coefficients and the EMG equation.   
5.4.3   Chromatogram Analysis and Algorithms 
Single peak elution profiles with baseline resolution are unusual in elution 
chromatography except with the use of affinity sorbents or unrealistically 
slow elution gradients, particularly for primary capture unit operations.  To 
address the multi-peak systems expected the Matlab curve fitting algorithms 
EMGCurveFitLSQBig and PlotIt  (S. Edwards-Parton, University College 
London) were utilised, using the inbuilt Curve Fitting toolbox supplied with 
Matlab. 
The EMGCurveFitLSQBig algorithm accepts input arguments from the user 
which specifies how many and the approximate location of the relevant 
peaks, at which point the sub-routine Findnearest  will analyse the peak each 
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side of the input and locate the exact highest point.  The x value then 
becomes both z within the EMG equation and the start point for the rest of 
the algorithm for each peak.  EMGCurveFitLSQBig  then iteratively applies the 
lsqcurvefit function to the data, which deconvolutes the chromatogram into 
the respective number of peaks as inputted by the user.  This curve fitting 
algorithm is a proprietary function of Matlab and works on the least squares 
principle; it is highly effective in practical terms but can be inexact with too 
few iterations or with poorly resolved peaks.  The subroutine EMG2 is then 
applied, which outputs the curve coefficients h, w, s and z for each peak.  
The original algorithm was named EMGCurveFitLSQ.  It was written for data 
generated on 1mL column volume Hi-Traps (GE Healthcare) and was found 
to be very inaccurate on data generated at laboratory scales above 10mL 
column volume.  This was traced to the start point for peak width (w), which 
is a fixed value in the algorithm; within the number of iterations stated it was 
not reaching the width necessary for peaks generated on a much larger 
column.  This value was increased by a magnitude of 10 and was found to be 
effective on both small scale and large scale data, so this modified code 
replaced the original algorithm and was renamed EMGCurveFitLSQBig. 
The breakdown of a chromatogram by this algorithm is shown in Figure 5.3.   
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The PlotIt algorithm rebuilds a chromatogram from the curve coefficients 
using the EMG equation, as shown in Figure 5.4.  Matlab code for these 
algorithms may be found in Appendix 1. 
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Figure 5.3:  The left chromatogram is an elution profile of FAb fragments 
from a crude E. coli lysate separated on PPA HyperCel under a 10CV pH  
gradient (pH 8.8-2.2).  The right chromatogram shows the individual peaks 
elucidated from this chromatogram by the EMGCurveFitLSQBig algorithm. 
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Figure 5.4:  The • series in this chromatogram is the original experimentally 
derived elution profile.  The • series is the pseudo-chromatogram produced 
by the 16 curve coefficients from the four separate peaks in Figure 5.3, 
produced using the PlotIt algorithm within Matlab. 
5.4.4 Experimental Data Collection 
The changes in the curve coefficients were investigated with regards to 
changing the height of the packed bed and linear velocity of loading/elution.  
Two data sets were required for comparison and contrast, one at small scale 
utilising PRC pre-packed columns and one at large or laboratory scale utilising 
XK16/40 columns packed with the appropriate resin. 
For the small scale data set all data points within the design space were 
collected as minimal feedstock was required.  For the large scale data set a 
factorial experimental design was employed to reduce the experimental 
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duration and feedstock quantities required.  The experimental grids 
identifying the experimental parameters are detailed in Figure 5.5.  
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Figure 5.5:  The experiments that were required to be performed to produce 
the chromatographic data sets for the variables bed height and linear 
velocity.  The UV280nm chromatogram was recorded for each set of conditions 
marked above. 
 
The factorial design concept requires that the four corners of the design 
space be investigated together with a point central to the design space, 
which is typically repeated to ascertain a measure of experimental 
reproducibility.  Having two separate points in the centre (as shown in Figure 
5.5) is not strictly necessary; however, sufficient quantities of feedstock were 
available in this study and additional experimental data increases confidence 
in the accuracy of the trends seen within the design space.   
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Each chromatogram generated by the experiments proposed in Figure 5.5 is 
analysed separately as detailed in section 5.4.3.  It is important to note that 
the experimental plan outlined in Figure 5.5 is designed to generate detailed 
data for the development of the ultra scale-down methodology, rather than 
being a proposed experimental method for the final methodology.  The final 
methodology will only require a maximum of three experiments at large 
scale, to validate the small scale data set and to ensure the predicted large 
scale results are both accurate and consistent.   
5.5 Results and Discussion 
In this section chromatograms obtained from small scale and large scale 
experiments were analysed, as outlined in section 5.4 above.  This includes 
the chromatograms themselves, the deconvolution of the peaks involved and 
the production of response surfaces to facilitate graphical analysis. The curve 
coefficients derived from this data were then correlated and transformation 
functions describing the relationship between the curve coefficients at large 
and small scale were defined.   
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5.5.1 Chromatograms 
The chromatograms representing the edges of the design space for both the 
small and large scales are shown in Figure 5.6, the design space edges 
referring to the shortest bed height/fastest flow rate to the tallest bed 
height/slowest flow rate.  The data obtained from the extreme edges of the 
design space will show the best chromatographic resolution expected and the 
worst, with all non-presented data falling between these two boundaries.   As 
expected, increasing the flow rate and reducing the bed height had a 
detrimental effect to chromatographic resolution. Flow rate had relatively 
more impact than bed height.  The two peaks seen in this chromatographic 
separation are labelled 1 and 2 in section D of Figure 5.6 and will be referred 
to as such throughout this chapter. 
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Figure 5.6:  Four chromatograms demonstrating how the complete 
chromatogram changes between the edges of the factorial design space for 
both small scale and large scale systems.  The chromatograms are an elution 
profile from the separation of a periplasmic E. coli lysate containing FAb 
fragments using the HCIC sorbent MEP HyperCel.  A: Small scale 5cm bed 
height and 300cm/h linear velocity  B: Small scale 15cm bed height and 
50cm/h linear velocity,  C: Large scale 5cm bed height and 300cm/h linear 
velocity,  D:  30cm bed height and 50cm/h linear velocity.  The stated linear 
velocity values refer to the linear velocity of both the loading and elution 
steps.   
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5.5.2 Chromatogram Analysis 
 
 
 
 
 
 
 
 
Figure 5.7:  The four chromatograms shown in Figure 5.6 after processing 
through the EMGCurveFitLSQBig algorithm to produce a prediction of the 
individual peaks within the chromatogram.  series: original chromatogram,  
 series:  peak one,   series:  peak two. 
 
Figure 5.7 demonstrates the effectiveness of the Matlab algorithm 
EMGCurveFitLSQBig in elucidating the individual peaks.  There are several 
assumptions that are necessary to use this data reliably.  It has to be 
assumed that there are no completely concealed peaks underneath other 
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peaks, in that each peak consists of only a single species and if more than 
one species is present its peak can be located and inputted into the 
algorithm.  The other assumption is that the operator can reliably and 
accurately input the peak location as an argument into the algorithm, 
although the curve fitting algorithm is robust enough to search for the peak 
maximum if the inputted location is in close proximity.  Decisions also have to 
be made about what constitutes a peak, particularly with the smaller scale 
experiments in which the chromatograms can contain significant artefacts, 
though this can be solved by using the highest resolution chromatogram as a 
reference and always specifying the same number of peaks.  This particular 
chromatographic separation system using MEP HyperCel and FAb fragment 
containing lysate has been well characterised in Chapter 4 and therefore two 
peaks were always specified for this study. 
The curve fitting algorithm EMGCurveFitLSQBig processes artefacts by 
ignoring small peaks or short volume spikes such as those produced by small 
air bubbles or UV detector glitches, unless the peak is directly specified in the 
algorithm arguments.  The algorithm outputs the series for each peak and 
also the peak curve coefficients h,s,w,z.   The values for each experiment are 
shown in Table 5.1. 
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Scale LV BH 
Peak One Peak Two 
h 
(mAU) 
s 
w 
(mL) 
z 
(mL) 
h 
(mAU) 
s 
w 
(mL) 
z 
(mL) 
Small 50 5 169.3 0.40 0.38 7.9 74.5 0.32 0.12 9.4 
Small 100 5 109.6 0.57 0.44 8.1 25.7 0.20 0.12 9.9 
Small 150 5 41.5 0.84 0.54 9.2 6.9 0.15 0.12 11.3 
Small 200 5 50.7 1.07 0.51 8.5 8.2 0.20 0.12 10.4 
Small 300 5 34.0 0.68 0.64 7.9 12.9 0.30 0.41 9.5 
Small 50 10 146.4 0.75 0.46 14.3 51.8 0.15 0.12 17.4 
Small 100 10 88.1 1.00 0.64 12.8 25.7 0.15 0.20 15.9 
Small 150 10 99.6 1.13 0.75 12.8 25.2 0.20 0.17 16.4 
Small 300 10 73.8 1.51 0.97 14.4 14.0 0.15 0.39 18.0 
Small 50 15 126.1 0.86 0.6 25.8 28.8 0.15 0.25 30.6 
Small 100 15 156.6 1.24 0.7 24.7 29.6 0.15 0.32 29.1 
Small 150 15 88.4 1.43 0.9 21.0 19.0 0.15 0.27 26.0 
Small 200 15 128.1 1.58 1.0 19.5 22.2 0.17 0.30 24.5 
Small 300 15 66.7 1.88 1.2 21.9 15.0 0.15 0.30 27.3 
Large 50 5 170.6 8.0 3.3 113.9 45.0 2.14 0.86 128.9 
Large 300 5 97.1 8.8 6.2 118.0 15.7 6.17 3.49 134.0 
Large 150 15 174.7 16.0 8.9 315.8 44.9 7.85 4.12 365.5 
Large 200 15 199.9 18.0 9.3 279.9 28.1 1.03 5.21 334.8 
Large 200 15 163.3 13.9 10.4 285.2 25.2 2.09 4.44 337.9 
Large 50 30 315.8 27.2 7.5 553.9 157.0 2.63 1.73 632.9 
Large 150 30 264.4 27.8 11.9 563.0 84.0 3.77 3.16 658.7 
Large 300 30 149.7 42.8 19.5 599.7 49.7 4.92 5.98 695.1 
Small-scale 
Error 
8.9 0.057 0.014 0.39 3.8 0.035 0.057 0.35 
Large-scale 
Error 
15.9 2.8 0.778 3.8 2.0 0.75 0.54 2.1 
Table 5.1:  The curve coefficients generated for each peak, regarding the 
chromatograms gained at variable bed heights (cm) and linear velocities 
(cm/h).  Error for each curve coefficient was calculated by triplicate 
experiments (shown in red) to 1 standard deviation. 
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5.5.3 Response Surface Production 
To facilitate analysis of the data for each curve coefficient for both small and 
large scales the data was visualised using response surfaces.  These 
response surfaces were graphical structures with the x-axis as bed height, 
the y-axis as linear velocity and the z-axis as the curve coefficient for either 
the small or large scale experimental data, be it height, skew, width or 
location, with the data interpolated across the surface.   Representative 
examples of these response surfaces are shown in Figure 5.8.  The complete 
sets can be found in Appendix 2. 
In total there are 16 response surfaces for the MEP HyperCel/FAb fragment 
containing lysate data set, eight for the small scale and eight for the large 
scale.   
 
 
 
 
 
144 
 
 
 
 
 
0
100
200
300 5 10
15 20
25 30
50
100
150
200
250
300
350
Bed Height (cm)
Linear
 Velocity
 
(cm/h)
P
eak
 H
eight
50
100
150
200
250
300
0
10
20
30
0
100
200
300
400
500
Bed
 Height
 (cm) Linear Velo
city 
(cm/h)
P
e
ak
 Locatio
n
50
100
150
200
250
300 5
10
15
0
10
20
30
40
Bed Heig
ht (cm)
Linear
 Velocity
 
(cm/h)
P
e
ak
 Locatio
n
0
100
200
300
5
10
15
0
50
100
150
200
Bed
 Height
 (cm) Linear
 
Veloc
ity 
(cm/h)
P
eak
 H
eight
A B
C D
P
eak
 H
eight
P
eak
 H
eight
P
e
ak
 Locatio
n
P
e
ak
 Locatio
n
P
e
ak
 Locatio
n
P
e
ak
 Locatio
n
P
eak
 H
eight
P
eak
 H
eight
 
Figure 5.8:  A selection of response surfaces to demonstrate how the curve 
coefficients changes with respect to bed height and linear velocity. A:  Large 
scale peak one height, B: Large scale peak two location, C: Small scale peak 
one height, D: Small scale peak two location.  All of the response surfaces for 
this study may be found in Appendix 2. 
 
145 
 
 
5.5.4 Peak Location 
Peak location (z), as described by the EMG equation, is described in this work 
as the distance from the start of the sample loading to the maximum peak 
height, in terms of elution volume.  Although this will very accurately 
describe a chromatographic peak the value itself is somewhat relative if the 
pre-elution stages of the chromatogram are included, such as loading and 
washing.  For the purposes of the transformation function the peak location 
of peak one was taken as 0 (or equal to the large scale peak one location 
value) and the location of the second peak was calculated relative to this 
value.  If the chromatogram included more than two peaks then each peak 
location would be described as its distance from the first peak.  This was 
referred to as relative location in the transformation function calculations and 
was calculated back into an absolute peak location during the chromatogram 
reconstruction. 
5.5.5 Response Surface Averaging 
It was found that the response surfaces for the small scale curve coefficient 
data in particular had a high degree of error.  For this reason all response 
surfaces generated were processed using a surface smoothing function that 
was designed in Excel; this averaged the results using 3 iterations of linear 
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regression in 2 dimensions.  This was performed by separating out the 
response surfaces into 9 separate series, presenting the 3D surface data as 9 
individual 2D graphs.  A linear regression was then performed on each and 
resulting data from the trend line incorporated into the response surface, 
with an average of the bed height and linear velocity value taken at each 
point on the surface.   As seen in Figure 5.9 this renders experimental trends 
clearly visible on high error response surfaces while make very little 
difference to response surfaces that have clear, near linear slopes. 
 
 
 
 
 
 
 
Figure 5.9: A series of response surfaces showing the original response 
surfaces, an intermediate with the averaged response surface on the same 
axes as the original and the final averaged response surface. 
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5.5.6 Response Surface Transformation – Axis Stretching  
The objective of the transformation function is to mathematically transform 
the small scale response surface until it accurately mimics the large scale 
response surface.  In the case of the majority of potential variables in a given 
process this can be done directly as the variables are in the same range; for 
example the range of linear velocities tested is 50cm/h to 300cm/h at both 
small and large scales and this would directly follow for all scale independent 
variables.  However, in the experimental study detailed here the bed height is 
not scale independent and as such the small scale response surface will not 
be able to mimic the full large scale response surface without significant 
extrapolation. 
A solution to this was to include the extrapolation into the transformation 
function by elongating the bed height axis to match the large scale.  This has 
the effect of making the surface slope shallower and then has to be corrected 
by the linear velocity and curve coefficient transformation functions.  As the 
response surfaces for each curve coefficient are mostly linear this is very 
effective and allows direct prediction of the entire large scale design space.  
All small scale response surfaces had the bed height variable multiplied by a 
factor of 2 to achieve this. 
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5.5.7 Response Surface Transformation Function 
It should be noted that the transformation functions produced within this 
thesis are still in development and were formulated as a way of testing the 
ultra scale-down methodology, to prove that a single transformation function 
could be utilised across the entire response surface.  A great deal of time and 
resources would be required to fully investigate the correlations between the 
response surfaces at different scales and how these are potentially related to 
operational characteristics, which can then be included in any ultra scale-
down model.  The proposed work to fully investigate the transformation 
functions is outlined in Chapter 8, ”Future Work”.  The method utilised for 
elucidating these basic functions is outlined in flowchart 5.1.  The function* 
mentioned in the flowchart consists of relating operational parameters, such 
as the linear velocity or bed height, to ensure the response surface slopes at 
small and large scales are equal on all four sides. 
As shown in Figure 5.10, the large and small scale response surfaces for a 
particular curve coefficient are very dissimilar.  The transformation function 
development approach was to match the small and large scale surface slopes 
for bed height and linear velocity axes, then to multiply the entire small scale 
response surface upwards to match the large scale surface.  The method for 
developing this is summarised in Figure 5.11. 
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Flowchart 5.1 
Select minimum linear velocity.  
Compare the small and large 
response surface s lopes of the 
other two axes
Are the s lopes 
equivalent?
Calculate multiplier to 
equalise the s lopes
Are the maximum linear 
velocity response 
surface s lopes also 
equal?
Record multiplierRecord function*
Select minimum bed height.  
Compare the small and large 
response surface s lope of the 
other two axes
YES
NO
Attempt to relate 
multiplier to 
operational parameters
Are the s lopes 
equivalent?
Calculate multiplier to 
equalise the s lopes
Are the maximum linear 
velocity response 
surface s lopes also 
equal?
Record multiplierRecord function*
YESNO YES
NO
Attempt to relate 
multiplier to 
operational parameters
Add a fixed value to the small 
scale response surface until it 
intersects the large scale 
response surface
Do the large scale and small 
scale response surfaces overlay 
within error of 1 standard 
deviation?
Record complete transformation 
function for this curve coefficient
YESNO
NO
YES
Small Scale Response 
Surface
Present Response Surfaces on Same 
Axes
Small Scale Bed 
Height Axis x2
Large Scale Response 
Surface
START
150 
 
 
Examples of the response surface fitting are demonstrated in Figure 5.11 and 
examples showing the fit within error are shown in Figure 5.12.  Apparent fit 
is very good as seen by eye and all points for all response surfaces fall within 
the error of 1 standard deviation, as compared to the large scale response 
surface. 
 
 
 
 
 
 
 
Figure 5.10:  The response surfaces produced from the data for the peak 
width of peak one.  The response surface on the bottom is the response 
surface for the small scale data, the one on the top is for the large scale 
data.  The bed height axis has been stretched by a factor of 2 for the small 
scale response surface. 
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Figure 5.11:  A selection of response surfaces showing the original response 
surface from the large scale experiments (maroon) overlaid the transformed 
small scale response surface (jet).  As it is difficult to see a three dimensional 
image in two dimensions two aspects of the same response surface are 
displayed.  A: Peak One Width, B: Peak Two Height, C: Peak Two Relative 
Location. 
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Figure 5.12:  Three representative response surfaces showing the 
transformed small scale response surface (solid surface).  The wire mesh 
surfaces above and below the small scale response surface represent the 
large scale surface to 1 standard deviation. 
 
Figure 5.11 and Figure 5.12 demonstrate the good fit that is obtained with 
the small scale response surfaces once they have been transformed and for 
most surfaces all points are within 1 standard deviation of the large scale 
response surface standard, even for non-linear surfaces.  It was found that 
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the peak width.  As the skew curve coefficient is partially based on the peak 
width coefficient this calculation simply normalises the data. 
There is still an issue with rogue points derived from the small scale 
experiments.  Due to the very small scale of the experiments errors produce 
disproportionate effects in the response surface, whether the error derives 
from equipment or operator error.  The response surface averaging function 
reduces the effect on the overall trends visible within a response surface to 
an extent.  Response surfaces however provide very clear visual cues that a 
particular experiment in the data set has produced rogue points and the 
experiments can be repeated as necessary.  The data obtained from the 
large scale experiments, in contrast, was very consistent. 
5.5.8 Transformation Function 
The transformation functions for each curve coefficient for this particular 
experimental system are listed in Table 5.2.  Effort was made to relate linear 
velocity and bed height parameters within these functions rather than using 
an empirical approach, to better understand how the function relates to the 
hydrodynamics and potentially reducing system specificity of the functions. 
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Table 5.2: The details of the transformation function for each curve 
coefficient for the MEP HyperCel separation of FAb fragments from crude 
lysate.  h: peak height, s: peak skew, w: peak width, b: bed height (cm), f: 
linear velocity (cm/h), z: peak location.  For each of the transformation 
functions the bed height axis was multiplied by 2.   
 
5.5.9 Chromatogram Comparison 
It has been shown that the individual curve coefficients can be accurately 
modelled from small scale to large scale for a two peak system.  To review 
this the transformed curve coefficients were added as arguments to the PlotIt 
Matlab algorithm, which produces a predicted chromatogram via the EMG 
equation.  Results are shown for a representative sample of experimental 
chromatograms in Figure 5.13. 
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5.5.10  
5.5.11  
 
 
 
 
 
Figure 5.13:  Four chromatograms comparing the chromatogram predicted by 
the modelled small scale data directly with the reference large scale 
chromatogram.  Series : original large scale chromatogram, series : 
predicted chromatogram from transformed small scale data. A: 5cm bed 
height 50cm/h linear velocity, B: 15cm bed height 200cm/h linear velocity,  
C: 30cm bed height 300cm/h linear velocity, D: 30cm bed height 50cm/h 
linear velocity. 
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5.5.10 Normalised Root Mean Square 
It is clear from the chromatograms in Figure 5.13 that, qualitatively, the 
predicted chromatogram is a very good fit.  To quantify this, Table 5.3 shows 
the normalised root mean square values for the predicted chromatograms 
versus the reference large scale chromatograms.  
Bed Height Linear Velocity 
Normalised Root Mean 
Square 
5 50 3.5 
5 300 11.1 
15 150 3.8 
15 200 3.8 
30 50 3.0 
30 300 4.0 
Table 5.3:  The normalised root mean square value for the compared 
chromatograms for each bed height and linear velocity parameter. 
5% error was selected as a confidence limit to signify good fit, to provide a 
criterion of success for the chromatogram comparison.  It is noticeable from 
that these values are very low, almost all beneath 5% error according to the 
root mean square.  The exception is the fastest linear velocity and shortest 
bed height (5cm and 300cm/h) which has over 11% error.  It was difficult to 
obtain a reproducible chromatogram at small scale with this bed height and 
linear velocity and this is demonstrated by a lack of a good predicted 
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chromatogram fit.  The experimental parameters in this case were testing the 
design space limits, with a very short bed and a very fast flow rate, so 
unpredictable chromatographic behaviour could be expected. 
The normalised root mean square only relates to the entire chromatogram 
and averages the error thus.  However, the same levels of inaccuracy in 
different parts of the chromatogram will have varying levels of impact upon 
the predicted purity and yield.  A small level of inaccuracy at the point where 
the target peak intersects with the second peak will produce large 
inaccuracies in predicted purity values.  A relatively larger level of inaccuracy 
at, for example, the start of the target peak or the trailing end of the second 
peak will have a correspondingly smaller effect on either purity or yield 
values.  However, as a general method of determining the accuracy of the 
chromatogram prediction the normalised root mean square value is a good 
overview.   
5.5.11 Purity and Yield 
The values which a process engineer would find particularly valuable to 
obtain for a  scale-down model are the purity and yield of a particular 
fraction cut.  The yield/purity diagrams and original chromatogram are shown 
in Figure 5.14. 
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Figure 5.14:  The left hand figure shows the large scale chromatogram for 
the parameters of 5cm bed height/50cm/h linear velocity, once the individual 
peaks have been elucidated by the algorithm EMGCurveFitLSQBig. The right 
hand figure shows the yield/purification diagram from this chromatogram. : 
peak one, : peak two, : purity, : yield. 
 
For the experimental system examined here these values are complicated by 
the fact that even for the fastest linear velocities and shortest bed heights 
resolution was very good, leading to very high purities and high yields.   
The data in table 5.4 shows a high level of accuracy in predicting expected 
purification factors using transformed small scale data, although differences 
are minimised by the high resolution of the separation. 
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Bed 
Height 
Linear 
Velocity 
Large Scale 
purification at 
99.8% recovery 
Predicted purification 
at 99.8% recovery 
5 50 99.75 99.81 
15 150 99.85 99.75 
15 200 99.73 99.79 
30 50 99.84 99.85 
30 300 99.69 99.73 
Table 5.4:  A table showing the actual purification obtained for a set % 
recovery at large scale and the predicted purification factor generated from 
the transformed small scale data. 
5.6 Conclusion 
This chapter provides evidence that it is possible to scale mathematically 
chromatographic data obtained from very small, non-geometrically similar 
devices to laboratory scale chromatographic systems, even when separating  
complex and realistic feedstocks.   
The set of transformation functions created as the basis of this method are 
not ideal however.  The necessary empirical nature of some of the curve 
coefficient transformations means they are likely to be system specific.  
Ideally the transformation functions should relate only to system properties, 
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such as bed height, linear velocity or column volume, but this did not prove 
possible.  What this chapter does prove however is the validity of using the 
concept of scaling between very dissimilar scales by the deconvolution of 
chromatographic peaks into the curve coefficients and then using statistically 
derived equations to form an accurate transformation function. 
A key weak point in this methodology is the accuracy of the curve fitting 
function EMGCurveFitLSQBig, as the curve coefficients it produces are critical 
to the transformation process.  The fitting function has been shown to be 
very accurate in the system used within the chapter, but its capabilities when 
applied to a more complex chromatogram remains to be seen. 
Analysis of the 5cm bed height experiments proved difficult.  It is reasonable 
to postulate that constraints will apply to how large a design space the curve 
coefficient transformation methodology can apply to, a limit beyond which 
the chromatographic parameters become very difficult to predict.  This would 
be accompanied by a combination of increased experimental error and 
hydrodynamic effects which only become apparent after a certain critical 
point.  For example, the linear velocity parameter effect on chromatographic 
behaviour would be linear and produce an accurate model up until the critical 
velocity is reached and the bed compresses, adding a new factor to the 
equation.  The edges of the design space would have to take this into 
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account but also would be constrained by the feasibility in an industrial 
process; no industrial chromatography unit operation is going to run with a 
5cm high bed or at linear velocities which compress the packed bed. 
It would also be possible to extend this methodology to a range of other 
parameters involved with chromatography.  Bed height and linear velocity of 
loading/elution were selected as they are hydrodynamic in nature and it was 
believed that they impact most on the chromatogram and facilitate analysis.  
The studies within this chapter utilised only two variables, bed height and 
linear velocity.  However, the methodology developed could be equally 
applied to a more complex system via a factorial multivariate experimental 
model (applying DoE principles to multiple variables, rather than limiting to 
bed height and linear velocity).  This would allow  large number of 
parameters simultaneously including loading pH, packing quality, buffer 
conductivity and sorbent selection.   
The ultra scale-down methodology presented within this chapter was 
developed for a single experimental system, using a single consistent 
feedstock on the same sorbent.  To ensure the methodology was not system- 
specific the validation of the methodology needed to be performed, in which 
key parameters such as target protein concentration, chromatographic 
ligand, sorbent backbone and characteristics of the feed liquor were varied 
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and the accuracy of the method validated.  This validation study is detailed in 
Chapter 6.   
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6 Validation of Methodology and Model for the 
 Ultra Scale-Down of Elution Chromatography 
6.1 Abstract 
This chapter concerns the validation of the ultra scale-down methodology by 
its application in 3 separate validation studies based upon the experimental 
methodology described in Chapter 5.  These studies consisted of a change in 
feedstock target molecule titre, a change of chromatographic ligand and a 
multivariate change where the ligand, the feedstock and the sorbent 
backbone were all altered.   
It was found that the ultra-scale down methodology, consisting of the 
collection of experimental data sets at both small and large scales then 
applying deconvolution algorithms to derive curve coefficients for 
mathematical analysis, was completely successful in all three validation 
studies. 
The transformation functions that were developed to mathematically 
transform the small scale curve coefficients to their large scale equivalents 
were consistent and allowed chromatogram prediction with a high level of 
accuracy.  However, it was found that these transformation functions were 
mostly unique to the experimental system except in the case of a reduction of 
target molecule titre, limiting the potential utility of the transformation 
function section of the methodology. 
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6.2 Introduction 
6.2.1 Validation of Ultra Scale-Down Methodology 
A functional methodology and model has been created for the prediction of 
large scale chromatographic behaviour using data generated by ultra scale-
down devices.  This was developed and tested using a single experimental 
system as detailed in Chapter 5. 
This chapter seeks to validate the methodology and model by implementing 
the methodology and model developed previously using different experimental 
conditions selected to test the broad applicability of the approach.  Three 
validation studies were performed:  
• Validation study 1 - Reduction in product titre  
• Validation study 2 - Change of chromatographic ligand 
• Validation study 3 - Change of chromatographic ligand, sorbent 
backbone and feedstock  
6.2.2 Process Optimisation 
Production and purification processes for biotechnologically derived products 
go through changes and optimisations throughout a product lifecycle.  These 
changes can occur for a multitude of reasons, such as regulatory requirement 
changes, improved process knowledge/optimisation and most commonly for 
scale up to produce sufficient quantities of material for late clinical 
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development phases or for commercial supply.  Due to the integrated nature 
of production and purification processes a change in the upstream or higher 
downstream conditions can have a cascading effect throughout the process, 
requiring re-evaluation and re-validation of subsequent unit operations with 
the new feed (Ladisch et al, 2001). 
A key objective of upstream development is often stated as being to produce 
as high titres as possible of the desired product to keep costs of goods to a 
minimum.  This can however have significant impact on the effectiveness of 
downstream operations; a raised product titre can lead to higher 
concentrations of host cell proteins (especially if the increased product titre 
was produced primarily via increased host cell biomass) and DNA/RNA 
contaminants.  Even if the host cell protein and genetic material 
concentrations are kept constant a  significant increase in feed viscosity will 
generally be observed, together with a higher incidence of aggregated 
products and insoluble product related impurities  (Doran et al, 1995).   
Downstream processes have to be robust in design and versatile in 
application to ensure good performance in the face of potential feed changes.  
Good application of Quality by Design (QbD), (Rathore et al, 2009; Clausing 
et al, 1990) principles are invaluable to this end as the extensive process 
knowledge, which is implicit in observing QbD principles, allows directed 
manipulation of process parameters to handle complex changes in process 
feeds whilst still maintaining product quality.  Educated chromatography 
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process decisions such as choice of ligand, sorbent backbone and operating 
conditions directly influence product critical quality attributes and as such are 
key to process effectiveness and economy.  
6.2.3 PPA HyperCel 
The phenylpropyl amine chromatography ligand (PPA) is considered, unlike 
the HCIC MEP ligand, to have a mechanism of action that is truly mixed 
mode.  In the case of hydrophobic charged induction chromatography the 
binding mechanism is in part affinity and in part hydrophobic; the elution of 
the target protein, brought about by a drop in pH conditions, is accomplished 
by the charge induction of both the ligand and the bound protein.  In the case 
of a true mixed mode ligand, such as PPA or hexyl-amine (HEA), binding is 
hydrophobic in nature and elution is typically brought about by a charge 
induction of the bound protein only.  This occurs because the HEA and PPA  
molecular moieties have a PKa of approximately 8 and therefore distant from 
the elution pH, while the MEP moiety has a PKa of 4.8.    
 
 
 
Figure 6.1:  The PPA ligand 
CH2 CH2 CH2
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There is however significant cross-over in chromatographic mechanisms 
between HCIC and mixed-mode ligands and the exact nature of binding and 
elution can depend on process and feedstock conditions.  All mixed mode 
sorbents (such as PPA and HEA) and HCIC sorbents have different affinities 
for different classes of proteins and so far the mechanism of binding has 
proven difficult to predict without experimentation (Brenac Brochier et al, 
2008), although computerised structure-property relationship modelling 
techniques have had some success in this area (Yang et al, 2007).  All mixed-
mode and HCIC sorbents however can be characterised by a high binding 
affinity at physiological pH irrespective of salt conditions.  
6.2.4 Cellulose Sorbent Backbone 
Natural cellulose polysaccharides have been in use as a chromatographic 
structural backbone of sorbents for many years.  Application was initially 
restricted as cellulose was only available in a micro-granular or fibrous form.  
Processes which allowed the formation of reproducible cellulose beads were 
introduced in the early 1970’s and allowed cellulose to become established as 
packing material for chromatographic applications (Peska et al, 1976).  
Crystalline regions found within the structure of the beads produce a porous 
structure and by selecting for a macro-porous material high flow rates can be 
used without significant back pressure problems (Leonard et al, 1997). 
Modern cellulose backbones can withstand 2000cm/h without serious 
deformation or compression, unlike most modern agarose derivatives.  
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However, a consequence of this is that packing is complicated by the very 
high flow rates (around 1000cm/h) required to pack the beads adequately for 
high resolution elution chromatography and that the natural elasticity of 
cellulose can interfere with conventional flow packing processes.   
The PPA and MEP sorbents used in this study each had a cellulose backbone 
marketed as HyperCel by Pall Life Sciences.   
6.2.5 Ceramic Sorbent Backbone 
The pressure drop developed in packed bed chromatography systems is due 
to a combination of different factors, including column dimensions, flow rate, 
feedstock viscosity, frit design and the physical properties of the sorbent.   
A critical factor in the exhibited pressure drop is due to the backbone material 
of the sorbent and this is shown by the relative compressibility of different 
sorbents (Stickel et al, 2001).  Most sorbents are inherently compressible due 
to the nature of the backbone material and the operational requirement for a 
porous cross linked structure with a large surface area and enhanced 
diffusivity characteristics.  As the flow rate is increased a critical point will be 
reached where the sorbent suddenly compresses or crushes, leading to a 
substantial and rapid increase in pressure drop which is a particular issue with 
columns that utilise fast flow packing (Keener et al, 2004b) or mechanical 
packing methods (Keener et al, 2004a).  For sorbents such as the original 
Sepharose this was rated at an operationally limiting 75cm/h, although the 
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invention and subsequent marketing of the Sepharose Fast-Flow variants 
have significantly increased these values.  The tendency for non-rigid 
sorbents to compress under the influence of fast flow rates can be countered 
somewhat by the support of the chromatography column walls which serve to 
stabilise the matrix structure of the beads within the column; however, 
industrial column designs have large diameters and sorbent compression is 
commonly seen when the beads packed into the centre of the column furthest 
from the walls compress and collapse.  The column design and wall effects 
have significant impact on packing effectiveness and flow behaviour and have 
been studied extensively (Guiochon et al, 1997; Shalliker et al, 2000). 
The immediate solution to the issue of packing material compressibility would 
be to utilise non-compressible materials as a sorbent backbone, such as a 
ceramic material.  These have been shown to achieve a linear pressure/flow 
profile (Cortes et al, 1987).  Incorporation of a macroporous structure into a 
ceramic backbone with the requisite diffusivity properties has however proved 
challenging, requiring an increased residence time/reduced linear velocity to 
obtain acceptable dynamic binding capacities and thus defeating the objective 
of a packing material with high compressible strength to withstand fast flow 
rates.   Many ceramic materials have been tested, including mesoporous silica 
(Gallis et al, 1999) and titania and zirconia (Kawahara et al, 1989). 
The Pall Life Sciences Ceramic HyperD range of sorbents utilise a giga-porous 
ceramic bead polymerised with a highly diffusive hydrogel which holds the ion 
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exchange ligand.  This design achieves the structural strength of a ceramic 
bead with the macroporous diffusive properties of a polysaccharide sorbent.  
With increasing product titres being generated by advances in fermentation 
technology feeds have become more viscous, which can apply further 
pressure drop to the chromatographic system.  Feeds obtained by natural 
(rather than recombinant) means with high polysaccharide and lipid content 
are also viscous by nature, and this can include traditional feedstocks such as 
sweet whey and egg white. 
6.2.6 Egg White Feedstocks 
The protein composition of hen’s egg white is shown in Table 6.1.  Egg white, 
or albumin, consists of a variety of proteins (ranging in size from 
approximately 12.5 KDa for lysozyme to 77KDa for ovaltransferrin), 
saccharides and lipids.  Many of the proteins found within egg white have 
industrial or  research uses; lysozyme and ovalbumin are used as bacteriolytic 
enzymes and as a reference marker respectively in laboratories, while 
ovaltransferrin has uses in iron fortified food products.   
Effective and efficient purification of these proteins from egg white has 
therefore been the subject of much research, particularly utilising ion-
exchange chromatography (Ming et al, 1993; Li-Chan et al, 1986), affinity 
chromatography (Cuatrecasas et al, 1968; Awade et al, 1996) and 
precipitation (Tankrathok et al, 2009). 
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Table 6.1:  A table presenting the major proteins found in hen’s egg albumin 
(Ternes et al, 2001). 
 
Egg white, compared to other biological products, is relatively simple in its 
protein composition and very inexpensive, so has proven popular as a model 
feedstock for chromatography experimentation and modelling  (Edwards-
Parton et al, 2008; Levison et al, 1989).  Egg white solutions are however 
relatively viscous due to the high protein and sugar content, and this may 
require dilution and pre-processing before use with packed bed 
chromatography.  Dilution of feeds is easily performed at small scale, but this 
presents serious logistical difficulties at industrial scales where capital 
equipment and holding tanks are fixed and very expensive.   
Despite the issues with viscosity egg white is an inexpensive feedstock that, 
although far more simple than a homogenate or lysate, is biologically complex 
Protein % Composition 
Ovalbumin 54 
Ovotransferrin 12 
Ovomucoid 11 
Ovaglobulins 8 
Ovamucin 3.5 
Lysozyme 3.4 
Other proteins 8.1 
172 
 
enough to be relevant and contains a range of discrete and characterised 
proteins.  This makes egg white an excellent model feedstock for 
chromatographic investigations.   
6.3 Materials and Methods 
Unless otherwise stated all reagents and chemicals were sourced from Sigma-
Aldrich (Dorset, UK). 
6.3.1 Validation Study 1 
6.3.1.1 FAb Lysate Feedstock – Reduced Titre Study 
The FAb containing E. coli lysate used within the study had a FAb fragment 
concentration of 0.27mg/mL.  In all other respects materials and methods are 
as section 2.3.2.  The single fermentation batch that produced the feedstock 
for this study in this chapter is referred to as “Batch 3”, as described in Table 
6.2 in section 6.5.1. 
6.3.2 Validation Study 2 
6.3.2.1 FAb lysate feedstock  
The E. coli derived lysate containing FAb fragments used in this study was 
“Batch 4” as described in Table 6.2 in section 6.5.1.  The method for its 
production is detailed in Section 2.3.2.   
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6.3.2.2 Chromatographic separations – PRC pre-packed columns 
 MEP and PPA HyperCel 
PPA HyperCel PRC pre-packed columns were obtained from Pall Life Sciences 
(Portsmouth, UK) and were packed and operated in an identical fashion to the 
MEP HyperCel PRC pre-packed columns used in Chapters 5 and 6.  Full 
experimental details of the chromatographic separation are provided in 
section 5.3.3.  In all other respects, except as explained in section 6.3.2.3, 
materials and methods were as described in section 5.3.3. 
6.3.2.3 10cm Bed Height 
A minor change to the experimental plan was implemented in this validation 
study.  It was noticed and discussed in section 5.6 that it was very difficult to 
emulate the 5cm bed height results at laboratory (XK16) scale and that 5cm 
was outside of any feasible or reasonable design space for an industrial 
chromatography process.  The small bed height axis was also stretched 
consistently by a factor of 2 during response surface transformation, 
restricting the design space it can model.  For this reason the bed heights 
tested at large scale were 10cm, 20cm and 30cm rather than 5cm, 15cm and 
30cm as seen in Chapter 5.   
174 
 
6.3.3 Validation Study 3 
6.3.3.1 IgG4 Spiked Egg White Feedstock 
Egg white was procured from standard large hen’s eggs (Sainsburys, London, 
UK), with the yolk manually separated.  100mL of the egg white was added to 
900mL of 20mM sodium phosphate and gently swirled to mix.  The feedstock 
was then spiked by the addition of bovine IgG4 (I5506, Sigma-Aldrich) to a 
final concentration of 0.1mg/mL.  The feedstock was then centrifuged at 
4000RPM in a Beckman JE-26 centrifuge for 30 minutes and then the 
supernatant was decanted into a clean Falcon tube.  Storage was at -20°C 
and a single batch was used for all experiments within this study. 
6.3.3.2 Chromatographic Separations – PRC pre-packed columns 
 CM Ceramic HyperD 
Each pre-packed column was equilibrated with an equilibration buffer 
consisting of 3CV 20mM pH 6 sodium phosphate.  The pH of the FAb 
fragment feed was adjusted with 0.1M HCl to pH 6 and then 1 CV was loaded 
onto the column. The column was then washed with 5CV of 20mM sodium 
phosphate equilibration buffer.  Elution was performed via a linear pH 
gradient over 10CV, utilising an elution buffer consisting of 20mM sodium 
phosphate pH6/1M NaCl.  1mL fractions were taken throughout the elution 
gradient for the purposes of analysis, as described in section 4.3.5.  Cleaning 
was performed with 5CV NaOH and the columns were stored in 20% ethanol.  
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The flow rate of loading and elution depended on the experimental variable 
being examined and ranged between 50cm/h and 300cm/h.  Apparent bed 
height was increased by linking up to 3 PRC columns together in series.   
6.4 Validation Strategy 
6.4.1 Validation Premise 
The ultra scale-down methodology described in Chapter 5, together with the 
transformation function set required to translate the small scale curve 
coefficients into the large scale equivalents, has been shown to be effective 
(in section 5.5) for a chromatographic separation system incorporating the 
MEP HyperCel sorbent on a cellulose backbone separating FAb fragments 
from an E. coli periplasmic lysate under gradient conditions.  However, a 
scale-up methodology that is entirely system-specific would be of very limited 
relevance to industrial chromatography process development therefore 
validation with other experimental systems is required. 
These studies sought to validate two components of the methodology 
developed in this thesis:  
• The ultra scale-down methodology: This study sought to validate the  
methodology of peak deconvolution via the EMG equation algorithm 
and resulting curve coefficient analysis over the bed height and linear 
velocity variables.  To be considered successful this method will have 
to produce a predictable set of response surfaces for each curve 
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coefficient and allow an accurate correlation between small scale and 
large scale curve coefficient values across the entire design space. 
• The transformation function set – The purpose of this study was to 
establish how the specific transformation functions for each curve 
coefficient and each peak translate between experimental systems.   
6.4.2 Validation Studies 
Three separate validation studies are incorporated into this chapter, each 
altering various aspects of the experimental system. 
• Reduction in product titre – upstream processes can produce a range 
of product titres due to the inherent variability of biological processes.  
Confirmation was required that large reductions in product titre or 
related changes in feedstock composition do not affect the 
effectiveness of the methodology or significantly alter the 
transformation functions for each curve coefficient.  If a significant 
alteration in transformation function was observed with a change in 
product titre then batch to batch variability of the feedstock will render 
further validation of other experimental systems very difficult. 
• Replacement of chromatographic ligand – The change of the MEP 
ligand for a PPA ligand will be used to determine how changes in 
ligand/protein chemistry alter elution profiles and also how these 
change when the bed height and linear velocity variables are altered.  
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The feedstock (FAb fragments within an E. coli periplasmic lysate), the 
sorbent backbone (cellulose), the ligand class (HCIC, mixed-mode) and 
the small scale device presentation (Pall PRC prepacked) remained 
fixed.   
• A multi-variate change – The final validation study was to change 
multiple variables in a simultaneous fashion.  The feedstock was 
changed to bovine IgG4 spiked egg white, the ligand to a carboxy-
methyl (CM) ion-exchanger and the sorbent backbone to ceramic.  
Small scale device presentation remained unchanged with Pall PRC 
prepacked columns being used.   
6.5 Validation Study Results and Discussion  - 
 Reduction in Product Titre 
The results of the validation studies are presented in this section, with each 
study being individually presented, separated into analysis of the 
chromatographic separation,  chromatographic peak analysis, curve 
coefficient data, the transformation function development and finally the 
chromatogram analysis.  The feedstock equivalence data was pertinent for all 
three studies and is therefore presented first. 
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6.5.1 Feedstock Equivalence 
Batch to batch variability is generally an issue when dealing with complex and 
realistic feedstocks such an E. coli lysate.  The lysate from three separate 
fermentation batches has been utilised in the entire investigation, as 
summarised in Table 6.2.   
To verify qualitative comparability a sample from each fermentation batch, 
purified and processed in an identical fashion, were run on a reducing SDS-
PAGE shown in Figure 6.2 below. 
Batch 
Number 
Production 
Bioreactor 
Scale 
Titre 
(mg/mL) 
Thesis Section 
1 20L 0.55 
Chapter 4 – Separation of FAb 
fragments by mixed mode 
chromatography 
2 20L 0.55 
Chapter 5 – Ultra Scale-Down 
Method Production 
3 75L 0.27 
Chapter 6.5.2 – Validation of Ultra-
Scale Down Method: Titre change 
4 75L 0.19 
Chapter 6.6 – Validation of Ultra 
Scale-Down Method: Ligand Change 
Table 6.2:  Details of the source of E. coli lysate batches used in the studies 
within chapters 4-7. 
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1                                                                                                 2 3            4
69KDa
25KDa
 
Figure 6.2:  A reducing SDS-PAGE comparing samples from different 
fermentation batches of FAb fragment containing E. coli lysate.  Staining is 
with Coomassie blue and the marker was Benchmark pre-stained marker 
(Invitrogen).  The gel lanes are: 1: Marker, 2: Batch 1, 3: Batch 2, 4: Batch 3. 
 
The sample were prepared to give the same concentration of FAb fragments 
on the gel.  Each of the batches was qualitatively equivalent in terms of 
protein composition and all produced a clean, sharp Protein G HPLC peak 
when analysed,  supporting batch comparability.   
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6.5.2 Chromatogram Analysis 
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Figure 6.3:  Four chromatograms demonstrating how the complete 
chromatogram changes between the edges of the factorial design space, with 
the variables being bed height and linear velocity of loading and elution.  
Chromatograms obtained with small scale and large scale systems are 
presented.  A: Small scale 5cm bed height and 300cm/h linear velocity, B: 
Small scale 15cm bed height and 50cm/h linear velocity, C: Large scale 5cm 
bed height and 300cm/h linear velocity,  D: 30cm bed height and 50cm/h 
linear velocity.  Linear velocity values  refer to both the loading and elution 
steps.   
The above chromatograms were analysed and processed exactly as 
described in section 5.5.2.  The elution profile for the feedstocks batch 2 and 
batch 3 are superficially similar in that a two peak pattern was observed.   
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6.5.3 Batch 2 and 3 Chromatogram Comparison 
As a point of reference the chromatograms for the same device and 
conditions were compared using feedstock derived from batch 2 and batch 3.  
The results are shown in Figure 6.4. 
 
 
 
 
 
 
 
 
 
Figure 6.4:  Eight representative chromatograms demonstrating how the 
elution profiles change when the feedstock titre was changed from 
0.55mg/mL FAb fragment concentration to 0.27mg/mL, for the same bed 
height and linear velocity conditions.  Series •: Batch 2 profile. Series •:  
Batch 3 profile.  A: Small scale 15cm bed height and 150cm/h linear velocity  
B: Small scale 10cm bed height and 100cm/h linear velocity  C: Large scale 
30cm bed height and 300cm/h linear velocity  D: 15cm bed height and 
150cm/h linear velocity. Linear velocity values refer to both the loading and 
elution steps. 
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As can be observed the elution profile is different between batch 2 and batch 
3 in scale, although the characteristic two peak chromatogram was still seen. 
 It is interesting to note that the differences are far more pronounced between 
the small scale chromatograms than the large scale chromatograms .  
6.5.4 Curve Coefficient Data 
Table 6.3 below details the curve coefficients for all linear velocity and bed 
height conditions at both large and small scales. Response surfaces were 
produced from this data in the method described in sections 5.5.3-5.5.6, 
including the axis stretching and response surface averaging. 
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Scale LV BH 
Peak One Peak Two 
h 
(mAU) s 
w 
(mL) 
z 
(mL) 
h 
(mAU) s 
w 
(mL) 
z 
(mL)  
Small 50 5 98.7 0.53 0.33 16.6 31.5 0.20 0.09 18.4 
Small 100 5 73.5 0.70 0.41 15.9 20.7 0.20 0.11 17.9 
Small 150 5 48.2 1.05 0.51 17.8 11.0 0.28 0.18 19.8 
Small 200 5 60.2 1.04 0.56 15.8 11.8 0.20 0.14 18.0 
Small 300 5 51.4 1.12 0.64 15.5 7.8 0.21 0.19 17.8 
Small 100 10 198 1.15 0.58 29.1 63.4 0.29 0.16 32.6 
Small 150 10 116 1.11 0.78 35.4 27.3 0.20 0.17 39.3 
Small 200 10 124 1.16 0.85 30.4 41.5 0.20 0.21 34.1 
Small 300 10 69.5 1.13 1.24 32.8 24.6 0.22 0.29 37.1 
Small 50 15 272 1.09 0.62 42.9 159 0.23 0.11 48.9 
Small 100 15 202 1.22 0.76 43.2 71.8 0.22 0.23 49.5 
Small 150 15 162 1.29 0.90 44.0 94.4 0.44 0.19 50.4 
Small 200 15 126 1.28 1.03 44.1 33.0 0.20 0.23 49.6 
Small 300 15 76.2 1.97 1.14 44.1 17.5 0.20 0.36 49.8 
Large 50 5 140 5.22 3.7 162 26.2 0.60 2.1 176 
Large 300 5 61.8 5.61 8.1 159 20.4 3.65 2.3 173 
Large 150 15 174 13.8 9.5 343 50.0 1.23 3.2 397 
Large 200 15 184 17.4 9.3 333 71.2 2.74 3.3 380 
Large 300 15 129 14.4 13.5 339 28.7 1.35 6.3 385 
Large 50 30 518 25.2 7.9 635 219 2.40 3.3 736 
Large 300 30 187 39.0 18.7 624 91.8 5.34 6.8 733 
Small scale error 4.79 0.02 0.02 0.87 2.98 0.03 0.05 0.99 
Large scale error 14.17 1.14 0.46 5.81 6.73 0.17 0.19 3.62 
Table 6.3: The curve coefficients generated for each peak from the elution 
profile of a FAb fragment containing lysate separated using MEP HyperCel, 
regarding the chromatograms gained at variable bed heights (cm) and linear 
velocities (cm/h).  Error for each curve coefficient was calculated by triplicate 
experiments (shown in red) to 1 standard deviation. 
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6.5.5 Transformation Function 
The transformation function formulated in Chapter 5 was applied to the 
response surfaces obtained from the batch 3 separation data. The results are 
shown below in Table 6.4. 
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Table 6.4:  A table detailing the transformation function for each curve 
coefficient for the system MEP HyperCel separating FAb fragments from batch 
3 derived crude periplasmic lysate.  In each case the bed height axis was 
multiplied by 2.  h: peak height (mAU), s: peak skew, w: peak width (mL), b: 
bed height (cm), f: linear velocity (cm/h), z: peak location (mL). 
For the justification of these functions see section 6.8.  The transformation 
functions for each curve coefficient are identical between batches 2 and 3, 
with the exception of the skew of peak 2.  The skew of the second peak is 
difficult to model in the MEP HyperCel gradient separation as a third peak 
does exist, but is usually very small and completely concealed by the second 
peak.  In the large bed height systems with slow flow rates this third peak 
can resolve, albeit poorly, after the second peak.  A user-inputted argument 
for the EMGCurveFitLSQBig algorithm for deconvolution of the chromatogram 
is the number and location of the peaks – if only two peaks are selected it will 
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consider the third peak to be part of the second peak and skew the second 
peak accordingly.  Therefore in this case the skew transformation function for 
peak can be considered an artefact. 
6.5.6 Chromatogram Comparison 
 
 
 
 
 
 
 
 
Figure 6.5:  Eight chromatograms comparing the predicted chromatogram 
directly with the reference large scale chromatogram, for the separation of a 
periplasmic lysate using MEP HyperCel.  Series : original large scale 
chromatogram, series : predicted chromatogram from transformed small 
scale data. A: 5cm bed height 50cm/h linear velocity,  B: 30cm bed height 
50cm/h linear velocity,  C: 15cm bed height 150cm/h linear velocity,  D: 30cm 
bed height 300cm/h linear velocity.  The value in the top right of each 
chromatogram overlay is the normalised root mean square value between the 
two chromatograms presented on the same axes. 
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A representative sample of large scale chromatograms and predicted 
chromatograms from the small scale data is shown in Figure 6.5.  Even for 
the most dissimilar result (30cm bed height, 300cm/hr) a normalised root 
mean square value of only 5.4% is observed, with all other results having a 
root mean square of under 5%.   
6.6 Validation Study Results and Discussion – 
 Change in Chromatographic Ligand 
Once it had been determined in section 6.5 that a change in the feedstock 
product titre does not affect the outputs of the methodology and the resulting 
transformation function, a more challenging validation study could be 
performed.  This involved implementing the same experimental system and 
the same feedstock, but utilising the mixed-mode PPA HyperCel instead of 
HCIC MEP HyperCel. 
6.6.1 Chromatogram Analysis 
Much higher resolution is observed at the lower linear velocities with the 
elution profiles obtained from the PPA HyperCel system, compared to the 
elution profiles obtained from the MEP HyperCel system as seen in sections 
4.4.3 and 6.5.2.  The number of visible peaks ranged from 3 (in 
chromatogram A in Figure 6.6) to 8 (in chromatogram B in Figure 6.6).  
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It is difficult for the EMGCurveFitLSQBig curve fitting deconvolution algorithm 
to accurately portray peaks that are very poorly resolved, therefore the peak 
limit is set at those visible in the least resolved chromatogram, A, with the 
analysed peaks numbered in Figure 6.6.  
 
 
 
 
 
 
 
Figure 6.6:  Four chromatograms demonstrating how the complete 
chromatogram changes between the opposing edges of the factorial design 
space.  The elution profiles were generated by the separation of FAb 
fragments from a periplasmic E. coli lysate using PPA HyperCel.  The variables 
were bed height and the linear velocity of both loading and elution steps.  
Relevant peaks are numbered for future reference in chromatogram A. A: 
Small scale 5cm bed height and 300cm/h linear velocity, B: Small scale 15cm 
bed height and 50cm/h linear velocity, C: Large scale 5cm bed height and 
300cm/h linear velocity,  D: 30cm bed height and 50cm/h linear velocity.   
It is demonstrated in Figure 6.7 that the FAb fragments are concentrated in 
peak 1 and peak 2 in a similar fashion to the MEP HyperCel separations.  This 
was further supported by the SDS-PAGE shown in Figure 6.8 which also 
demonstrates good qualitative purity of the separation for these conditions.  
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These results provide a good justification for restricting the deconvolution and 
mathematical analysis to the three peaks that are most relevant to the 
purification of the FAb fragments from the E. coli lysate. 
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Figure 6.7:  The elution profile of the separation of FAb fragment containing 
E. coli lysate using a pre-packed PRC PPA HyperCel chromatography column.  
Elution was performed by linear pH gradient (8.8-2.2) over 10CV.  Series : 
chromatogram 15cm bed height, 50cm/h linear velocity at PRC scale, series 
: - (second axis) Protein G HPLC data showing FAb concentration for each 
fraction.  The numbered peaks are the ones taken forward for mathematical 
analysis.   
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Figure 6.8:  A reducing SDS-PAGE showing the protein composition of peak 
fractions from the separation of FAb fragment containing E. coli lysate by PPA 
HyperCel in PRC pre-packed format.  Staining was by Coomassie blue and the 
marker was Benchmark pre-stained marker (Invitrogen). Conditions were 
15cm  bed height and 50cm/h linear velocity loading/elution.  M: Marker, F: 
Feedstock,  1: Peak 2,  2: Peak 1, 3: Peak 3. 
 
6.6.2 Curve Coefficient Data 
Table 6.5 below details the curve coefficients for all linear velocity and bed 
height conditions at both large and small scales. Response surfaces were 
produced from this data in the method described in sections 5.5.3-5.5.6, 
including the axis stretching and response surface averaging.  
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Scale LV BH Peak One Peak Two Peak Three 
   h (mAU) s w(mL) Z(ml) h (mAU) s w(mL) Z(ml) h (mAU) s w(mL) Z(ml) 
Small 50 5 680 0.45 1.06 36.5 706 1.45 0.79 39.6 527 4.55 1.38 43.9 
Small 100 5 659 0.26 0.57 23.1 643 0.61 0.36 24.7 488 2.31 0.88 26.5 
Small 150 5 1893 1.81 0.50 41.6 796 6.63 1.08 46.1 198 0.53 1.71 55.7 
Small 200 5 841 0.30 0.54 23.3 700 0.74 0.40 24.8 225 0.26 1.11 27.7 
Small 300 5 1077 0.47 0.68 37.6 512 0.40 0.98 40.8 470 2.57 1.70 43.8 
Small 100 10 1249 1.32 0.78 46.3 496 1.15 1.26 52.9 232 0.41 2.07 61.9 
Small 150 10 769 0.29 0.56 22.6 693 0.61 0.43 24.3 225 0.35 1.07 26.8 
Small 200 10 1173 0.97 0.62 36.3 609 1.87 0.94 39.6 273 0.42 1.41 46.3 
Small 300 10 763 0.72 2.10 47.0 843 2.55 1.22 52.7 414 2.23 2.40 61.3 
Small 50 15 785 0.40 0.64 23.1 751 0.96 0.42 24.7 541 2.62 0.85 26.7 
Small 100 15 702 0.55 1.11 36.6 504 1.97 1.00 40.1 212 0.49 1.86 46.8 
Small 150 15 771 0.69 1.48 46.9 473 1.95 1.40 51.9 206 0.59 2.13 61.6 
Small 200 15 952 0.99 0.61 22.7 654 1.30 0.40 24.6 473 2.71 0.88 26.7 
Small 300 15 723 0.73 1.53 36.5 860 1.74 0.83 40.4 521 3.75 1.66 45.1 
Large 50 5 992 1.64 1.16 47.0 549 1.74 1.19 53.1 217 0.43 2.41 62.2 
Large 300 10 1013 7.57 5.24 256 560 2.00 9.79 294 341 1.9 11.4 346 
Large 150 10 622 8.59 9.26 246 636 14.2 9.04 282 173 3.9 17.7 346 
Large 150 20 786 13.2 9.66 556 559 22.4 18.0 618 264 7.9 26.3 734 
Large 150 30 1484 21.9 8.46 656 467 15.8 15.4 726 279 12.1 19.9 945 
Large 200 30 1092 28.2 14.1 696 658 35.1 24.0 785 343 29.3 36.2 940 
Small scale error 23.8 0.03 0.03 0.68 9.21 0.11 0.03 0.80 10.1 0.10 0.04 1.0 
Large scale error 24.4 0.82 0.36 21.9 5.26 1.05 0.66 24.3 5.61 0.89 0.97 30.3 
Table 6.5:  Peak data for the chromatograms gained at variable bed heights (cm) and linear velocities (cm/h) for 
Batch 4 FAb fragment containing periplasmic lysate feedstock material, separated using PPA HyperCel 
chromatography sorbent.  Error was calculated by triplicate experiments (shown in red) to one standard 
deviation.
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6.6.3 Transformation Function 
The transformation function formulated in Chapter 5 was applied to the 
response surfaces obtained from the Batch 3 separation data.  The results are 
shown below in Table 6.6. 
Location
Width
Skew
Height
Peak ThreePeak TwoPeak One
Curve 
Coefficient
No change
21swb
0.9h + 275h
21swb 25swb
11w 18w
 
+ + 
 
3
30
f
w b
12z 16z ( ) ( )+18 250z b
f
 
Table 6.6:  A table detailing the transformation function for each curve 
coefficient for the system PPA HyperCel separating FAb fragments from batch 
4 derived crude lysate.  In each case the bed height axis was multiplied by 2.  
h: peak height, s: peak skew, w: peak width, b: bed height (cm), f: linear 
velocity (cm/h), z: peak location. 
It is clear from the transformation functions in Table 6.6 that there are major 
differences between the PPA HyperCel system and the MEP HyperCel system.  
In the case of the curve coefficients width and location the transformation 
functions were simpler for the PPA HyperCel model, involving a single numeric 
multiplier. In the case of the MEP HyperCel experimental system references to 
the linear velocity and bed height parameters were necessary to achieve 
acceptable accuracy within the function for these curve coefficients.  Peak  
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three required a relatively complex transformation function and did not give 
acceptably accurate prediction of the large scale peak; however it should be 
noted that the PPA HyperCel elution profile did contain a significant trail on 
the final peak which would have contributed to complex and potentially 
misleading outputs of the deconvolution of the third peak. 
6.4.6 Chromatogram Comparison  
A representative sample of large scale chromatograms and predicted 
chromatograms from the small scale data is shown in Figure 6.9.  The 
difficulties with elucidating a suitable transformation function for peak three is 
readily apparent in Figure 6.9, with the third peak being visibly very dissimilar 
between the predicted chromatogram and the experimentally derived one.  
However, the normalised root mean square values for the first two peaks in 
which the FAb fragments elute is lower than 2.5%, signifying a very accurate 
prediction.   
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Figure 6.9:  Eight chromatograms comparing the predicted chromatogram 
directly with the reference large scale chromatogram, for the separation of a 
periplasmic lysate using PPA HyperCel.  Series : original large scale 
chromatogram, series : predicted chromatogram from transformed small 
scale data. A: 5cm bed height 50cm/h linear velocity,  B: 30cm bed height 
50cm/h linear velocity,  C: 15cm bed height 150cm/h linear velocity,  D: 30cm 
bed height 300cm/h linear velocity.  The value in the top right of each 
chromatogram overlay is the normalised root mean square value between the 
two chromatograms presented on the same axes. 
 
6.7 Validation Study Results and Discussion – 
 Change of Ligand, Sorbent Backbone and 
 Feedstock 
This validation study investigated the effects of a multi-variate change in 
experimental parameters and evaluated whether the ultra scale-down 
methodology, which was developed on a different chromatographic platform, 
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would be effective under these conditions.  This study involved a change of 
sorbent to a CM ion exchange ligand with a ceramic backbone and a change 
of feedstock to an IgG spiked egg white.  The target molecule class (an 
immunoglobulin/immunoglobulin fragment) and the column presentation (Pall 
PRC) remained the same as in the previous two studies. 
6.7.1 Chromatogram analysis 
 
 
 
 
 
 
 
 
Figure 6.10:  Four chromatograms demonstrating how the complete 
chromatogram changes between the opposing edges of the factorial design 
space.  The elution profiles were generated by the separation of IgG spiked 
egg white using CM Ceramic HyperD.  The variables were bed height and the 
linear velocity of both loading and elution steps.  Relevant peaks are 
numbered for future reference in chromatogram A. A: Small scale 15cm bed 
height and 50cm/h linear velocity, B: Small scale 5cm bed height and 
300cm/h linear velocity, C: Large scale 30cm bed height and 50cm/h linear 
velocity,  D: Large scale 10cm bed height and 300cm/h linear velocity.   
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The separation of bovine IgG4 from hen’s egg white produced a clear elution 
profile with 2 main peaks that were well resolved from each other.  Peak 1 is 
shown (by Protein G HPLC) in Figure 6.11 to contain the majority of the IgG, 
although the antibody does elute over 0.5 CV prior to peak 1.  Although 
Figure 6.12 demonstrates that this elution profile is not a particularly effective 
separation the two main peaks are well defined and change in shape and size 
as the bed height/linear velocity variables are altered.  As such the separation 
was deemed suitable for this validation study.  
 
 
 
 
 
 
 
Figure 6.11:  The elution profile of the separation of FAb fragment containing 
E. coli lysate on a pre-packed PRC CM Ceramic HyperD chromatography 
column.  Elution was performed by linear NaCl gradient (0-1M) over 10CV.  
Series : chromatogram 15cm bed height, 50cm/h linear velocity at PRC 
scale, series : - (second axis) Protein G HPLC data showing FAb 
concentration for each fraction.   
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Figure 6.12:  A reducing SDS-PAGE showing the protein composition of the 
peak fractions from the separation of IgG spiked egg white by CM Ceramic 
HyperD in PRC pre-packed format.  Conditions were 15cm bed height and 
50cm/h linear velocity loading/elution.  Staining was with Coomassie blue.  
Key: 1: Peak eluted at 1.1 CV, 2: First half of peak 1, 3: Second half of peak 
1, 4: Peak 2, 5/6: NaOH cleaning peaks, 7: Marker. 
6.7.2 Curve Coefficient Data 
Table 6.7 below details the curve coefficients for all the linear velocity and 
bed height conditions investigated at both large and small scales. Response 
surfaces were produced from this data by the method developed in sections 
5.5.3-5.5.6, including the axis stretching and response surface averaging. 
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Scale LV BH 
Peak One Peak Two 
h 
(mAU) s 
w 
(mL) z (mL) 
h 
(mAU) s 
w 
(mL) 
z 
(mL) 
Small 5 50 1220 0.40 0.12 8.81 629 0.40 0.12 11.1 
Small 5 100 788 0.40 0.28 8.20 482 0.40 0.27 10.7 
Small 5 150 1118 0.40 0.15 8.45 344 0.40 0.25 10.8 
Small 5 200 755 0.41 0.22 9.40 226 0.45 0.34 11.7 
Small 5 300 1127 0.40 0.21 9.42 552 0.40 0.32 11.8 
Small 10 50 931 0.40 0.51 20.8 1743 0.40 0.22 24.9 
Small 10 150 607 0.40 0.80 15.4 865 0.65 0.33 19.8 
Small 10 300 1718 0.65 0.31 16.2 740 0.64 0.43 20.7 
Small 15 50 3507 0.61 0.27 25.2 1611 0.55 0.28 30.6 
Small 15 100 3030 0.77 0.31 23.4 1320 0.54 0.37 29.3 
Small 15 150 3349 0.81 0.35 34.1 1438 0.65 0.46 40.2 
Small 15 200 2862 0.81 0.34 23.6 1063 0.64 0.48 29.6 
Small 15 300 2677 0.79 0.31 22.9 903 0.69 0.53 28.9 
Large 10 50 5455 5.82 2.56 131 2830 3.49 2.24 176 
Large 10 300 4600 7.53 3.05 128 1303 7.29 5.26 177 
Large 20 150 5822 11.2 4.07 198 2606 6.41 4.75 280 
Large 30 50 4644 11.9 7.43 290 3270 3.55 5.07 424 
Large 30 300 6750 18.4 5.52 276 2358 9.79 7.81 406 
Small scale error 83.8 0.01 0.01 0.64 37.5 0.01 0.01 0.76 
Large Scale Error 178 0.97 0.40 15.4 147 0.53 0.40 23.9 
Table 6.7:  The curve coefficients generated for each peak from the elution 
profile of IgG spiked egg white separated using CM Ceramic HyperD, 
regarding the chromatograms gained at variable bed heights (cm) and linear 
velocities (cm/h).  Error for each curve coefficient was calculated by triplicate 
experiments (shown in red) to 1 standard deviation. 
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6.7.3 Transformation Function 
Curve 
Coefficient Peak One Peak Two
Height
Skew
Width
Location
4000h + 2 600h +
25swb ( )300 20sw −
* 3 1
3
b
w
 
+ 
 
12.5
10
b
w
 
+  
 
10z ( )1.1 37.5z b +
Table 6.8:  A table detailing the transformation function for each curve 
coefficient for the system CM Ceramic HyperD separating bovine IgG spiked 
egg white.  In each case the bed height axis was multiplied by 2.  h: peak 
height, s: peak skew, w: peak width, b: bed height (cm), f: linear velocity 
(cm/h), z: peak location (mL). 
 
The transformation functions for the curve coefficients shown in Table 6.8 are 
again very different to both the MEP HyperCel and PPA HyperCel experimental 
systems.  However, as shown in Figure 6.13, the above transformation 
functions produce a very accurate prediction of large scale chromatographic 
behaviour.   
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Figure 6.13:  Eight chromatograms comparing the predicted chromatogram 
directly with the reference large scale chromatogram, for the separation of 
bovine IgG spiked egg white using CM Ceramic HyperD.  Series : original 
large scale chromatogram, series : predicted chromatogram from 
transformed small scale data. A: 5cm bed height 50cm/h linear velocity,  B: 
30cm bed height 50cm/h linear velocity,  C: 15cm bed height 150cm/h linear 
velocity,  D: 30cm bed height 300cm/h linear velocity.  The value in the top 
right of each chromatogram overlay is the normalised root mean square value 
between the two chromatograms presented on the same axes. 
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6.8 Conclusions 
The objective of this chapter was to challenge and validate the ultra scale-
down methodology and transformation functions as developed in Chapter 5 
by its application to different experimental systems.  The different 
experimental systems consisted of a reduction in product titre, a change of 
the chromatographic ligand to PPA and a multi-variate change that altered the 
chromatographic ligand, the feedstock and the sorbent backbone material. 
6.8.1 Validation Study – Reduction in Product Titre 
It is apparent from the results that reducing the product concentration by 
50% in the feed has very little effect on how the curve coefficients change 
between small and large scales, allowing interchangeable use of the 
transformation function formed in Chapter 5.  This can be explained as to the 
nature of the process change; it has been postulated that the major changes 
in elution profile are seen through hydrodynamic and geometric effects, such 
as changing linear velocity conditions and bed height.  Other than potential 
changes to the viscosity of the feed product titre, the change is purely 
chemical in nature and as the total quantities of FAb loaded in both data sets 
was identical the difference between the chromatograms at small and large 
scale was kept constant.  However, it was essential to extensively test the 
effects a reduction in product titre would have on the outputs of the scale-
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down methodology, otherwise batch to batch variability of feedstock would 
render any validation study very difficult to analyse.   
6.8.2 Validation Study – Change of Chromatographic Ligand 
It was not possible to apply directly the transformation function obtained from 
the MEP HyperCel separation study to the PPA HyperCel study.  This implies 
that the functions are not totally generic for different chromatographic 
ligands, although some of the curve coefficients do exhibit limited correlations 
between experimental systems (see Section 6.8.5).  However, the new set of 
transformation functions formed for the PPA HyperCel experimental system  
proved to give excellent prediction capability between large and small scales 
for the two critical peaks that contain the target FAb fragments. 
Changing the chromatographic ligand produces a complex chromatogram, 
which is only fully resolved at the largest bed heights and slowest linear 
velocities.  The presence of unresolved chromatographic peaks under the 
three main peaks analysed in the study would have significant effects on the 
curve coefficients and therefore the transformation functions required for the 
translation of small scale data into large scale predictive data.  A potential 
solution to this problem would be for the deconvolution algorithm to take the 
number of peaks seen in the highest resolution chromatogram (8 in this case, 
as seen in the 50cmh/h linear velocity/30cm bed height elution profile) and 
extrapolate the peak positions to the less resolved chromatograms.  This 
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would however be an extrapolated figure and as such would introduce an 
uncertainty into the algorithm outputs that would be difficult to validate.  
6.8.3 Validation Study – Change of Ligand, Sorbent Backbone 
 and Feedstock 
The objective of this study was to investigate whether the ultra scale-down 
methodology and set of curve coefficient transformation functions described 
in Chapter 5 could be applied to a very dissimilar chromatography separation 
platform, where this change involves multiple responses.  In this case the 
changes included a change of sorbent backbone , a change in ligand class 
and a change in feedstock.  The translation was partially successful in that 
the ultra-scale down methodology was capable of producing a set of 
transformation functions that gave a good prediction of large scale elution 
profiles from a small scale data set.  However, the transformation functions 
that were produced with the MEP HyperCel/FAb fragment containing lysate 
experimental system proved to be highly unique to the system, with a new 
set of transformation functions required to produce an accurate 
chromatographic prediction. 
6.8.4 The Validation of the Ultra-Scale Down Methodology 
The validation of the ultra scale-down method methodology as described in 
Chapter 5 can be considered successful.  The same methodology and 
algorithm set as utilised in Chapter 5 successfully deconvoluted the elution 
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profiles seen in the MEP HyperCel,  PPA HyperCel and the CM Ceramic 
HyperD experimental systems and allowed the production of transformation 
functions for the translation of small scale curve coefficients into their large 
scale equivalents with a high degree of accuracy.   
6.8.5 Correlation of Transformation Functions 
It was deemed necessary for the transformation functions to utilise the 
hydrodynamic experimental parameters (the bed height and the linear 
velocity) if at all possible.  The response surfaces graphically represented how 
the bed height, linear velocity and curve coefficient values were related and 
as such the transformation function would need to include these arguments.  
This however was not necessary when the transformation function was a 
simple multiplier, as seen in the function for peak one location in all three 
studies. 
There was a significant difference in the transformation functions for peak 
one, peak two and (in the case of the PPA HyperCel experimental system) 
peak three.  It was observed that the transformation functions were simpler 
and generally contained far fewer terms for peak one compared to peaks two 
and three, and there could be a number of reasons for this.  Peak one in all 
cases was the largest and best resolved peak, and as such higher accuracy of 
the deconvolution function could be expected.  Also, peaks two and three are 
in someway dependent on the data for peak one, depending on the resolution 
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of the chromatogram and how severely peak one is skewed down the elution 
profile.  This would mean that the relationship between the small and large 
scale curve coefficients would be more complicated for peaks two and three 
and the transformation functions would need to reflect that.   
The transformation functions were developed for accuracy rather than 
simplicity, as a key objective was to mimic a large scale chromatogram with 
small scale data as closely as possible.  Many of the numerical terms in the 
transformation functions are for “fine tuning” to ensure this accuracy and 
could be dropped if a slightly less accurate chromatographic mimic was 
acceptable.   
It is clear that the transformation functions are not entirely generic and there 
are significant differences observed between experimental systems.  
However, there are some correlations that can be drawn, particularly with the 
target molecule elution peak (peak one).   
As far as correlations between small and large scale data are concerned, skew 
can be predicted on the basis of the skew curve coefficient itself, the width 
curve coefficient and, unexpectedly, the bed height.  The linear velocity is 
critical for determining how skewed a chromatographic peak will be, but it is 
constant as far as scaling from small to large scales are concerned.   The only 
difference between the experimental systems is the multiplier that is required. 
Peak location showed strong connections between experimental systems, at 
least for the first peak.  This was logical as the elution volume is dependent 
205 
 
almost entirely on column volume.  It was however very difficult to provide 
linking correlations for peaks two and three. 
Peak height also seemed to have little obvious correlation between the 
experimental systems, ranging from a simple multiplier, a fixed increase or 
even no change between small scale and large scale.  Peak width was similar 
to peak height, in that the transformation function required a complex 
association of numbers, the bed height parameter and the flow rate 
parameter, and was therefore dissimilar between experimental systems. 
This analysis was not designed to be exhaustive and there would be 
numerous ways in which the available parameters could be manipulated to 
produce a more generic set of transformation functions that had additional 
applicability between experimental systems.  This analysis would be facilitated 
by additional data sets from other experimental systems and additional 
mathematical analysis on the existing data sets, and as such would be 
suitable for future work.   
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7 Business Case 
7.1 Product Development and Intellectual Property 
The ultra scale-down methodology developed in this thesis represents a 
proven method but not a tangible product.  As such there are a number of 
options concerning its potential commercialisation.  The commercialisation 
could expose the methodology and algorithms to potential reverse-
engineering, and as such protection of the associated intellectual property will 
be critical for any long term marketing strategy. 
As discussed in future work, the scale-down methodology developed in this 
thesis is not complete and can instead be considered a beta prototype.  As 
the transformation functions are still broadly system specific this limits 
potential commercial uptake – further work to produce more generic 
transformation functions that are applicable across a range of 
chromatography systems and feedstocks would be required to ensure the 
methodology is suitable for a customer’s needs. 
7.2 Software Development 
The methodology and transformation function could not be marketed in its 
current form.  Matlab is currently required for all the algorithms that are run, 
not including the response surface averaging function which was written in 
MS Excel.  Other than the requirement for specific and expensive software, 
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the interface is not user friendly or self-explanatory.  As such there would be 
a requirement for a polished and user-accessible front end to facilitate the use 
of the methodology and also to conceal proprietary algorithms that are key to 
the effectiveness of the ultra scale-down methodology.  
It can however be expected that a potential client will have MS Excel, as the 
MS Office suite is ubiquitous amongst many computing platforms.  
Mathworks, the developers of the Matlab application, also produce a plug-in 
for Excel that will allow code in M file format to run natively within the Excel 
system.  With some development this could be integrated into an Excel macro 
to provide a user friendly experience that will generate the required outputs.   
Ideally the only user input the Excel macro would need is the 
chromatographic data itself, identification of the peak locations and the 
operating parameters such as linear velocity, bed height and sorbent ligand 
class, manipulated via a GUI.   
7.3 Pre-Packed PRC Chromatography Columns and 
 Integrated System Solutions 
It is unlikely that the marketing of the ultra scale-down methodology software 
package on its own would be successful as it would be difficult to integrate it 
with the client’s existing equipment.  However, the methodology was 
developed utilising a Pall Life Sciences product, the PRC pre-packed 
chromatography columns, which are commercially available.   
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It would therefore be logical to market the USD methodology software and 
the PRC chromatography columns together as an integrated unit.  This would 
also restrict the quality testing required of the software to Pall Life Science 
products only, rather than having to validate the software with competing 
chromatography products.   
The cost of goods for the USD methodology software would be difficult to 
ascertain from a development perspective, but actual production and 
maintenance would be inexpensive.  Some training would be required of 
technical support departments to handle technical enquiries with the software 
and there would need to be some support of the licensing model in the long 
term, but compared to the manufacture of a quality controlled precision 
product the ongoing costs are negligible.   
It is envisaged then that the USD methodology software would be used as an 
intellectual loss leader for the PRC pre-packed chromatography columns 
themselves.  Once the software system is in use with a client and satisfactory 
results are gained it would be very difficult to use a competitor’s 
chromatography products without the risk of losing the effectiveness of the 
USD methodology software. 
From a very long term perspective the PRC columns and the USD 
methodology software could be part of an integrated systems approach to 
downstream processing of biologics, where the software and it’s associated 
products are implemented as a “service” from Pall Life Sciences regarding the 
scale up of all unit operations.  Being able to offer an integrated system and 
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product solution to minimise time and resources required for downstream 
scale up, rather than a combination of various non-integrated products, would 
be extremely attractive to clients involved heavily in downstream process 
development.   
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8 Future work 
This thesis has a structured narrative but many of the earlier chapters can be 
considered to be self-contained.  As such future work will be considered on a 
chapter by chapter basis, followed by a section for future work on the thesis 
as a whole. 
8.1 Chapter 2 – Feedstock Selection 
A number of other potential feedstocks could be utilised as model feeds.  The 
other possibilities considered were:  
• CHO cell line supernatant: CHO cell lines have become very common 
hosts in bioprocessing as the cell lines are well characterised and can 
perform complex post-translational modifications to a recombinant 
protein product, including complex glycosylation.   
• E. coli homogenate: The periplasmic lysate utilised as a feedstock in 
Chapters 5 and 6 has considerably fewer contaminants than a typical 
E. coli homogenate, making for a less complex separation.   
8.2 Chapter 3 – Small Scale Device Selection 
There are a large number of manufacturers of very small chromatography 
columns, with a range of sorbents and columns designs.  These are mostly, in 
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essence, very similar to the columns investigated within Chapter 3 so further 
work would be unlikely to be needed if different commercial designs were to 
be used.    
8.3 Chapter 4 – Separation of FAb Fragments by 
 Mixed-Mode Chromatography 
This chapter is essentially a methods chapter, similar to an industrial 
investigation to optimise a downstream chromatography process for a new 
product.  The chapter however only investigated the separation to a level of 
detail sufficient to provide a robust model system for use in the ultra scale-
down methodology development in Chapter 5 and 6, rather than a fully 
optimised process.   
The investigation in Chapter 4 concluded that PPA HyperCel would be the 
most suitable mixed-mode sorbent for the separation of FAb fragments from 
a crude E. coli periplasmic lysate.  Further pertinent work would be in 
applying Quality by Design principles to further optimise this separation as 
regards linear velocities, loading buffer pH and composition and modifications 
of the feed, such as the addition of differing concentrations of ammonium 
sulphate.  The ultra scale-down methodology developed in Chapter 5 could be 
well used to this effect. 
An investigation into a different feedstock would also be very relevant, for 
example the aforementioned CHO cell supernatant containing an intact IgG, 
rather than an antibody fragment. 
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8.4 Chapter 5 - Formulation of an Ultra Scale-Down  
 Methodology for Chromatography Scale-Up 
There would be two sections to the future work to this chapter. 
8.4.1 Experimental Ultra Scale-Down Methodology 
The concept of the ultra scale-down methodology was shown to be sound in 
the form described in Chapter 5.  Future work would therefore concern 
expansion of this concept to other parameters rather than just bed height and 
linear velocity.  This could involve operational decisions, such as buffer 
conditions, gradient length, feed processing and ligand selection.  The 
eventual aim would be to input all critical quality attributes (CQAs) into the 
methodology and allow the entire chromatographic development and 
optimisation process to be initiated at very small scales, with progression to 
large scales only for validation. 
8.4.2 Transformation Functions 
As described in Chapter 6, the transformation functions are not entirely 
generic and contain components unique to each experimental system.  
Further mathematical analysis could potentially identify important correlations 
within this data and harmonise more of the components within the 
transformation functions for each experimental system.  This most likely 
would require more validation data sets, as mentioned in the next section. 
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8.5 Validation of Methodology and Model for the 
 Ultra Scale-Down of Elution Chromatography 
There are currently four different data sets to which the ultra scale-down 
methodology has been applied.  The addition of extra data sets would further 
validate the ultra scale-down methodology itself.  This would also provide 
more data for the optimisation of the transformation functions. 
The extra validation studies would have to focus on uni-variate studies to fully 
understand how each chromatographic parameter affects the scale up within 
the methodology.  Now that the methodology has been validated with a 
complex feed, a synthetic feed of four analytical grade proteins (for example 
the major proteins in egg white, but pre-purified and purchased from Sigma) 
would allow clearer analysis of the relationships, as the experimental error 
from the non-protein contaminants would be reduced.   
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9 Appendices  
9.1 Appendix 1 - MatLab Algorithms Code (all code   
provided by S. Edwards-Parton, UCL, London, 
UK) 
9.1.1 Deconvolution Algorithm (EMGCurveFitLSQBig) 
 
function [Peaks, VerticalData]=EMGCurveFitLSQBIG(XAxis, Curve, 
NoPeaks, KnownPos); 
%function [Peaks, VerticalData]=EMGCurveFit(XAxis, Curve, NoPeaks, 
KnownPos); 
%known pos specifies which curves if any you have a known location 
for, if %you know 3 peak location of 1 4 10 then known pos should be 
[1 4 10], %program will then ask you to make guesses on the rest 
  
flag_reduce=0; 
  
%if max(XAxis)>100 
%    XAxis=XAxis/100; 
%    flag_reduce=1; 
%end 
     
%how many do we know 
[NoKnownPeak IGNORE]=size(KnownPos); 
  
Maximums=[]; 
  
for i=1:NoKnownPeak 
    Maximums(i)=KnownPos(i); 
end 
  
if NoKnownPeak<NoPeaks 
for i=1:NoPeaks-NoKnownPeak 
    %get user to select remaining peaks 
    figure 
    plot(XAxis, Curve, 'r', XAxis(Maximums), Curve(Maximums), 'bo'); 
    [Points]=ginput(1); 
    [Distance, Points]=findnearest(Points, [XAxis Curve]); 
    Maximums=[Maximums find(XAxis==Points(1))]; 
    close 
end 
end 
LowerWZ=XAxis(2); 
UpperWZ=max(XAxis)*1; 
  
PeakMove=max(XAxis); 
  
for i=1:NoPeaks 
    h=Curve(Maximums(i));%'h 
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width(1)=(XAxis(max(find(Curve(1:Maximums(i))<Curve(Maximums(i))*0.6)
))-XAxis(Maximums(i))); %low curve width 
    
width(2)=(XAxis(Maximums(i)+min(find(Curve(Maximums(i):length(XAxis))
<Curve(Maximums(i))*0.6)))-XAxis(Maximums(i))); %low point of curve 
  
    StartPoint((i-1)*4+1)=h*1.5; 
    StartPoint((i-1)*4+2)=2;  %s 
%    StartPoint((i-
1)*4+2)=max([2*min(abs(width))*abs(width(2)/width(1)) 1]); %s 
  
    StartPoint((i-1)*4+3)=min(abs(width)); %w    
    StartPoint((i-1)*4+4)=XAxis(Maximums(i))-min(abs(width)); % %z 
     
    Lower((i-1)*4+1)=Curve(Maximums(i))*0.5; 
    Lower((i-1)*4+2)=0.2*StartPoint((i-1)*4+2); %s  
    Lower((i-1)*4+3)=min(abs(width))*0.01; %w 
    Lower((i-1)*4+4)=XAxis(Maximums(i))-max(abs(width))*2; %z 
  
     
    Upper((i-1)*4+1)=Curve(Maximums(i))*4; 
    Upper((i-1)*4+2)=100; %s 
    Upper((i-1)*4+3)=min(abs(width))*2; %w 
    Upper((i-1)*4+4)=XAxis(Maximums(i))+max(abs(width))*2; %z 
     
end 
StartPoint 
Lower 
Upper 
  
Options=Optimset; 
Options.MaxFunEvals=48000; 
Options.TolX=1e-17; 
Options.TolFun=1e-17; 
 x = lsqcurvefit(@EMG2, StartPoint, XAxis , Curve, Lower, Upper, 
Options) 
  
VerticalData=x; 
  
for i=1:NoPeaks 
         
    Peaks(:,i)=EMG2(x( ((i-1)*4+1) : ((i-1)*4+4) ), XAxis); 
    if flag_reduce==1 
        VerticalData((i-1)*4+3)=VerticalData((i-1)*4+3)*10; 
    end 
  
end 
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9.1.2 Peak Locator (Findnearest) 
 
function [Distance, Points]=FindNearest(Points, Data) 
%function [Distance, Points]=FindNearest(Points, Data) 
%finds the nearest actual point from Data to Points 
  
%find x and y points on curve that match x and y points from click 
%selection 
  
%VariableDeclare=   {'VariableDeclare' 'ans' ... %Standard info 
%                    'Points' ... %input of rough points to find 
nearest from  
                                 %and output variable giving nearest 
points based on Data 
%                    'Data' ... %list of all known points 
%                    'XNearest' ... %Nearest points on X axis 
%                    'YNearest' ... %Nearest points based on Y axis 
%                    'YPoint', 'XPoint' ... %Corresponding complete 
point data for XNearest and YNearest 
%                    'YDist', 'XDist' ... %Distance of these points 
from Points variable 
%                    } 
  
[XNearest]=Nearest(Data(:,1)', Points(1)); 
[YNearest]=Nearest(Data(:,2)', Points(2)); 
  
%set two pairing pointy and point x that are based on nearest x and y 
vals 
%(could be same points but easier to assume there not rather than 
check and 
%then process) 
YPoint=Data(find(Data(:,2)==YNearest),:); 
XPoint=Data(find(Data(:,1)==XNearest),:); 
  
%Find distance to original point for each of these 
YDist=(((YPoint(1)-Points(1))^2)+((YPoint(2)-Points(2))^2))^(0.5); 
XDist=(((XPoint(1)-Points(1))^2)+((XPoint(2)-Points(2))^2))^(0.5); 
  
%take points with smallest distance 
if YDist<=XDist 
    Points=YPoint; 
    Distance=YDist; 
else 
    Points=XPoint; 
    Distance=XDist; 
end 
  
%VariableCheck(who,VariableDeclare); 
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9.1.3 Nearest (sub-procedure of Findnearest) 
 
function NearestValue = Nearest(Numbers,PinPoints) 
% 
% NEAREST Find nearest values to the pin points provided. 
% 
%   Example: If a = 0:0.01:1; b = sin(2*a*pi); plot(a,b) 
% 
%            then nearest(b,[-0.5 0 0.25 2]) is [-0.4818 0 0.2487 
1.0000]. 
% 
%   See also FIND. 
  
%   Copyright (c) 2000- by Heekwan Lee (heekwan.lee@reading.ac.uk) 
%   $Revision: 1.1 $  $Date: 2000/04/16 16:17:18 $ 
  
  
if nargin < 2 
   NearestValue = []; 
   return 
end 
  
  
Numbers = real(Numbers); 
Pins = length(PinPoints); 
  
Max = max(Numbers); 
Min = min(Numbers); 
  
for iPin = 1:Pins 
    
   if PinPoints(iPin) > Max 
      NearestValue(iPin) = Max; 
   elseif PinPoints(iPin) < Min 
      NearestValue(iPin) = Min; 
   else 
      nul = abs(Numbers - PinPoints(iPin)); 
      iValue = find(nul==min(nul)); 
      NearestValue(iPin) = Numbers(iValue); 
   end 
    
end 
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9.1.4 PlotIt (Plots chromatographic peaks from curve 
 coefficients) 
 
 
function Y=PlotIt(XAxis, CurveData, Peaks, Type); 
%function Y=PlotIt(XAxis, CurveData, Peaks, Type); 
  
for i=1:Peaks 
    StartP=(i-1)*4; 
    switch upper(Type) 
  
    case 'EMG' 
        Y(:,i)=EMG2(CurveData(StartP+1:StartP+4), XAxis); 
    case 'GAUSSIAN' 
        Y(:,i)=Gaussian(XAxis, CurveData(StartP+1), 
CurveData(StartP+2), CurveData(StartP+3)); 
    case 'LOGNORMAL' 
        Y(:,i)=LogNormal(XAxis, CurveData(StartP+1), 
CurveData(StartP+2), CurveData(StartP+3), CurveData(StartP+4)); 
    otherwise 
        Y=[]; 
        disp('No curve mathc function found'); 
    end 
  
end 
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9.1.5 EMG (Incorporates the EMG equation) 
 
function [Y]=EMG(x, xdata); %x is coefficients xdata is the xaxis 
%[Y]=EMG(x, xdata);  
%x is coefficients xdata is the xaxis 
 
[rows cols]=size(x); 
 
if mod(rows,4)~=0 
    error('GAH wrong number of coefficients') 
end 
     
nocurves=rows/4; 
 
 
if (s<0.01) && (s > (-0.01)) 
    if s>0 
        s=0.01; 
    else 
        s=-0.01; 
    end 
end 
     
Section1=((h.*w)./abs(s)).*((pi/2)^0.5); 
 
Section2=((0.5*(w.^2))./(s.^2))   -   ((X-z)./s); 
 
Section3=(2^(-0.5)); 
 
Section4=((w./abs(s))   -   (((X-z)./w).*(s./abs(s)))); 
 
Y=Section1.*exp(Section2).*(1-erf(Section3.*(Section4))); 
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9.2 Appendix 2 – Response Surfaces 
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